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Lung cancer
Each year, 1.8 million people around the world receive a lung cancer diagnosis (Bray 
et al. 2013). In Western countries incidence rates among males continue to decline 
and there is evidence that the increasing rates among females are starting to plateau 
(Lortet-Tieulent et al. 2015; Youlden, Cramb & Baade 2008), reflecting previous trends 
in smoking prevalence. With continuing endemic smoking in many less developed 
countries, increases in incidence are expected to continue. In the Netherlands, around 
6900 males and 5300 females are yearly diagnosed with lung cancer (IKNL 2016). 
In contrast to the improved survival outcomes for many other types of  cancers, the 
prognosis for lung cancer patients remains poor (Youlden, Cramb & Baade 2008). As 
the majority of  patients (75%) present with locally advanced or metastatic disease at 
time of  diagnosis (Morgensztern et al. 2010; Van der Drift et al. 2012), only a small 
percentage of  lung cancer patients survive the first year after diagnosis. With the 
refinement and application of  new (combined) treatment options, the 5-year survival 
rate has improved from 15% to 18% in the last 20 years (Van der Drift et al. 2012; 
IKNL 2016). This rate is considerably lower than in other major cancer types, such 
as breast (90%), prostate (99%), and colorectal cancer (65%) (Howlader et al. 2015). 
The high incidence combined with the poor prognosis makes lung cancer the leading 
cause of  death by cancer worldwide, accounting for 1.6 million cancer deaths annually 
(approximately 20% of  all cancer deaths) (Ferlay et al. 2014). In the Netherlands, 
around 6200 males and 4200 females die from lung cancer each year (IKNL 2016).
Besides facing a poor prognosis, lung cancer patients often suffer from severe physical 
symptoms, such as problems with breathing, pain, fatigue and coughing (Tishelman 
et al. 2005). Patients also endure intensive treatments, such as surgery, chemo-, radio-, 
targeted  and immunotherapy (Van der Drift et al. 2012). In addition, due to the 
strong relationship between smoking and lung cancer, patients need to cope with the 
social stigma associated with lung cancer, which can result in feelings of  guilt and 
self-blame (Chambers, Dunn et al. 2012; Chapple, Ziebland & McPherson 2004). 
Globally, lung cancer ranks number 20 of  conditions with the highest disease burden 
(WHO 2012). In the Netherlands and other Western countries lung cancer is ranked 
number 5 of  most burdensome diseases.
Psychological distress in lung cancer patients
Overall, approximately one-third of  cancer patients experience significant levels of  
psychological distress (Carlson et al. 2004). The National Comprehensive Cancer 
Network (2016) has defined distress as “a multi-factorial unpleasant emotional experience 
of  a psychological (i.e. cognitive, behavioral, emotional), social, and/or spiritual nature that may 
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interfere with the ability to cope effectively with cancer, its physical symptoms, and its treatment. 
Distress extends along a continuum, ranging from common normal feelings of  vulnerability, sadness 
and fears to problems that can become disabling, such as depression, anxiety, panic, social isolation, 
and existential and spiritual crisis.”
Several studies have shown that lung cancer patients report among the highest rates 
of  distress (43-62%) of  all cancer patients (Carlson et al. 2004; Zabora et al. 2001; 
Graves et al. 2007). In a general community sample of  cancer patients, Gao and 
colleagues (2010) showed that psychological distress appeared to be three times more 
common in lung cancer than in other types of  cancer. In approximately 19% of  lung 
cancer patients psychological distress is so severe the symptoms meet the criteria of  
a psychiatric disorder, with depressive disorders (5-15%) and adjustment disorders 
(14%) being most common (Akechi et al. 2001; Uchitomi et al. 2000; Walker, Hansen, 
Martin, Symeonides, Ramessur et al. 2014). A survey of  21,151 cancer patients 
(including 4361 lung cancer patients) revealed that lung cancer patients reported the 
highest rates of  depressive disorders (13%) (Walker, Hansen, Martin, Symeonides, 
Ramessur et al. 2014). 
Psychological distress and psychiatric morbidity in cancer patients have been 
associated with several incapacitating factors, such as decreased quality of  life (Chen 
et al. 2015), decreased compliance with medical care (Colleoni et al. 2000; Greer et 
al. 2008), prolonged hospital stay (Prieto et al. 2002) and increased health care costs 
(Egede 2007). A meta-analysis including 43 prospective studies concluded that, while 
controlling for prognostic somatic factors, a diagnosis of  depression and self-reported 
higher levels of  depressive symptoms were associated with mortality in cancer patients 
(risk ratio 1.22) (Pinquart & Duberstein 2010).
Psychological distress in partners 
Close others and in particular life partners of  patients are also emotionally affected 
by the patient’s lung cancer. Partners are often burdened with the role of  informal 
caregiver. They face significant role transitions and the responsibilities of  managing 
the patients’ needs (Mosher et al. 2013). At the same time, they are confronted with 
the fear of  potentially losing their life partner and may feel overwhelmed by grief  
and sadness while watching their loved one suffer. In fact, they report similar rates 
of  psychological distress as patients (Mosher, Bakas & Champion 2013; Ostlund et 
al. 2010). The prevalence of  psychiatric disorders in partners of  cancer patients is 
approximately 13 to 38%, with anxiety disorders being most common (Bambauer et 
al. 2006; Drabe et al. 2008; Vanderwerker et al. 2005). 
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In partners, psychological distress and psychiatric morbidity has also been linked to 
several debilitating factors, such as decreased quality of  life (Drabe et al. 2008; Ostlund 
et al. 2007), poor immune functioning (Rohleder et al. 2009), marital dissatisfaction 
(Pitceathly & Maguire 2003), and prolonged grief  after the patient’s death (Thomas 
et al. 2014). Moreover, in a cohort study of  392 older caregivers, those who reported 
distress associated with caregiving had a 63% higher mortality risk than non-caregiver 
controls (Schulz & Beach 1999). 
The partner relationship
The vast majority of  studies has examined the factors associated with psychological 
distress separately for lung cancer patients and their partners. However, the challenges 
and stressors of  the cancer experiences that affect patients and partners are situated 
within a larger relationship context (Manne & Badr 2008). The cancer can challenge 
couples’ established roles, responsibilities and interaction patterns. While some 
couples report the cancer has brought them closer together, others report adjustment 
problems resulting in more interpersonal conflicts and decreased relationship 
satisfaction (Karraker & Latham 2015). 
Importantly, partners in long-term relationships mutually affect one another (Kelley 
& Thibaut 1978). In couples coping with lung cancer, the coping of  the patient 
presumably affects the extent to which the partner is able to cope, and vice versa. 
A meta-analysis of  35 studies, including 2468 couples coping with various types of  
cancer revealed that psychological distress levels of  cancer patients and their partners 
are moderately associated with one another (r = .29) (Hagedoorn et al. 2008). In 
lung cancer, a longitudinal dyadic study showed that several risk factors (giving up 
the attempt to cope, blaming the patient for having cancer, caregiver-related health 
problems) affected one’s own and often the other partner’s psychological distress (Badr 
& Carmack Taylor 2008; Carmack Taylor et al. 2008; Milbury, Badr & Carmack 
2012; Milbury et al. 2013). With regard to psychiatric morbidity, a dyadic study with 
advanced cancer patient-caregiver dyads demonstrated that when caregivers met the 
criteria for a psychiatric disorder, patients were 7.9 times more likely to meet the 
criteria of  a psychiatric disorder, and vice versa (Bambauer et al. 2006). These findings 
support the notion that couples coping with cancer respond as an interdependent 
emotional system rather than as two separate individuals (Hagedoorn et al. 2008), 
emphasizing the importance of  including both the patient and the partner when 
examining (and potentially treating) psychological distress in lung cancer. 
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Psychosocial interventions
A recent global lung cancer research output analysis, including more than 32 thousand 
research articles, reported that lung cancer research represented only 5.6% of  overall 
cancer research in 2013 (Aggarwal et al. 2016). The authors concluded that relative 
to the huge health, social and economic burden lung cancer poses, research output 
has fallen significantly behind that of  research in other cancer types. Importantly, the 
relative commitment to lung cancer research is falling in most of  the leading research-
active countries, which will likely affect clinical outcomes in patients (Aggarwal et al. 
2016). 
A similar picture is seen in studies on psychosocial interventions for cancer patients. 
A large-scale prevalence study revealed that lung cancer patients were less likely to 
receive psychosocial care than patients with other types of  cancer (Walker, Hansen, 
Martin, Symeonides, Ramessur et al. 2014). Moreover, a limited number of  trials 
examined the effectiveness of  psychosocial interventions in lung cancer patients 
and their partners (Walker et al. 2013), especially in comparison to psychosocial 
intervention trials that have been conducted in women with breast cancer (Fors et al. 
2011; Matthews, Grunfeld & Turner 2016; Tatrow & Montgomery 2006). 
One of  the reasons for this might be the poor prognosis and fast deterioration of  
physical health in lung cancer, which can have a negative effect on the uptake and 
adherence of  (studies on) psychosocial interventions (Schofield et al. 2008). In addition, 
Aggarwal  and colleagues (2016) suggested that the limited number of  studies in 
lung cancer overall might be related to the limited extent by which lung cancer is 
covered by the media and the subsequent impact this has on research funding. Studies 
that examined the content presented by media outlets found that lung cancer was 
underrepresented relative to its incidence while breast cancer was overrepresented 
(Konfortion, Jack & Davies 2014; Slater et al. 2008; Williamson, Jones & Hocken 
2011). Moreover, due to anti-smoking campaigns the stigmatization of  smoking has 
unfortunately translated into the stigmatization of  lung cancer patients (Stuber, Galea 
& Link 2008). The perception that lung cancer is a self-inflicted disease potentially 
also has a negative impact on lung cancer research funding (Tran et al. 2015).  
The few randomized controlled trials (RCT) that examined psychosocial interventions 
in lung cancer (for a systematic review, see Walker et al. 2013) demonstrated the 
effectiveness of  integrated supportive psychotherapy (Linn, Linn & Harris 1982; Walker, 
Hansen, Martin, Symeonides, Gourley et al. 2014), an intervention for breathlessness 
(Bredin et al. 1999) and early palliative care (Temel et al. 2010). These results indicate 
that psychosocial and supportive care interventions can benefit patients’ psychological 
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wellbeing, emphasizing the importance of  studying psychosocial care in lung cancer. 
There are multiple treatments that have been found effective in reducing psychological 
distress in cancer patients. One of  the most often studied psychosocial interventions 
in cancer patients is Cognitive Behavioural Therapy (CBT). Several meta-analyses 
have concluded it is effective in reducing anxiety and depressive symptoms in cancer 
patients, especially in those who were diagnosed with a psychiatric disorder (Beltman, 
Voshaar & Speckens 2010; Li, Fitzgerald & Rodin 2012; Tatrow & Montgomery 
2006). CBT focuses on identifying and challenging dysfunctional thoughts in order 
to change them into more realistic or helpful ones. It also aims to alter maladaptive 
behaviour (Beck 2005). However, given the fact that there is nothing unrealistic about 
the lung cancer and that one of  the major challenges of  both patients and partners is 
to emotionally come to terms with this reality and its consequences, an experiential 
approach such as Mindfulness Based Stress Reduction (MBSR) (Kabat-Zinn 1990) 
might be more suited to help support this aim. 
Mindfulness-Based Stress Reduction
MBSR is a protocolised group-based intervention, consisting of  8 weekly 2.5-hour 
sessions and a silent retreat day between session six and seven. Mindfulness is defined 
as intentionally paying attention to present moment experiences, in an accepting, 
non-judgmental way (Kabat-Zinn 1990). Jon Kabat Zinn originally developed the 
MBSR programme for patients with chronic conditions, such as chronic pain and 
psoriasis to help them cope more effectively with their condition (1990). During 
the sessions, participants practice mindfulness by means of  the bodyscan, sitting 
meditation, gentle yoga and walking meditation. Each session also contains didactic 
teaching on coping with stress and there is room to share experiences with one 
another. Moreover, participants receive an information folder and CDs with guided 
mindfulness meditation exercises to support home practice for  45 minutes a day. 
Participants are also encouraged to practice and integrate mindfulness in their 
daily lives, by paying attention to daily activities, such as brushing one’s teeth and 
communicating with others.  
During the mindfulness exercises, participants learn to repeatedly bring the attention 
back to current moment experiences. Rather than dwelling in the past and rehashing 
old events or worrying about the future and thinking about all the things that could 
go wrong, participants learn to be present with the experiences of  this moment. This 
experiential approach allows participants to become more aware of  their thoughts, 
feelings, bodily sensations and in time, it enables them to recognize and gain insight 
into automatic behavioural patterns. By acknowledging thoughts, feelings and bodily 
sensations, participants can consciously choose how to respond to a stressor rather than 
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automatically react to it (Segal, Williams & Teasdale 2002). MBSR aims to support 
participants in dealing with stress more effectively and being more compassionate 
towards oneself  and others (Kabat-Zinn 1990). 
In 2002, the MBSR programme was adapted by Zindel Segal, Mark Williams and 
John Teasdale in their efforts to prevent relapse in patients with recurrent depressive 
symptoms (2002). They added elements of  CBT to the MBSR programme, resulting in 
Mindfulness-Based Cognitive Therapy (MBCT). Such elements included identifying 
negative automatic thoughts and developing a relapse prevention plan (Segal, Williams 
& Teasdale 2002). In contrast with CBT, rather than changing the content or specific 
meaning of  automatic negative thoughts, MBCT emphasizes to relate differently to 
thoughts by observing thoughts as thoughts rather than identifying with them.  
In recent years, MBSR, MBCT and other mindfulness-based interventions (MBI) 
have been applied successfully as a psychosocial intervention for cancer patients. An 
increasing amount of  research has been devoted to examine the effectiveness of  MBIs 
in cancer. Since the first RCT in 2000 showed positive effects of  MBSR on anxiety 
and depression in cancer patients (Speca et al. 2000), more than 15 RCTs have been 
published. Several meta-analyses demonstrated moderate effects of  MBIs compared 
to care as usual (CAU) in reducing psychological distress in cancer patients (Cramer 
et al. 2012; Piet, Würtzen & Zachariae 2012; Zhang, Wen et al. 2016). RCTs also 
demonstrated improvements with regard to fear of  cancer recurrence, pain, fatigue, 
quality of  life and wellbeing (e.g. Carlson et al. 2013; Johannsen et al. 2016; Lengacher 
et al. 2016; Van der Lee & Garssen 2012; Würtzen et al. 2013; Zernicke et al. 2014; 
Zhang, Zhou et al. 2016). 
Although MBIs seem effective in cancer patients, the generalizability of  these findings 
is limited by the fact that the vast majority of  the more than 2000 RCT participants so 
far were women (approximately 90%), diagnosed with breast cancer (approximately 
85%) and treated with a curative intent. Hardly any evidence is available on the 
effectiveness of  MBIs in lung cancer patients. In a small RCT (n = 40), Lehto and 
colleagues (2015) showed that a shortened MBI (6 sessions of  45 minutes) delivered at 
home was more effective than a usual care group in improving the physical and social 
functioning of  lung cancer patients, but not their mental health. Our uncontrolled 
pilot study (n = 19) demonstrated no significant effects of  MBSR on psychological 
distress in lung cancer patients (Van den Hurk et al. 2015). Interestingly, the qualitative 
evaluation indicated that participation seemed feasible and helped patients to gain 
insight into their feelings, thoughts and bodily sensations, and helped them to come 
to terms with their situation. Regarding partners of  cancer patients, only three non-
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controlled studies on MBIs have been conducted (Birnie, Garland & Carlson 2010; 
Lengacher et al. 2012; Van den Hurk et al. 2015), showing preliminary evidence that 
partners might also benefit from MBIs. While Birnie and colleagues (2010) reported 
less mood disturbance and stress in partners, Lengacher and colleagues (2012) reported 
no improvements after MBI participation. In our pilot study, partners of  lung cancer 
patients reported less caregiver burden after MBSR (Van den Hurk et al. 2015).   
Aims of  the thesis
The primary aim of  this thesis is to examine the effectiveness of  MBSR in reducing 
psychological distress in lung cancer patients and their partners. The following 
questions will be addressed:
1.  First of  all, we will examine the ability of  commonly used self-report questionnaires 
to screen for psychiatric disorders in patients with lung cancer. 
  How suitable are commonly used self-report questionnaires to differentiate between lung cancer 
patients and partners with and without a psychiatric disorder?
2. To examine the effectiveness of  MBSR in reducing psychological distress in patients 
with lung cancer we will carry out a literature review on the effectiveness of  MBIs 
in cancer patients. 
  What is the currently available evidence for the effectiveness of  MBIs in reducing psychological 
distress in cancer patients? 
3. Subsequently, we will conduct an RCT to study whether MBSR is of  additional 
value to CAU in terms of  the reduction of  psychological distress in lung cancer 
patients and their partners. 
  What is the effectiveness of  MBSR added to CAU compared to solely CAU in reducing 
psychological distress in lung cancer patients and their partners? 
4. In addition to the effectiveness of  MBSR, we will also look more deeply into the 
possible differences between those refusing participation and those participating 
and their reasons for doing so. 
  How do lung cancer patients and their partners who refuse participation in a trial on MBSR 
differ from those who do participate? And what are the reasons of  patients and partners to refuse 
or to participate?
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5. Finally, we will take the opportunity to examine the role of  mindfulness and self-
compassion in the relationship between lung cancer patients and partners.
  What kind of  role do mindfulness and self-compassion play in the relationship between patients 
and partners with respect to psychological distress and communication about cancer? More 
specifically, to what extent are mindfulness and self-compassion of  oneself  and mindfulness and 
self-compassion of  one’s partner related to one’s psychological distress and communication about 
cancer?
Thesis outline
Chapter 2 addresses the first question concerning psychiatric disorders in lung 
cancer patients and their partners. We conducted a systematic screening study in a 
consecutive sample of  144 lung cancer patients and 98 partners. The prevalence of  
anxiety, depression and adjustment disorders in patients and partners are reported. 
Furthermore, we examined the suitability of  the Hospital Anxiety and Depression 
Scale (HADS) and other instruments to differentiate between those patients and 
partners with and those without psychiatric disorders. 
Chapter 3 provides a review of  the currently available evidence of  the effectiveness 
of  MBIs in cancer patients. In 2012, a comprehensive meta-analysis concluded MBIs 
are effective in reducing anxiety and depressive symptoms in cancer patients. The 
authors noted, however, that the methodological quality and generalizability of  several 
studies were limited. Since then, several high-quality RCTs have been conducted. We 
conducted a systematic review, in which we examined the results of  the five RCTs 
that have been published since the publication of  the  meta-analysis from 2012 and 
whether these RCTs address the limitations.  
Chapter 4 describes the design and protocol of  the Mindfulness for Lung Oncology 
Nijmegen (MILON) study, a multi-centre RCT, which examined the effectiveness of  
MBSR added to CAU compared to solely CAU in reducing psychological distress 
in lung cancer patients and their partners. We reported detailed information on the 
methodological aspects of  the trial, including the design, eligibility criteria, study 
procedure, outcome measures, sample size calculation and a statistical analysis plan. 
Chapter 5 reports the results of  the MILON study. In total, 63 lung cancer patients 
and 44 partners were randomized to either MBCT+CAU or solely CAU. After the 
intervention and at three-month follow-up the effects on psychological distress, quality 
of  life, caregiver burden and several other psychological outcomes were evaluated. 
Additionally, moderation and mediation analyses were conducted.
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In a mixed methods study, Chapter 6 addresses the comparison of  lung cancer 
patients and partners who refused to participate in the MILON study with those 
who did participate. We examined which demographic, clinical and psychological 
characteristics predicted whether patients and partners would either refuse or 
participate. Subsequently, via semi-structured interviews the underlying reasons for 
refusing and participating were explored. 
Chapter 7 focuses on the relationship of  patients and partners facing lung cancer. 
In a cross-sectional sample of  88 couples coping with lung cancer we explored 
how mindfulness and self-compassion are related to psychological distress and 
communication about cancer. By taking a dyadic approach we could not only examine 
associations within individuals but also between partners.    
 
A summary of  the findings can be found in Chapter 8, followed by a general discussion 
of  the results in relation to the current literature. Subsequently, methodological 
considerations, implications for future research and implications for clinical practice 
are discussed.
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ABSTRACT
Background
Lung cancer patients and their partners report high rates of  distress. Although 
distress is of  importance, psychiatric disorders might be more important in terms 
of  prognostic value and additional psychological treatment. This study examined 
the suitability of  the Hospital Anxiety and Depression Scale (HADS), Distress 
Thermometer (DT), Beck Depression Inventory (BDI-II) and State subscale of  State 
Trait Anxiety Inventory (STAI-S) to screen for psychiatric disorders in lung cancer 
patients and partners. 
Methods
A consecutive sample of  lung cancer patients and partners completed the screening 
instruments. The Structured Clinical Interview DSM-IV (SCID-I) was used to 
diagnose psychiatric axis I disorders. 
Results
In 144 patients, overall ability of  HADS total score (HADS-T) screening for patients 
with psychiatric disorders was good, whereas DT appeared less suitable. In 98 partners, 
the performance of  HADS-T was good. Although no instrument was successful in 
identifying psychiatric disorders, HADS-T came closest with a fair performance in 
patients and partners.
Limitations
Several patients and partners declined participation because they perceived 
participation as too distressing. As decliners possibly have the highest rates of  
disorders, our findings might underestimate the prevalence of  psychiatric disorders. 
A low prevalence negatively affects the positive predictive value and complicates 
efficient screening for psychiatric disorders.
Conclusion
The HADS-T appears to be a suitable screening instrument for ruling out those lung 
cancer patients and partners without a psychiatric disorder. Regarding identifying 
those with a psychiatric disorder, HADS-T should be used to refer both patients and 
partners for further diagnostics and treatment to a psychiatrist/psychologist.
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INTRODUCTION
Lung cancer is the leading cause of  death by cancer worldwide. As patients often 
develop severe physical symptoms, undergo intrusive treatment and face a poor 
prognosis, lung cancer has a major impact on psychological wellbeing. Patients 
report among the highest rates of  psychological distress (43-45%) (Carlson et al. 
2004; Linden et al. 2012) and depressive disorders (11%) (Walker, Hansen, Martin, 
Symeonides, Ramessur et al. 2014) of  all cancer patients. Generally, 15 to 19% of  
lung cancer patients meet the criteria of  a psychiatric disorder (Akechi et al. 2001). 
Psychiatric disorders in cancer patients have been associated with decreased quality 
of  life, decreased compliance with medical care, prolonged hospital stay and even 
decreased overall survival (Prieto et al. 2002; Colleoni et al. 2000; Okamura et al. 
2005; Lloyd-Williams et al. 2009). 
Not only patients, but also their partners can be profoundly affected by the lung 
cancer diagnosis. Factors contributing to heightened distress include dealing with 
practical tasks, such as coordinating the patient’s medical care, managing the 
patient’s emotional reactions to the illness, facing the possible prospect of  losing their 
beloved one and coping with an uncertain future (Mosher et al. 2013). Up to 50% of  
partners of  lung cancer patients report heightened levels of  distress (Mosher, Bakas 
& Champion 2013). In partners of  cancer patients the prevalence of  psychiatric 
disorder lies around 13 to 38% and has been associated with decreased quality of  
life and increased likelihood of  a psychiatric disorder in patients (Drabe et al. 2008; 
Bambauer et al. 2006).
Although psychological distress is of  significance, psychiatric disorders might be more 
important in terms of  both prognostic value and need for additional psychiatric or 
psychological treatment. For that reason it is important to know which screening 
instruments could help us to identify those with a high likelihood of  having a 
psychiatric disorder in both lung cancer patients and their partners, so these people 
can be referred for further diagnostics and treatment. Although lung cancer patients 
report the highest rates of  depressive disorders, a recent prevalence study in 21,151 
cancer patients (including 4361 lung cancer patients) revealed that they are the least 
likely to receive treatment for it (Walker, Hansen, Martin, Symeonides, Ramessur et 
al. 2014).
The Hospital Anxiety and Depression Scale (HADS) has been the most thoroughly 
evaluated screening instrument in cancer patients (Wakefield et al. 2015; Zigmond 
& Snaith 1983). The HADS combines the assessment of  anxiety (HADS-A) and 
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depressive (HADS-D) symptoms in one total scale (HADS-T) and has often been 
validated against standardized psychiatric interviews. A meta-analysis (nstudies = 24) 
examined the suitability of  the HADS as a screening instrument for psychiatric 
disorders established by a structured clinical interview (Mitchell, Meader & Symonds 
2010). The weighted sensitivity and specificity of  the HADS-T for any psychiatric 
disorder over 16 studies was fair to good with values of  0.73  and 0.81, respectively, of  
the HADS-D 0.76 and 0.66 (n = 4) and of  the HADS-A 0.66 and 0.71 (n = 4) (Mitchell, 
Meader & Symonds 2010). However, the reported cut-offs of  the HADS-T (from ≥10 
to ≥16), HADS-A (from ≥7 to ≥9) and HADS-D (from ≥5 to ≥8) varied greatly between 
studies. Possibly, due to differences in cancer types and stages. Moreover, as far as 
we know, only two studies examined the suitability of  the HADS-D as a screening 
instrument in lung cancer patients, using the Montgomery Ashberg Depression Rating 
Scale (MADRS), which is an observer-rated scale rather than a structured diagnostic 
interview (Montgomery & Asberg 1979; Néron et al. 2007; Castelli et al. 2009). These 
studies used small sample sizes (49 and 53 patients, respectively) and resulted in optimal 
sensitivities and specificities of  .63 and 1.00, and .73 and .75 respectively (Néron et al. 
2007; Castelli et al. 2009). In partners, up till now no screening studies for psychiatric 
disorders have been conducted, despite their heightened psychological distress.
Aim
The aim of  the current study is to examine the suitability of  the HADS to screen for 
psychiatric disorders in a larger sample of  both lung cancer patients and their partners 
using the Structured Clinical Interview for Diagnostic Statistical Manual (DSM) 
version IV (SCID) as the gold standard (First et al. 1997). Moreover, since it is widely 
used in routine clinical care of  cancer patients, we were also interested in the possible 
suitability of  the Distress Thermometer (DT) to screen for psychiatric disorder (Roth 
et al. 1998; Tuinman, Gazendam-Donofrio & Hoekstra-Weebers 2008). As policy in 
several countries, including the Netherlands, dictates that adjustment disorders in 
cancer patients are excluded from reimbursement of  the national health insurance, 
we screened for psychiatric disorders including and excluding adjustment disorders. In 
addition, we examined the possible suitability of  the HADS-D and Beck Depression 
Inventory (BDI-II) to screen for depressive disorders and the HADS-A and the state 
subscale of  the State Trait Anxiety Inventory (STAI-S) to screen for anxiety disorders 
in both populations (Beck, Steer & Brown 1996; Spielberger et al. 1983). The BDI-
II and STAI-S are often employed by psychiatrists to help diagnose depressive and 
anxiety disorders, respectively. While the HADS-D and HADS-A might be more 
appropriate for cancer patients because it was designed to use in populations with 
physical illnesses, the BDI-II and STAI-S might be more suitable for partners. 
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MATERIAL AND METHODS
Study population
The study population consisted of  a consecutive sample of  lung cancer patients and 
partners attending the outpatient clinic of  the Department of  Pulmonary Diseases of  
the Radboud University Medical Centre (Radboudumc). As an academic tertiary care 
clinic, the Radboudumc receives a large number of  referrals for surgery and other 
specialized treatment, as well as second opinions. Inclusion criteria for patients were: 
(a) cytologically or histologically proven non-small cell lung cancer or small cell lung 
cancer; and (b) having completed or still receiving treatment. Exclusion criteria for both 
patients and partners were: (a) younger than 18 years old; (b) not able to understand or 
use the Dutch language; and (c) suffering from physical and/or cognitive impairments 
which would limit participation.
Procedure
Between March 2013 and December 2014, all patients attending the clinic with the 
diagnosis of  lung cancer were invited to participate in the study. Based on a review of  
their charts a nurse practitioner contacted eligible patients and their partners to explain 
the study procedure at least one month after their diagnosis. Patients and partners who 
were willing to participate were sent an information leaflet, consent form and set of  
screening questionnaires. An appointment for a face-to-face or telephone interview was 
made for the SCID in the same week. Three psychologists (MS and two others) were 
trained in conducting the SCID by a psychiatrist (AS). The interviewers were blind 
to results of  the questionnaires. The study was approved by our ethical review board 
(CMO Arnhem-Nijmegen) and registered under number 2011–519. 
Measures
Structured Clinical Interview for Diagnostic Statistical Manual (DSM-IV) (SCID). 
The SCID-I was used for the diagnosis of  psychiatric disorders according to the criteria 
outlined in the DSM-IV (First et al. 1997; Van Groenestijn et al. 1998). To check for 
the possible presence of  a psychiatric disorder, the interview started with 12 screening 
questions. If  necessary, the interviewer asked additional questions on the frequency and 
severity of  symptoms and the extent of  suffering caused by the symptoms. The following 
parts were used: A. Mood episodes; D. Mood disorders; E. Substance abuse; F. Anxiety 
disorders; G. Somatoform disorders; I. Adjustment disorder. When it was unclear 
whether a participant fulfilled the criteria of  a psychiatric disorder, the interviewer 
discussed the case with a psychiatrist (AS). Based on a subsample of  28 interviews, the 
inter-rater reliability of  two independent assessors (MS and one other psychologist) was 
high (Kappa = 0.91) for both the face-to-face as well as the telephone interviews. 
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Hospital Anxiety and Depression Scale (HADS). The HADS, including the 7-item 
HADS-A and 7-item HADS-D, has been validated in several populations, including 
cancer patients and their caregivers (Lambert, Pallant & Girgis 2011; Bjelland et al. 
2002; Zigmond & Snaith 1983; Spinhoven et al. 1997). For each item, participants are 
asked to choose one of  four options that best reflects how they felt in the past week. 
Internal consistency in the present sample for HADS-T was .92 in patients and .91 in 
partners, for HADS-A .88 in patients and .88 in partners and HADS-D .86 in patients 
and .84 in partners.  
Distress Thermometer (DT) (only for patients). The single-item DT has been 
developed as an easily applicable instrument to screen cancer patients on general 
distress (Roth et al. 1998). On an 11-point numerical analogue scale, participants are 
asked to pick a score between 0 (no distress) and 10 (extreme distress) that summarizes 
best how they felt in the past week, including today. The thermometer is accompanied 
by a dichotomous 46-item problem list and the wish for referral. For establishing the 
most suitable cut-off  score, only the numerical analogue scale is used. The DT has 
commonly been used as a first-stage screening tool for psychological distress in cancer 
patient for both research as practice purposes (Mitchell 2010).
Beck Depression Inventory (BDI-II). The second edition of  the 21-item BDI has 
been validated in psychiatric outpatients and in several medical populations, including 
oncology patients (Wang & Gorenstein 2013; Beck, Steer & Brown 1996). It has also 
been used to assess depressive symptoms of  cancer patients and their caregivers 
(Braun et al. 2007; Wang & Gorenstein 2013). Participants are asked to choose one of  
four to seven options for each item that best describes how they felt in the past week, 
including today. In the present sample, the BDI-II had an internal consistency of  .88 
in patients and .84 in partners.
State subscale of  State Trait Anxiety Inventory (STAI-S). The 20-item STAI-S 
has been used to assess current symptoms of  anxiety in cancer patients and their 
caregivers and has been validated in several medical populations (Mystakidou et al. 
2013; Stark et al. 2002; Spielberger et al. 1983). For each item, participants are asked 
to choose one of  four options that best reflects how they feel at this moment. In the 
present sample, it had an internal consistency of  .95 in patients and .95 in partners.
Statistical analysis
The suitability of  the questionnaires to screen for psychiatric disorders based on the 
SCID was assessed using receiver operating characteristic (ROC) curve. The area 
under the ROC curve (AUC) indicates overall performance, with a greater AUC 
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reflecting better performance (excellent: ≥.90; good: .80-.89; fair: .70-.79; poor: 
≤.69). Sensitivity (Se) and specificity (Sp) were calculated at all potential cut-off  
points. Sensitivity refers to the proportion of  correctly identified cases and specificity 
to the proportion of  correctly identified non-cases. From a clinical point of  view, no 
patient with a psychiatric disorder should go undetected, emphasizing the importance 
of  tests with high sensitivity. However, as psychosocial resources are limited in the 
majority of  institutions, an optimal cut-off  level was chosen where both sensitivity 
and specificity were closest to a value of  .80 or higher. At the chosen cut-off  level, the 
positive and negative predictive values (PPV and NPV) were determined (excellent: 
≥.80; good: .60-.79; fair: .40-.59; poor: .20-.39; very poor ≤.19). PPV can be seen as 
the ability to identify or rule in those with the disorder while NPV is the ability to 
identify or rule out those without the disorder (Mitchell 2009). In clinical practice, the 
discriminatory ability of  a test (PPV and NPV) will be valued more, if  the occurrence 
of  the test result (Se and Sp) is higher. To approximately qualify the applied value of  
the test for clinical practice, the clinical utility index (UI) was calculated, which takes 
into account both discriminatory ability and occurrence of  a test. The positive utility 
index (UI+) = Se × PPV and the negative utility index (UI–) = Sp × NPV (excellent: 
≥.81; good: .64-.80; fair: .49-.63; poor: .37-.48; very poor ≤.36) (Mitchell 2009). All 
performance measures are reported with 95% confidence intervals.
The HADS-T and DT were compared with psychiatric disorders including and 
excluding adjustment disorders according to the SCID. The HADS-T, HADS-D 
and BDI-II were compared with depressive disorders and the HADS-T, HADS-A 
and STAI-S with anxiety disorders based on the SCID. Analyses were conducted 
separately for patients and partners with SPSS 20.0.
I. RESULTS IN LUNG CANCER PATIENTS
Study sample
Of  the 314 patients with lung cancer attending the clinic (see Figure 1 for study 
flow), 46 could not be contacted by the nurse practitioner either because they had 
died or for other reasons. Of  268 patients who were contacted about the study, 34 
were excluded because of  physical or cognitive impairments or language barriers. Of  
the 234 remaining patients, 157 (67%) were willing to participate. Participants were 
younger (M = 64.1 (SD = 8.7) vs. M = 66.9 (SD = 8.2), p = .025) than non-participants. 
Demographic, clinical and psychological characteristics of  the participants are shown 
in Table 1. 
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Figure 1. Studyflow of  patients and partners.
Note. Too distressing = participants felt anxious about participation. Too burdensome = participants 
felt participation was ‘too much’ next to treatment, feeling ill and/or their daily life activities. 
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Table 1. Demographic and clinical characteristics of  patients and partners.
Patients (n = 157) Partners (n = 110)
Demographic characteristics, n (%)
Males 97 (61.8) 37 (33.6)
Age, M (SD) 64.1 (8.7) 62.4 (8.3)
Marital Status
     Married / living together 130 (82.8) 110 (100.0)
     Widow(er) / divorced / alone 27 (17.2)
Educational level A
     Low 51 (32.5) 24 (21.8)
     Intermediate 58 (36.9) 54 (49.1)
     High 37 (23.6) 23 (20.9)
Clinical characteristics, n (%)
Diagnosis
     First tumor 133 (84.7)
     Recurrent 8 (5.1)
     Second primary 4 (2.5)
Time since diagnosis in months, M (SD) 2.1 (1.0)
Stage of  cancer
     I 48 (30.6)
     II 26 (16.6) 
     IIIa 29 (18.5)
     IIIb 12 (7.6)
     IV 42 (26.8)
Treatment 
     Surgery 74 (47.1)
     Radiotherapy 12 (7.6)
     Radio- and chemotherapy 10 (6.4)
     Chemotherapy 52 (33.1)
Psychological characteristics, M (SD)
HADS-T 10.6 (7.9) 12.5 (7.5)
HADS-D 5.0 (4.3) 5.4 (4.0)
HADS-A 5.6 (4.2) 7.1 (4.1)
BDI-II 11.7 (7.6) 10.0 (6.9)
STAI-S 38.4 (11.8) 40.7 (11.5)
DT 4.4 (2.4)
Note. A Low = primary/lower secondary education; intermediate = upper secondary education; 
high = higher vocational training/university.
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Psychiatric morbidity and psychological distress
The majority of  patients were interviewed a few days after completing the 
questionnaires (Median = 5; Range = 0-51). As the HADS, DT and BDI-II reflects 
participants’ psychological symptoms of  the past week and the SCID-I refers to the 
last month or a longer period of  time, participants should receive the SCID interview 
at least within 3 weeks of  completing the questionnaires in order for these time frames 
to overlap. Thirteen patients received the interview after 3 weeks of  questionnaire 
completion as interviews were cancelled due to rescheduling of  treatment or illness 
progression. Of  the 157 patients who completed the questionnaires, only 144 (92%) 
were interviewed with the SCID, of  which 105 (73%) face-to-face and 39 (27%) 
by telephone. No differences in the frequency of  psychiatric disorders were found 
between patients who were interviewed face-to-face (n = 18, 17.1% and interviewed 
by telephone (n = 6, 15%; p = .801). Thirteen patients dropped out after filling 
in the questionnaires because they thought the interview would be too stressful. 
On average, patients with a primary tumour were interviewed within 2.1 month 
(SD = 1.0) after diagnosis while patients who visited the Radboudumc for a 2nd opinion 
(n = 12) were interviewed within 6.2 month (SD = 5.6) after the initial diagnosis. Of  
the 144 patients who were interviewed, 24 (16.7%; 95% CI = 10.6-22.8) met the 
criteria of  a depressive, anxiety or adjustment disorder according to the DSM-IV 
(see Table 2). No patients met the criteria of  substance abuse disorder or somatoform 
disorder.
Table 2. Prevalence of  psychiatric disorders in lung cancer patients and their partners.
Patients (n = 144) Partners (n = 98)
n % (95% CI) n % (95% CI)
All disorders 24 16.7 (10.6 - 22.8) 20 20.4 (12.4 - 28.4)
Depressive disorder 12 8.3 (3.8 - 9.9) 7 7.1 (2.0 - 12.2)
Anxiety disorder 3 2.1 (0.0 - 4.4) 7 7.1 (2.0 - 12.2)
     Specific phobia 1 0.7 (0.0 - 2.1) 3 3.1 (0.0 - 6.5)
     Post-traumatic stress disorder 0 0.0 2 2.0 (0.0 - 4.8)
     Generalized anxiety disorder 1 0.7 (0.0 - 2.1) 1 1.0 (0.0 - 3.0)
     Panic disorder 1 0.7 (0.0 - 2.1) 0 0.0
     Agoraphobia 0 0.0 1 1.0 (0.0 - 3.0)
Adjustment disorder 9 6.3 (2.3 - 10.2) 6 6.1 (1.4 - 10.9)
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Screening for psychiatric disorder  
The ROC curves of  the HADS-T and DT compared with all psychiatric and adjustment 
disorders according to the SCID are shown in Figure 2A. The AUC and cut-off  scores 
are shown in Table 3, indicating a good performance for the HADS-T, but not for 
the DT. PPV was fair in HADS-T and poor in DT, while NPV was excellent in both 
HADS-T and DT. When comparing the HADS-T and DT to psychiatric disorders 
excluding adjustment disorders, the AUC of  HADS-T also outperformed the DT. 
The cut-off  scores of  HADS-T (≥15) and DT (≥6) when adjustment disorders were 
excluded were the same as when adjustment disorder was included. PPV was poor in 
both HADS-T and DT, while NPV was excellent in both questionnaires. 
When comparing HADS-T, HADS-D and BDI-II with depressive disorders according, 
the AUC of  HADS-T was excellent compared to a good performance of  HADS-D 
and BDI-II. PPVs of  HADS-T, HADS-D and BDI-II were poor, while NPVs were 
excellent on all questionnaires. When comparing HADS-T, HADS-A and STAI-S 
with anxiety disorders, STAI-S outperformed the HADS-T and HADS-A regarding 
AUC. PPVs of  HADS-T, HADS-A and STAI-S were very poor, while NPVs were 
excellent on all questionnaires. When the 13 patients that received the interview 
later than 3 weeks of  questionnaires completion were excluded from the analysis, the 
questionnaires performed in the same category of  discriminatory ability as when they 
were included in the analysis.
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II. RESULTS IN PARTNERS
Study sample
Of  the 268 patients who were assessed for eligibility, 199 (74%) had a partner. Three 
patients did not give consent to invite their partner for the study and we were unable 
to contact 8 partners. Of  the remaining 188 partners, 12 were excluded from the study 
due to physical and cognitive impairments or language barriers. Of  the 176 eligible 
partners, 110 (63%) participated (see Table 1 for demographic characteristics). 
Psychiatric morbidity and psychological distress
The majority of  partners were interviewed a few days after completing the 
questionnaires (Median = 3; Range = 0-38). Five partners received the interview 
after 3 weeks of  questionnaire completion Of  the 110 partners who completed the 
questionnaires, 98 (89%) were interviewed with the SCID, 64 (65%) face-to-face and 
34 (35%) by telephone. Partners who were interviewed face-to-face were more often 
diagnosed with a psychiatric disorder (n = 18, 28.1%) than partners interviewed by 
telephone (n = 2, 6%; p = .009). Twelve partners dropped out after filling in the 
questionnaires because they thought the interview would be too stressful. Of  the 98 
partners who were interviewed, 20 (20.4%; 95% CI = 12.4-28.4) met the criteria of  
a depressive, anxiety or adjustment disorder according to the DSM-IV (see Table 2). 
No partners met the criteria of  substance abuse disorder or somatoform disorder. 
The mean scores on the HADS-T, HADS-D, HADS-A, BDI-II, and STAI-S are also 
shown in Table 1.
Screening for psychiatric disorder  
The ROC curves of  the HADS-T compared with all psychiatric and adjustment 
disorders according to the SCID are shown in Figure 2B. The AUC indicates a good 
performance for the HADS-T (see Table 3). The HADS-T performed similar when 
screening for psychiatric disorders excluding adjustment disorders. The cut-off  score 
of  the HADS-T was slightly higher (≥17) when compared with psychiatric disorders 
excluding adjustment disorders than including them (≥15). PPV of  HADS-T when 
screening for all disorders was fair while screening for psychiatric disorders excluding 
adjustment disorders was poor. NPV of  HADS-T in both screenings was excellent. 
When comparing HADS-T, HADS-D and BDI-II with depressive disorders, the good 
performance of  the BDI-II based on the AUC, outperformed the fair performances 
of  the HADS-T and HADS-D. PPVs of  HADS-T, HADS-D and BDI-II were poor 
to very poor, while NPVs were excellent on all questionnaires. When comparing 
HADS-T, HADS-A and STAI-S with anxiety disorders according to the SCID, the 
237
good performance of  the HADS-T based on the AUC, performed better than the 
HADS-A and STAI-S, which performed fairly. PPVs of  HADS-T, HADS-A and 
STAI-S were poor to very poor, while NPVs were excellent on all questionnaires. 
When the 5 partners that received the interview later than 3 weeks of  questionnaires 
completion were excluded from the analysis, the questionnaires performed in the 
same category of  discriminatory ability as when they were included in the analysis.
DISCUSSION
The present study is the first to examine the suitability of  different screening 
questionnaires for psychiatric disorder in lung cancer patients at a larger scale. It is 
also innovative in that it includes screening for psychiatric disorders in partners. We 
compared the screening questionnaires with a well-validated structured diagnostic 
interview, the SCID, which is widely used by psychologists and psychiatrists.
Our findings indicate that in lung cancer patients, overall the HADS performed well 
as a screening instrument for psychiatric disorder. These results are consistent with 
the literature showing that the HADS is a suitable screening instrument for psychiatric 
disorders in patients with other types of  cancer as well (Wakefield et al. 2015). The 
sensitivity (.75) and specificity (.87) in the present study was slightly superior to that 
reported in a meta-analysis of  16 studies on screening for psychiatric disorder by the 
HADS (.73 and .81, respectively) (Mitchell, Meader & Symonds 2010). The cut-off  
point of  the HADS-T in the present study (≥15) falls within the range of  the cut-off  
points reported in the studies of  the meta-analysis which varied between ≥10 and 
≥16 (Mitchell, Meader & Symonds 2010). Interestingly, both screening performance 
and cut-off  levels were very similar whether comparing the HADS with psychiatric 
disorders including or excluding adjustment disorders. This might indicate that in 
lung cancer patients adjustment disorders should be considered as equally severe 
as other psychiatric disorders. These results oppose the policy in several countries, 
including the Netherlands, that adjustment disorders in cancer patients are excluded 
from reimbursement of  the national health insurance.
 
The results of  our study indicate that the DT is not suitable as a screening instrument 
for psychiatric disorder and that it should not be used as such. This is in line with the 
conclusion of  a meta-analysis on short screening instruments, implying also that the 
DT cannot be used to screen for psychiatric disorders and that it should be considered 
as a first-stage screening tool for general distress only (Mitchell 2007). The HADS-T 
also outperformed the BDI-II when screening for depression disorders. However, 
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when screening for anxiety disorders, the STAI-S performed better than the HADS-T. 
Note, however, that het confidence intervals of  the poorly/fairly performing screening 
questionnaires varied between poor and excellent, suggesting it is uncertain whether 
similar results will be found when the study is repeated.
While the HADS-T performed good to excellent in ruling out those patients without 
a disorder, no instrument was successful in ruling in those with a psychiatric disorder. 
This might be due to the modest prevalence of  psychiatric disorders (17%). The 
HADS-T came closest with a PPV of  .529, indicating a fair performance in identifying 
psychiatric disorders, including adjustment disorders. This means that only 53 out of  
100 patients with a heightened HADS-T score would eventually be diagnosed with 
a psychiatric disorder, suggesting that we should not only rely upon the HADS-T 
when we want to identify a suspected psychiatric disorder. Regarding ruling out non-
cases, all questionnaires performed excellent. In terms of  clinical utility, the HADS-T 
outperformed the other screening instruments when ruling out patients without 
psychiatric disorders. 
Interestingly, the prevalence of  psychiatric disorders in partners (20%) was at least 
as high, if  not higher, than that in patients (17%). The HADS-T also appeared to be 
a suitable screening instrument for psychiatric disorders in partners, even though its 
performance was slightly worse than in patients. Although the screening performance 
of  the HADS-T in detecting psychiatric disorders including and excluding adjustment 
disorders was very similar, the cut-off  levels excluding them were higher than those 
including them. This might indicate that in partners adjustment disorders are indeed 
associated with less severe symptomatology than other psychiatric disorders. In 
partners, the BDI-II was better in detecting depressive disorders than the HADS-D. 
The screening performance of  the STAI-S, however, was inferior to that of  the 
HADS-A, both not exceeding the qualification of  fair. Like in patients, no instrument 
was successful in ruling in those partners with a disorder. The HADS-T showed the 
best performance with a PPV of  .432. As in patients, when identifying a suspected 
psychiatric disorder in partners, one should not solely rely upon the HADS-T.
Despite the strengths of  the study, a few limitations should also be noted. As the 
Radboudumc is an academic tertiary care cancer treating a large number of  patients 
in the early stage of  the disease, the study population might not be representative 
of  those in other settings. A substantial number of  patients and partners declined 
participation due to functional limitations or because they thought participation 
would be too distressing or burdensome. As patients and partners declining to take 
part might have the highest rates of  psychiatric disorders, it is conceivable that our 
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findings underestimate the prevalence of  psychiatric disorders. A low prevalence has 
a negative effect on the positive predictive value and makes it more difficult to screen 
efficiently for psychiatric disorders. Moreover, we should examine the characteristics 
and reasons for not participating much more closely in order to improve the 
acceptability of  screening for psychiatric disorders in lung cancer patients and their 
partners in routine clinical practice (Mitchell, Vahabzadeh & Magruder 2011). 
In a large number of  participants the interview was conducted a few days after the 
questionnaires were completed, which might compromise our estimation of  the 
performance of  the screening questionnaires. Furthermore, in a few participants 
the time frame of  the interview did not overlap with the questionnaire completion. 
When those participants were removed from the analysis, however, similar results 
were found. Moreover, a part of  the SCIDs were conducted by telephone, which 
might have negatively affected its reliability (Muskens et al. 2014). Indeed, in partners 
we found that those interviewed face-to-face were more often diagnosed with a 
psychiatric disorder than those interviewed by telephone. However, we did find a high 
inter-rater reliability, which was based on a sample including both face-to-face as well 
as telephone interviews. 
In addition, the STAI-S might be less comparable to the other screening questionnaires 
as it asks about patients current symptoms at just one brief  moment in time, while 
the other screening instruments reflects participants’ symptoms in the past week. This 
particular moment at which the STAI-S was measured, was not controlled for in the 
study and thus might have varied across participants. The test-retest reliability of  
the STAI-S, however, has an acceptable value of  .70 (Barnes, Harp & Jung 2002) 
and it has often been used to screen for anxiety in other patient samples (Bunevicius 
et al. 2013; Tendais et al. 2014). Although these studies report that screening with 
the STAI-S led to a number of  missing cases and false positives, they conclude it is a 
reasonably valid and reliable screening instrument.
Conclusion
The present study implies that the HADS-T could be used as a first step screening 
tool for ruling out those without a psychiatric disorder in routine clinical care for 
both lung cancer patients and their partners. With regards to identifying patients and 
partners with a psychiatric disorder, the HADS-T performed less well. Patients and 
partners scoring 15 or higher at the HADS should be referred for further psychiatric 
assessment and treatment by a psychiatrist or psychologist. This will likely benefit 
both lung cancer patients and their partners, as psychiatric disorders are associated 
with all kinds of  impairments (Prieto et al. 2002; Unal et al. 2015; Drabe et al. 2008).
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CHAPTER 3
The effectiveness of  mindfulness-based interventions for patients 
with cancer: A systematic review of  recent randomised trials
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ABSTRACT
Mindfulness is increasingly being offered to people with cancer. A recent meta-analysis 
concluded that mindfulness-based interventions seem to be effective in reducing 
anxiety and depressive symptoms in patients with cancer. The reviewed studies had 
several limitations, such as low methodological quality and low external validity. The 
goal of  this systematic review is to give an overview of  novel randomized controlled 
trials (RCTs) studying the effectiveness of  mindfulness-based interventions in patients 
with cancer that have been published since the meta-analysis. Two electronic 
databases were searched. Five RCTs with a total of  690 participants and 3 currently 
recruiting studies were included in this review. Mindfulness-based interventions were 
found to be effective in improving psychological distress and quality of  life. One study 
also showed that Mindfulness-Based Stress Reduction (MBSR) positively affected 
cortisol profiles. The methodological quality of  the studies was good. Three RCTs 
reported on a comparison with an active control group, of  which 2 studies showed 
that the mindfulness-based intervention was more effective than the active control 
group in reducing psychological distress. Once again, the external validity was low. 
The majority of  participants was female, diagnosed with breast cancer and in the 
curative stage of  the disease. Fortunately, current trials are examining other cancer 
populations in different stages as well. 
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INTRODUCTION
Receiving a cancer diagnosis and subsequent anticancer treatment can have an 
enormous impact on the psychological wellbeing of  patients. Twenty-seven to 58% of  
cancer patients report heightened levels of  psychological distress, mostly anxiety and 
depressive symptoms (Carlson et al. 2004; Zabora et al. 2001). The most extensively 
studied mood complication associated with cancer is depression. Depressive symptoms 
can cause severe suffering, reduce compliance with medical care and prolong the 
duration of  hospital stay (Mitchell et al. 2011). Moreover, depression is a determinant 
of  reduced quality of  life and shortened survival time (Pinquart & Duberstein 2010). 
A recent meta-analysis showed that in the long run, people with cancer primarily 
experience anxiety symptoms (Mitchell et al. 2013). Anxiety symptoms also have 
a major impact on the quality of  life of  patients. Effective psychosocial care is of  
importance in order to help cancer patients cope with psychological distress. 
Mindfulness and mindfulness-based interventions
In the past ten years mindfulness-based interventions have been increasingly offered 
to cancer patients. Mindfulness is defined as intentionally paying attention to present 
moment experiences, in an open, accepting, non-judgmental way. Jon Kabat-Zinn 
developed the so-called Mindfulness-Based Stress Reduction (MBSR) training, which 
was originally offered to people with chronic untreatable symptoms, such as chronic 
pain and psoriasis to help them cope with these conditions (Kabat-Zinn 1990). 
MBSR is a protocolized eight-week group intervention with 2.5 hour sessions for 8 
to 12 participants. During these sessions, mindful attention is practiced by means 
of  the bodyscan, gentle yoga, sitting and walking meditation. There is time to share 
experiences with one another and participants receive didactic teaching on, for 
example, different ways to react to stress. In addition to the weekly sessions, participants 
are expected to practice at home for 45 minutes on a daily basis. To support daily 
practice, participants receive a workbook with home practice instructions, background 
information and CDs with guided mindfulness meditation exercises. By repeatedly 
bringing the attention back to present moment experiences, participants learn to 
disengage from dysfunctional cognitions and become more aware of  experiences in 
the current moment. This enables participants to recognize automatic reactions and 
behavioural patterns. By observing thoughts and feelings from a distance, participants 
learn to not directly react to them. Instead, participants can consciously choose how 
they want to respond. This can help them cope more effectively with stress and take 
better care of  themselves. 
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Later on Segal, Williams and Teasdale adapted the MBSR programme in their efforts 
to prevent relapse in people with recurrent depressive symptoms (Segal, Williams & 
Teasdale 2002). Mindfulness-Based Cognitive Therapy (MBCT) combines elements of  
cognitive behavioural therapy with the MBSR training to prevent relapse in recurrent 
depression. For example, participants are encouraged to compose a list of  automatic 
negative thoughts that they have become aware of  during the training. In contrast 
with cognitive behavioural therapy, MBCT does not emphasize changing the content 
or specific meaning of  automatic negative thoughts. MBCT encourages participants 
to take a step back by seeing thoughts as thoughts and not as facts. 
Since the development of  the MBCT protocol, much research has been conducted 
on the effectiveness of  MBCT in recurrent depression. A meta-analysis of  6 studies 
(n = 593) concluded that an MBCT training reduces the chance on relapse in 
depression with 34%, compared to treatment as usual or a placebo (Piet & Hougaard 
2011). MBCT seemed as effective as antidepressant medication in reducing relapse 
in depression. Mindfulness-based interventions are also increasingly studied in other 
physical and psychological conditions. A recent meta-analysis of  46 studies, with a 
total of  3,515 participants (such as patients with diabetes, HIV, anxiety disorders), 
showed that mindfulness-based interventions resulted in significant improvements in 
anxiety, depression and pain in comparison with nonspecific active control conditions 
(Cohen’s d of  respectively 0.38, 0.30 en 0.33) (Goyal et al. 2014).
Effectiveness of  mindfulness-based interventions in cancer
An ever increasing amount of  research effort is being devoted to the effectiveness 
of  mindfulness-based interventions on the psychological wellbeing of  patients with 
cancer. Since the first randomized study in 2000 showing positive effects of  MBSR 
on mood, distress, anxiety and depression, dozens of  studies have followed (Speca et 
al. 2000). In 2012, a meta-analysis including 9 RCTs and 13 non-randomized studies 
(n = 1403) showed that mindfulness-based interventions reduce psychological distress 
in cancer patients. Both anxiety as well as depressive symptoms decreased (Hedges’ g 
of  respectively 0.37 and 0.44) (Piet, Würtzen & Zachariae 2012).
 
A few recent studies also examined the relation between mindfulness-based 
interventions and biomarkers in cancer patients. These studies have not been 
included in the present study since these were part of  larger studies that were already 
included in Piet et al. (Lengacher et al. 2009). These studies report on the effects of  
MBSR on telomerase activity and lymphocyte recovery in women with breast cancer. 
Telomerase activity is an indicator of  disease risk and disease progression, and is 
associated with psychological distress. In comparison with usual care, participation in 
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MBSR had positive effects on telomerase activity (Lengacher et al. 2014). In addition, 
compared to usual care MBSR seemed to lead to more rapid lymphocyte recovery 
after chemo- and radiotherapy. More specifically, after MBSR women showed a more 
rapid recovery of  functional T cells that can be activated by a mitogen with the 
Th1-phenotype. The recovery of  B and NK cells occurred similarly in the MBSR 
condition as in the usual care condition (Lengacher et al. 2013). 
Although mindfulness-based interventions seem effective in reducing psychological 
distress and there is preliminary evidence of  the effects on biomarkers in cancer 
patients, Piet and colleagues emphasized some limitations in the current research 
(2012). One limitation was the limited methodological quality. The majority of  studies 
was non-randomised and based on small patients samples. Within the RCTs only 
5 of  the 9 studies reported intention-to-treat analyses. Moreover, the mindfulness-
based interventions were only compared with a waitlist or usual care control group 
and not with active control conditions. The comparison with active control groups 
is of  importance to control for nonspecific effects, such as participants’ expectation 
to improve, group support and receiving attention from a teacher. In addition, the 
external validity of  the studies was limited. The majority of  the studied participants 
were female (85%), diagnosed with breast cancer (77%) and in the curative stage of  
the disease or survivors at time of  inclusion. Therefore, the current results cannot 
be generalised to male cancer patients, other cancer population or patients in the 
palliative stage of  the disease. 
Aim
The aim of  the present study is to provide an overview of  the RCTs studying the 
effectiveness of  mindfulness-based interventions in patients with cancer. This involves 
the RCTs that were published after the meta-analysis (Piet, Würtzen & Zachariae 
2012). In addition, ongoing trials will also be included in the review, so a complete 
overview of  research on mindfulness in people with cancer will arise. This enables us 
to map the development in the literature since the meta-analysis of  Piet, Würtzen & 
Zachariae (2012).
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METHODS
Inclusion criteria
Studies were included when meeting the following inclusion criteria:
•  RCTs or study protocols of  RCTs on the effectiveness of  (online) MBSR or MBCT 
in cancer patients that were not included in Piet, Würtzen & Zachariae (2012).
•  Participants are 18 years or older with a current or former cancer diagnosis. 
•  MBSR following the guidelines of  Kabat-Zinn (1990) or MBCT following the 
guidelines of  Segal et al. (2002). 
Search strategies
Two electronic databases (PubMed and Web of  Science) were searched to identify 
eligible studies until August 2014, using the search terms (randomized controlled trial 
AND mindfulness AND [cancer OR oncology]). After duplicates were removed, the 
abstracts of  the remaining studies were screened and relevant articles were retrieved 
for eligibility assessment. The search was conducted independently by the first 2 
authors. Disagreements were discussed until consensus was reached. 
Data collection
In line with Piet, Würtzen & Zachariae (2012), the first and second author 
independently collected the following information:
•  Demographic and clinical characteristics: age, sex, cancer type and stage, treatment, time 
since diagnosis and severity of  symptoms.
•  Design and characteristics of  the different conditions: type of  mindfulness-based intervention, 
comparison condition, number of  sessions, number of  participants completing the 
MBSR/MBCT programme. 
•  Methodological quality of  the studies according to the Jadad criteria (Jadad et al. 1996), as 
described by Piet and colleagues: (1) the study was randomized, (2) the randomization 
procedure was described and appropriated, that is, allocation was randomly 
conducted independent of  the researchers, in which participants had equal chances 
of  being assigned to the intervention or control condition(s), (3) blind outcome 
assessment was reported, (4) number and reasons of  declining participation and 
dropouts were collected and reported for each group. One point was given for each 
criterion met, such that scores varied from 0 to 4 (Piet, Würtzen & Zachariae 2012; 
Jadad et al. 1996). 
•  Findings: outcome measures, findings on the outcome measures and effect sizes. 
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RESULTS
Selection of  studies
The search strategy resulted in 185 potentially relevant articles. After removing the 
duplicates (n = 39) and the articles that did not meet the inclusion criteria (n = 123), 
23 articles remained. Next, we removed: (1) studies already included in the review 
of  Piet and colleagues (n = 9), or studies of  which the sample showed overlap with 
the RCTs already included in the present overview or in the overview of  Piet et al. 
(n = 5) and (2) studies without outcome measure (n = 1). Of  the remaining 8 articles, 
5 articles reported on results of  an RCT and 3 articles reported on the study protocol 
of  an RCT of  which no data was published yet. 
Characteristics of  the RCTs
The characteristics of  the 5 included studies are summarized in Table 1 (Van der Lee 
& Garssen 2012; Henderson et al. 2012; Carlson et al. 2013; Zernicke et al. 2014; 
Garland et al. 2014).
Demographic and clinical characteristics of  participants. The sample size varied 
between 62 and 271 participants, with in total 690 participants. Participants were 
on average between 50 and 59 years of  age and 72 to 100% was female. Participants 
were patients with breast cancer (nstudies = 2) or different types of  cancer (nstudies = 3). 
The majority of  participants were diagnosed with breast cancer (varying between 
47 and 100%). Only 1 study included patients in the palliative stage of  the disease. 
Four studies reported the percentage of  patients that were treated prior to the start 
of  the study (surgery: 82-93%; chemotherapy: 38-52%; radiotherapy: 45-57%) and 
1 study reported the percentage of  patients that received treatment during the study 
(chemotherapy: 12%; radiotherapy: 25%). The average time since diagnosis was 
reported in three studies and varied between 26 to 38 months. In 4 studies participants 
were only included when they met a certain level of  symptoms: high level of  general 
distress (score ≥4 on Distress Thermometer (Roth et al. 1998)) in 2 studies, high level 
of  fatigue (≥35 on subscale Fatigue of  Checklist Individual Strength (CIS) (Vercoulen, 
Alberts & Bleijenberg 1999) in 1 study and meeting the diagnostic criteria of  insomnia 
in 1 study. 
Design and characteristics of  different conditions. The studies examined the 
effectiveness of  MBCT (nstudies = 1), MBSR (nstudies = 3) or online MBSR (nstudies = 1). 
The 5 studies used the usual 8 sessions with a silent retreat day. Three studies reported 
shortened sessions but did not describe which parts of  the programme were shortened 
(Carlson et al. 2013; Garland et al. 2014; Zernicke et al. 2014). In the online MBSR 
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intervention participants received headphones and webcams, enabling them to follow 
the MBSR programme at home behind their computer (Zernicke et al. 2014).
The mindfulness-based interventions were compared with a waitlist/usual care 
(nstudies = 2) or active control conditions (nstudies = 3). The active control conditions 
included a Nutrition Education Programme (NEP), Supportive Expressive Group 
Therapy (SET), and Cognitive Behavioural Therapy for Insomnia (CGT-I). NEP was 
designed to be equivalent to MBSR with respect to contact hours, group support and 
homework. Participants received education about food and they cooked together. SET 
is a validated and often studied 12-week psychosocial intervention for cancer patients. 
The programme is focused on peer support and expression of  emotions. The CGT-I is 
an 8-week therapy with 90-minute sessions that is specially developed for people that 
suffer from insomnia and has often been shown to be effective in improving sleeping 
patterns. In the mindfulness conditions, the number of  participants varied between 30 
and 113 participants, while in the control conditions the number varied between 24 
and 104. In the 3 studies reporting on the number of  followed sessions, the percentage 
of  participants following 5 or more sessions varied between 75 and 82%. 
Methodological quality. The methodological quality of  the studies, as measured 
with the Jadad criteria, varied between 2 and 4 with an average of  3. All studies 
were randomized. One study did not report whether the randomisation occurred 
independently from the researcher and in 2 other studies the randomization was not 
appropriate because the randomization was not equally distributed among conditions. 
The 3 studies that reported on testing for baseline differences between conditions 
showed that all 3 studies were randomized successfully. Since the outcome measures 
were not directly assessed by the researcher in the studies, every study fulfilled the 
criteria regarding blinding. In 3 studies both the number and reasons for declining 
participation and dropping out were reported, while in the other 2 studies only 
the number of  declining participation and dropout were reported. The percentage 
of  eligible participants that refused to participate varied between 10 to 53%. The 
percentage of  participants that dropped out the study varied between 2 to 35%.
Findings. Psychological distress was studied in 4 of  the 5 RCTs. These 4 studies found 
significant improvements in self-reported mood, stress, depression and hostility. The 
mindfulness-based interventions were more effective than the waitlist, usual care and 
the active control groups NEP and SET, and as effective as CBT-I. No significant 
improvements were found on anxiety. 
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In the 4 studies examining quality of  life, mindfulness-based interventions were 
effective in improving self-reported quality of  life and fatigue. MBSR seemed to be 
more effective on quality of  life than the waitlist, usual care and NEP, as effective as 
SET and less effective in reducing insomnia than CBT-I.  
One study measured physical effects. MBSR seemed to normalise cortisol profiles in 
comparison with the waitlist control group. Cortisol, the primary stress hormone, is 
largely responsible for the down regulation of  the immune system. Cortisol levels that 
vary little during the day, depicted as flattened cortisol slopes, are associated with 
worse psychological functioning and shorter survival. Participants of  MBSR and SET 
maintained the daily steep cortisol slopes, while participants in usual care showed 
flattened cortisol slopes. 
Ongoing studies
Besides the 5 RCTs, we selected 3 papers reporting the research protocols of  an 
RCT, of  which 1 study is conducted in the Netherlands (Sarenmalm et al. 2013; 
Chambers et al. 2013; Schellekens et al. 2014). Sarenmalm and colleagues described 
the protocol of  an RCT on the effectiveness of  MBSR versus self-instructed MBSR 
versus usual care on the psychological distress in patients with early stage breast 
cancer (Sarenmalm et al. 2013). Next to follow-up measures at 3, 6, 9 and 12 months, 
the outcome questionnaires will also be measured 5 years after inclusion. Secondary 
outcomes included besides psychological self-report questionnaires also physiological 
responses, illness progression and survival.  
Chambers and colleagues are currently examining the effectiveness of  a telephone-
based MBCT group intervention versus usual care including patient education 
material on psychological distress and quality of  life in men with advanced prostate 
cancer (Chambers et al. 2013). Up until 9 months, every 3 months patients will fill in 
the questionnaires. 
In the Dutch RCT, the (cost-)effectiveness of  MBSR versus usual care is studied on 
psychological distress in patients with lung cancer and their partners (Schellekens et 
al. 2014). Furthermore, the effects on quality of  life in patients, caregiver burden in 
partners, and quality of  the relationship are studied. Also possible mediators of  MBSR 
are studied. 
As far as we know, there are two studies in The Netherlands of  which no research 
protocols have been published (at the time of  writing). One study examines the (cost-)
effectiveness of  MBCT versus online MBCT versus a waitlist in patients with all sorts of  
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cancer and stages of  cancer (Compen et al. 2015). In addition to psychological distress, 
health-related quality of  life and psychological wellbeing are also studied. Moreover, 
the predictors and mediators of  MBCT are studied. In another RCT, online MBCT 
is compared with online physical exercise therapy. Compared with a control group, 
the effectiveness of  these two online programmes on reducing cancer-related fatigue is 
studied (Wolvers et al. 2015). The predictors and mediators of  both online programmes 
are studied, so it can be predicted which therapy is most effective for which patient. 
DISCUSSION
Mindfulness-based interventions seem promising for cancer patients. A meta-analysis 
of  9 RCTs and 13 non-randomized studies (n = 1403) concluded that mindfulness-
based interventions seem effective in reducing anxiety and depressive symptoms in 
patients with cancer (Piet, Würtzen & Zachariae 2012). However, the studies had some 
shortcomings, such as a low methodological quality and low external validity. The goal 
of  the current paper was to provide a review of  (ongoing) RCTs on the effectiveness of  
mindfulness-based interventions in patients with cancer that were published after the 
meta-analysis of  Piet et al. This allows us to map the developments in the literature since 
the meta-analysis of  Piet and colleagues. Our literature review on RCTs has resulted 
in a description of  8 papers that were published after the meta-analysis. Five of  these 
papers reported on results of  RCTs and 3 papers described the protocols of  ongoing 
studies.  The results of  the five papers showed that MBSR and MBCT are effective in 
improving psychological distress and quality of  life. One study even showed that MBSR 
showed positive effects on cortisol profiles, which is in line with recent research showing 
improvements in different biomarkers after participation in MBSR (Speca et al. 2000; 
Lengacher et al. 2014; Lengacher et al. 2013).
Regarding the development of  research since the meta-analysis of  Piet and colleagues, 
we can conclude that the 5 studies are of  good methodological quality. The studies are 
randomised and 3 RCTS report on a comparison with an active control group, of  which 
2 studies showed that MBSR/MBCT is superior to an active control group in reducing 
psychological distress. This suggests that the effect of  the mindfulness training cannot 
be explained by non-specific effects. 
The external validity in these recent studies remains low. The majority of  the 
participants is female, diagnosed with breast cancer and in the curative stage of  the 
disease. However, the ongoing studies took this into account. In two ongoing studies 
the effects of  MBSR in patients with others sorts of  cancer (lung cancer and prostate 
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cancer) is studied. A significant part of  these participants will be males and will be in 
the palliative stage of  the disease. In two other ongoing studies that are conducted in 
the Netherlands, of  which no protocols were published at the time of  writing, patients 
with all sorts of  cancer in different stages of  the disease are studied. When the results of  
these studies become available, we will know more about the effect of  mindfulness on 
male cancer patients, patients with other sorts of  cancer and patients in the palliative 
stage of  the disease. 
New developments in research
Besides the original ‘face-to-face’ mindfulness-based groups, some papers report on an 
online intervention. Zernicke and colleagues showed that an online MBSR training was 
feasible for patients and it seemed effective in reducing psychological distress. Three 
ongoing studies are also examining the effectiveness of  an online training. The results 
of  these studies will show whether an online intervention is a suitable alternative for 
patients who feel too burdened to participate in an 8-week group-based training. 
The ongoing studies that are conducted in the Netherlands do not only study clinical 
effectiveness but also cost-effectiveness. In a cost-effectiveness analysis, the costs of  an 
intervention are compared with its health effects, such that researchers can estimate 
how much clinical improvements costs. This is important as it can advise policy makers 
whether mindfulness-based interventions should be reimbursed by the National Health 
Insurance. Until now, no articles were identified that reported on the cost-effectiveness 
of  mindfulness-based interventions for people with cancer. 
Societal developments
Like previous systematic reviews and meta-analysis, this overview shows that 
mindfulness-based interventions are effective in reducing psychological distress for 
people with cancer. However, as of  January 2014 the Dutch National Health Insurance 
(Zorginstituut Nederland) advised the ministry to only reimburse MBCT for patients 
with recurrent depression. This has large consequences for the psychosocial care that can 
be offered to Dutch cancer patients by mental health care institutions and therapeutic 
centres connected to IPSO (Centres for Psychosocial Oncology: www.ipso.nl). Since the 
foundation in 1988 the Helen Dowling Institute (a Dutch mental health care institute 
for cancer patients, the oldest ISPO centre) has offered 78 MBCT courses and since 
2009 426 clients followed the online programme for anxiety disorders or severe fatigue 
after cancer. As most cancer patients with anxiety and depressive symptoms do not fulfil 
the diagnostic criteria for a recurrent depression, they cannot be offered a mindfulness 
training. It is unfortunate that the Netherlands has a health care system that refrains 
from reimbursing evidence-based psychosocial care to people who suffer from cancer. 
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ABSTRACT
Background
Lung cancer is the leading cause of  cancer death worldwide and characterized by a 
poor prognosis. It has a major impact on the psychological wellbeing of  patients and 
their partners. Recently, it has been shown that Mindfulness-Based Stress Reduction 
(MBSR) is effective in reducing anxiety and depressive symptoms in cancer patients. 
The generalization of  these results is limited since most participants were female 
patients with breast cancer. Moreover, only one study examined the effectiveness of  
MBSR in partners of  cancer patients. Therefore, in the present trial we study the 
effectiveness of  MBSR versus treatment as usual (TAU) in patients with lung cancer 
and their partners.
Methods/Design
A parallel group, randomized controlled trial is conducted to compare MBSR with 
TAU. Lung cancer patients who have received or are still under treatment, and their 
partners are recruited. Assessments will take place at baseline, post intervention 
and at three-month follow-up. The primary outcome is psychological distress (i.e. 
anxiety and depressive symptoms). Secondary outcomes are quality of  life (only for 
patients), caregiver appraisal (only for partners), relationship quality and spirituality. 
In addition, cost-effectiveness ratio (only in patients) and several process variables are 
assessed.
Discussion
This trial will provide information about the clinical and cost-effectiveness of  MBSR 
compared to TAU in patients with lung cancer and their partners.
Trial Registration Number: ClinicalTrials.gov NCT01494883
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BACKGROUND
With an estimated 1.4 million deaths per year, lung cancer is the leading cause of  
death by cancer worldwide. Even with the best available treatment, five-year survival 
is merely 16% and about 60 to 70% of  patients die within the first year after diagnosis 
(Jemal et al. 2011). This poor prognosis is often caused by a late diagnosis as the 
presentation usually occurs when the lung cancer is advanced. Patients may develop 
burdensome symptoms like pain, dyspnoea, fatigue and cough and they may undergo 
radical treatment, including, surgery, chemo- and radiotherapy. Not surprisingly, 
lung cancer has a major impact on the psychological wellbeing of  patients and their 
family. Akechi and colleagues (Akechi et al. 2001) showed that 19% of  patients with 
advanced lung cancer meet the criteria of  psychiatric disorders, especially depressive 
and adjustment disorders. Of  patients who had been successfully treated for lung 
cancer 15% met the criteria for a minor or major depressive disorder (Uchitomi et al. 
2000). The prevalence rate of  depressive and anxiety symptoms among lung cancer 
patients ranges from 20 to 47% (Montazeri et al. 1998; Hyodo et al. 1999; Turner 
et al. 2007; Hopwood & Stephens 2000). Compared to patients with other cancer 
diagnoses, lung cancer patients report the highest rates of  distress (43 to 58%) (Zabora 
et al. 2001; Carlson et al. 2004) resulting in a lower quality of  life (Temel et al. 2010). 
Family, friends and especially partners of  patients with lung cancer also have to deal 
with its psychological impact (Abernethy et al. 2002; Thielemann & Conner 2009; 
Pinquart & Duberstein 2005; Kim et al. 2005). Partners not only provide emotional 
and practical support, they also have to cope with their own concerns, including the 
uncertainty regarding the course of  the illness and the fear of  losing their partner 
(Mosher et al. 2013). More than 50% of  partners of  lung cancer patients report 
negative emotional effects of  caregiving (Mosher, Bakas & Champion 2013). Around 
40% of  partners of  patients with advanced lung cancer report high levels of  distress 
(Ostlund et al. 2010). The relationship between patient and partner can also be 
affected by the cancer. It has been shown that some partners report a lower quality of  
their relationship after the diagnosis of  lung cancer (Wennman-Larsen et al. 2008). 
Though numerous studies examined the psychological distress of  lung cancer patients 
and their partners (Mosher et al. 2013; Mosher, Bakas & Champion 2013; Akechi 
et al. 2001; Thielemann & Conner 2009; Turner et al. 2007; Montazeri et al. 1998; 
Siminoff, Wilson-Genderson & Baker 2010; Manne & Badr 2010; Badr & Carmack 
Taylor 2008; Zabora et al. 2001; Carlson et al. 2004; Temel et al. 2010; Hopwood 
& Stephens 2000; Buccheri 1998; Hyodo et al. 1999; Pinquart & Duberstein 2005; 
Abernethy et al. 2002; Kim et al. 2005; Wennman-Larsen et al. 2008; Ostlund et al. 
2010; Uchitomi et al. 2000), not much research is done on how to alleviate distress in 
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these groups (Walker et al. 2013). In addition, the available studies on managing the 
psychosocial care needs of  cancer patients and their families have focused on care at 
the very end of  life (e.g. Follwell et al. 2009; Jordhoy et al. 2001; Gustafson et al. 2013). 
Recently, studies have demonstrated that palliative care initiated early in treatment 
improves the quality of  life and depressive symptoms of  lung cancer patients (Temel et 
al. 2010; Greer et al. 2012). This stresses the importance of  integrating psychosocial 
care for lung cancer patients and their partners early in the treatment, rather than 
instigating it once life-prolonging therapies fail. 
In the past ten years MBSR has become a promising psychosocial intervention for 
cancer patients. Mindfulness is defined as intentionally paying attention to moment-
by-moment experiences in a non-judgmental way (Kabat-Zinn 1990). MBSR is an 
8-week group-based training consisting of  meditation practices, such as the bodyscan, 
gentle yoga, sitting and walking meditation. By repeatedly bringing attention back to 
the current experience, participants gradually learn to disengage from dysfunctional 
thoughts and directly experience the emotions and bodily sensations of  the present 
moment. MBSR aims to provide participants with the ability to step back from 
ruminating about the past or worrying about the future and simply allow experiences 
to unfold (Kabat-Zinn 1990; Segal, Williams & Teasdale 2002). A recent meta-
analysis of  13 nonrandomized studies and 9 randomized controlled trials (RCT) 
concluded there is positive evidence for the use of  mindfulness-based interventions in 
reducing psychological distress in cancer patients (Piet, Würtzen & Zachariae 2012). 
Among the RCT’s, a reduction in symptom severity was found for both anxiety and 
depression corresponding to moderate pooled controlled effect sizes (Hedges’ g = 
0.37 and Hedges’ g = 0.44, respectively) (Piet, Würtzen & Zachariae 2012). Though 
mindfulness-based interventions seem to be effective, the authors note that across 
studies the majority of  participants were women (85%) and diagnosed with breast 
cancer (77%). Compared to breast cancer patients, patients with lung cancer are more 
often male, older and have a poorer prognosis. Furthermore, of  these 22 studies only 
one study included the partners of  the patients, showing that partners also benefit 
from the MBSR training (Birnie, Garland & Carlson 2010). This is quite surprising 
since partners of  cancer patients also report high levels of  distress (Hagedoorn et al. 
2008). 
Aims     
The aim of  the Mindfulness for Lung Oncology Nijmegen (MILON) study is to 
examine the effectiveness of  MBSR compared to TAU in reducing psychological 
distress in patients with lung cancer and their partners. We hypothesize that patients 
in the MBSR group will report a lower level of  psychological distress (i.e. anxiety 
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and depressive symptoms), higher levels of  quality of  life, quality of  relationship and 
spirituality than those in the TAU group. Medical and societal costs will be lower in the 
MBSR versus TAU group. We expect partners in the MBSR group to report a lower 
level of  psychological distress and higher levels of  caregiver appraisal, relationship 
quality and spirituality than their counterparts in the TAU group. With regard to 
the working mechanisms of  the MBSR programme, we will examine changes in 
mindfulness skills, self-compassion, rumination, intrusion, avoidance and adherence 
to MBSR.
METHODS/DESIGN
Study design
The design of  the ‘MILON’ study is a parallel group randomized controlled trial with 
an embedded process study. Participants are randomized between MBSR and TAU. 
The study protocol has been approved by our ethical review board (CMO Arnhem-
Nijmegen) and registered under number 2011–519.
Participants and procedure
Patients and partners are recruited at the outpatient clinic of  the Department of  
Pulmonary Diseases, Radboud University Nijmegen Medical Centre (RUNMC) by a 
nurse practitioner and the attending physician. Patients and partners are invited to 
participate together but both are welcome to participate on their own if  they do not 
have a partner or their partner is not willing to participate. Patients and/or partners 
who are interested are provided with an information leaflet. If  they are willing to 
participate, they are invited for a research interview, in which in- and exclusion 
criteria are assessed and informed consent is taken.
At other participating hospitals (Department of  Pulmonary Diseases, Canisius-
Wilhelmina Hospital, Nijmegen; Department of  Pulmonary Medicine, Rijnstate, 
Arnhem; Department of  Oncology, Elkerliek Hospital, Helmond; Department of  
Pulmonary Medicine, Jeroen Bosch Hospital; Department of  Pulmonary Diseases, 
Maas hospital Pantein, Boxmeer) patients and their partners will be sent a letter 
with the invitation to participate in the study. One week later the researcher calls 
the patients to answer possible questions and asks whether the patient and partner 
are interested in participation. If  so, they are invited for a research interview at the 
RUNMC.
Chapter 4. MILON: trial design
66
Eligibility
We include patients and/or partners of  patients, who are (a) diagnosed with cytologically 
or histologically proven non-small cell lung cancer or small cell lung cancer and (b) 
have received or are still under treatment. Exclusion criteria for both patient and 
partner include: (a) being under 18 years of  age, (b) not being able to understand 
or use the Dutch language, (c) former participation in MBSR or Mindfulness-Based 
Cognitive Therapy (MBCT), (d) current and regular treatment by psychologist or 
psychiatrist, (e) current participation in other psychosocial programme and (f) physical 
or cognitive (<26 on the Mini-Mental State Examination (MMSE)) impairments 
hampering participation in MBSR training or completion of  questionnaires.
Baseline 
Patients and partners are interviewed to obtain demographics and clinical 
characteristics, after which they are screened for cognitive impairments with the 
MMSE (Folstein, Folstein & McHugh 1975). After that, baseline questionnaires, 
including the Distress Thermometer (DT) (Roth et al. 1998; Tuinman, Gazendam-
Donofrio & Hoekstra-Weebers 2008), are administered, followed by randomization. 
Table 1 shows the assessment instruments and time points at which the questionnaires 
are administered to patients and partners.
Randomization
Randomization is stratified according to setting and minimized for (a) stage of  disease 
(curative versus palliative), (b) baseline level of  anxiety and depressive symptoms 
(anxiety or depression subscale score of  Hospital Anxiety and Depression Scale 
(HADS) <8 versus ≥8), (c) treatment during MBSR (no treatment versus chemo- 
and/or radiotherapy) and (d) participation (patient alone versus partner alone versus 
patient and partner together). Randomization is computerized, using a randomization 
website, specifically designed for this study, on which the researcher can fill out 
the required data. The researcher communicates treatment allocation to the nurse 
practitioner, who informs the patient and/or partner.
Follow-up assessments
Follow-up assessments take place post intervention and at three-month follow-up. 
Participants who have access to the internet and have an email address receive the 
questionnaires online. If  not, they receive the questionnaires on paper along with a 
reply envelope. In case of  dropout, the researcher tries to contact the participant by 
phone to complete a minimum set of  outcome measures and to identify the main 
reason for dropout.
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Table 1. Measurements and corresponding time points for patient and partner.
Measure Target T0 T1 T2
pt pr pt pr pt pr
MMSE Cognitive Impairments x x
DT General Distress x x
HADS Anxiety and Depressive Symptoms x x x x x x
QLQ-C30 Quality of  Life x x x
QLQ-LC13 Quality of  Life x x x
SIP Impact of  Sickness x x x
SPPIC Caregiver Burden x x x
CRA-SE Caregiver Self-Esteem x x x
IMS-S Relationship Satisfaction x x x x x x
MIS Communication about Cancer x x x x x x
SAIL Spirituality x x x x x x
FFMQ Mindfulness skills x x x x x x
SCS Self-Compassion x x x x x x
RRS-EXT Rumination x x x x x x
IES Psychological stress reaction x x x x x x
Diary Health care use, work absence Monthly during study period for pt
Calendar Mindfulness adherence Monthly during study period for pt and pr    
Note. T0 = baseline measurement; T1 = post-intervention measurement; T2 = 3-month follow-
up measurement; Pt = patient; pr = partner; MMSE = Mini Mental State Examination; 
DT = Distress Thermometer; HADS = Hospital Anxiety and Depression Scale; QLQ-C30 = 
Quality of  Life – Cancer; QLQ-LC13 = Quality of  Life – Lung Cancer; SIP = Sickness Impact 
Profile; SPPIC = Self-Perceived Pressure from Informal Care; CRA-SE = Caregiver Reaction 
Assessment – Care-Derived Self-Esteem; IMS-S = Investment Model Scale-Satisfaction; MIS = 
Mutuality and Interpersonal Sensitivity; SAIL = Spiritual Attitude and Involvement List; FFMQ 
= Five Facet Mindfulness Questionnaire; SCS = Self-Compassion Scale; RRS-EXT = Rumination 
Response Scale – Extended Version; IES= Impact of  Event Scale.
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Intervention
The MBSR curriculum used is primarily based on the Mindfulness-Based Stress 
Reduction programme as developed by Kabat-Zinn (1990) but contains some 
elements of  the MBCT programme by Segal, Williams and Teasdale (2002), like 
psycho-education on the interrelatedness of  feelings, thoughts and bodily sensations. 
Moreover, some modifications have been made to make the intervention more 
suitable for patients with lung cancer and their partners, such as psycho-education 
about grief  (Kübler-Ross 1969). In addition, a mindful communication exercise in 
which partners talk with each other about the cancer was added. The programme 
consists of  8 weekly 2.5-hour sessions, a silent day between session six and seven 
and home practice assignments of  about 45 minutes, 6 days per week. Participants 
receive a set of  CDs with guided mindfulness meditation exercises for home practice 
and a folder with information and home practice instructions for the forthcoming 
week. Table 2 shows the content of  the MBSR programme per session. The MBSR 
courses are taught by mindfulness trainers with extensive training in MBSR. They 
all fulfil the advanced criteria of  the Center for Mindfulness of  the University of  
Massachusetts Medical School and maintain a regular personal meditation practice. 
Trainers were trained, supervised and assessed to ensure their competency levels met 
the qualification criteria to instruct the MBSR classes. During the trial, trainers will 
receive weekly supervision and a number of  sessions will be videotaped to evaluate 
competence and adherence with the Mindfulness-Based Interventions – Teaching 
Assessment Criteria (Crane et al. 2012). 
Primary outcome measure
Psychological distress. The primary outcome measure is the total score on the 
HADS (Zigmond & Snaith 1983; Spinhoven et al. 1997; Norton et al. 2013), which 
is developed to measure psychological distress in somatic patient populations. It 
consists of  a 7-item anxiety (HADS-A) and 7-item depression (HADS-D) subscale. 
The HADS shows good psychometric properties in the general medical population, 
including oncology patients (Bjelland et al. 2002). Internal consistency as measured 
with Cronbach’s α varied from .84 to .90 (Bjelland et al. 2002; Spinhoven et al. 
1997). Test-retest reliability was good as Pearson’s r >.80 was obtained (Spinhoven 
et al. 1997; Herrmann 1997). Though the cut-off  scores of  the HADS vary among 
populations (Vodermaier & Millman 2011), in lung cancer patients they have found 
to be <8 versus ≥8 on the HADS-A or HADS-D (Castelli et al. 2009). The HADS 
has been shown to be highly correlated with the Beck Depression Inventory. It has 
previously been used in intervention studies of  mindfulness and shown to be sensitive 
to change (e.g. (Branstrom et al. 2010)).  
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Table 2. Content of  MBSR programme per session. 
Theme of  Session Meditation exercise  Didactic teaching Homework
1. Automatic Pilot - Bodyscan -  Intention of  
participating
- Raisin exercise 
- Bodyscan
- Eating one meal mindfully
-  Attention for routine 
activity 
2.  Mindfulness of   
the breath
- Bodyscan
-  Sitting mediation with 
focus on breath
-  Imagery exercise 
to demonstrate 
relationship between 
thoughts and feelings
- Bodyscan
- Attention for breath
-  Awareness of  pleasant 
events
-  Attention for routine 
activity
3. Observing limits - Yoga while lying down, 
- 3-min breathing space
-  Seeing exercise to 
demonstrate difference 
between observation 
and interpretation
- Bodyscan or yoga
- Sitting meditation
-  Awareness of  unpleasant 
events
- 3-min breathing space
4.  Opening up to 
distress
-  Sitting mediation with 
focus on breath, body, 
sound
- 3-min breathing space
-  Interrelatedness of  
feelings, thoughts and 
bodily sensations
-  Psychoeducation about 
grief  
- Bodyscan or yoga
- Sitting meditation
-  Awareness of  stress 
reactions
- 3-min breathing space
5.  Responding to 
distress
-  Sitting mediation with 
focus on breath, body, 
sound,  thoughts, 
difficulty 
- Walking meditation
- 3-min breathing space
-  Reacting versus 
responding
- Coping with grief  
- Meditation by choice
-  Awareness of  reaction in 
difficult situation
-  Awareness of  
communication difficulties 
- 3-min breathing space
6.  Mindful 
Communication
- Yoga in standing position
- 3-min breathing space
-  Mindful 
communication exercise 
about effect of  lung 
cancer with their own 
partner
- Sitting meditation or yoga
-  Awareness of  
communication 
-  3-min breathing space 
during stress
Silent day -  Varying meditation 
exercises
- Silent lunch and tea break
7.  Taking Care of  
Yourself
-  Sitting meditation ending 
in choiceless awareness
-  Yoga or walking 
meditation
- 3-min breathing space
-  Exercise on taking 
care of  yourself  by 
examining how to 
improve balance in life
- Meditation without CD
- Reflect on training
8.  The Rest of  Your 
Life
- Bodyscan
- Sitting meditation
- Reflection on training
- Maintaining practice 
-  Further sources of  
information 
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Secondary outcome measures
Quality of  life (only for patients). The European Organisation for Research and 
Treatment of  Cancer (EORTC) Core Quality of  Life Questionnaire (QLQ-C30) 
(Bjordal et al. 2000) is included, along with the supplemental Lung Cancer questionnaire 
module (QLQ-LC13) (Bergman et al. 1994). The QLQ-C30 is designed to use in 
clinical trials on physical treatments for cancer patients. It incorporates five functional 
scales (physical, role, cognitive, emotional, social), three symptom scales (fatigue, 
pain, nausea and vomiting), a global health and quality of  life scale and an array of  
single-item symptom measures. After revisions in the role functioning, global health 
and physical functioning scale, internal consistency of  the subscales varied between 
.65 and .94,  except for the cognitive functioning scale with  varying from .56 to .63 
(Osoba et al. 1994; Osoba et al. 1997; Bjordal et al. 2000). Test-retest varied from .63 
to .86 (Hjermstad et al. 1995). The lung cancer questionnaire module is designed to 
supplement the core questionnaire and comprises specific symptoms associated with 
lung cancer (coughing, haemoptysis, dyspnoea, pain) and side-effects from conventional 
chemo- and radiotherapy (hair loss, neuropathy, sore mouth, dysphagia). While the 
multi-item dyspnoea scale showed high internal consistency, the pain subscale did not. 
When combined with the dyspnoea and pain items of  the core questionnaire, both the 
dyspnoea (α = .86) and pain (α = .71) subscale showed high internal consistency. Since 
the QLQ-C30 and QLQ-LC13 are mainly focused on physical symptoms, we added the 
items Social Interaction and Alertness Behaviour of  the Sickness Impact Profile (SIP) 
(Bergner et al. 1981). Internal consistency was .94 and test-retest reliability was .92. The 
SIP correlated with self-assessed sickness and dysfunction (Bergner et al. 1981).
Caregiver appraisal (only for partners). We use the 9-item Self-Perceived Pressure 
from Informal Care (SPPIC) (Pot, Van Dyck & Deeg 1995) to assess the extent to 
which caregiving is experienced as burdensome. To also measure positive aspects of  
caregiving, the 9-item subscale Care-Derived Self-Esteem of  the Caregiver Reaction 
Assessment (CRA-SE) (Given et al. 1992) is included. Internal consistency of  the 
SPPIC was .79 and of  the CRA-SE was .73. The SPPIC and CRA-SE were unrelated 
to each other (Nijboer et al. 1999). 
Relationship quality. To measure relationship satisfaction we included the 10-item 
Satisfaction subscale of  the Investment Model Scale (IMS-S) (Rusbult, Martz & Agnew 
1998). Internal consistency varied from .79 to .95 and the IMS-S was related to the 
Dyadic Adjustment Scale. Also, the Mutual Interpersonal Sensitivity scale (MIS) 
(Lewis et al. 2008) is included to measure communication between partners about the 
cancer. It contains 18 items and is divided into two scales: open communication and 
avoiding negative thoughts about the cancer. 
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Spirituality is measured with the Spiritual Attitude and Involvement List (SAIL) (de 
Jager-Meezenbroek et al. 2006) and consists of  26 items, divided into the subscales 
meaningfulness, trust, acceptance, caring for others, connectedness with nature, 
transcendent experiences, and spiritual activities. The internal consistency varied 
from .74 to .88 and test-retest reliability varied from .77 to .92. All subscales, except 
for connectedness with nature, were related with the Functional Assessment of  
Chronic Illness Therapy - Spiritual Well-Being Scale. 
Costs (only for patients)
The cost-effectiveness evaluation is carried out from a societal perspective, considering 
direct as well as indirect health costs. Data on costs are collected prospectively using 
a diary in which participants register a) health care utilization: the type of  care and 
its duration, and b) cancer-related absence from work. Unit cost estimates are derived 
from the national manual for cost prices in the health care sector (Hakkaart-Van 
Roijen, Tan & Bouwmans 2010 [[in Dutch] actualized version]). Costs of  reduced 
ability to work are estimated using the friction costs method, which results in a more 
realistic estimate than the human capital approach (Koopmanschap et al. 1995). 
Treatment costs of  MBSR are calculated using activity-based-costing methods, thus 
measuring actual resources (time of  therapist, time of  patients, facilities) used. All 
unit cost prices are adjusted to 2013 prices. Unit cost estimates are combined with 
resource utilization data to obtain a net cost per patient over the entire follow-up 
period. 
Process measures
Mindfulness skills are examined with the 39-item Five Facet Mindfulness 
Questionnaire (FFMQ) (Baer et al. 2008; Veehof  et al. 2011). The FFMQ is based on 
an exploratory factor analysis of  five mindfulness measures, which allowed items from 
different instruments to combine to form factors, providing an empirical integration 
of  these independent attempts to operationalize mindfulness. This led to the following 
five subscales: observing, describing, acting with awareness, non-judging of  inner 
experience and non-reactivity to inner experience. Internal consistency varied from 
.72 to .93 among the different subscales. Most subscales were related to meditation 
experience, Psychological Well-Being scales and psychological symptoms, including 
the Brief  Symptom Inventory (Baer et al. 2008). FFMQ is sensitive to change in 
mindfulness-based interventions and is found to mediate the relationship between 
mindfulness practice and improvements in psychological symptoms (e.g. Carmody & 
Baer 2008).
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Self-compassion is assessed with the Self  Compassion Scale (SCS) (Neff 2003; Neff & 
Vonk 2009), which has 26 items and is divided into six subscales: self-kindness versus self-
judgment, common humanity versus isolation, and mindfulness versus over-identification. 
Internal consistency of  the different subscales varied from .75 to .81 and test-retest 
reliability varied from .80 to .93. SCS correlated moderately with self-esteem measures, 
including the Rosenberg Self-Esteem Scale. Furthermore, whereas the self-esteem 
measures correlated significantly with the Narcissistic Personality Inventory, the SCS was 
unrelated to narcissism (Neff 2003). SCS is sensitive to change through mindfulness-based 
interventions and is found to mediate MBCT’s treatment effects (Kuyken et al. 2010). 
To measure rumination we administered the extended version of  the Ruminative Response 
Scale (RRS-EXT) (Treynor, Gonzalez & Nolen-Hoeksema 2003; Raes & Hermans 2007). 
The RRS-EXT contains 26 items in which a more adaptive thinking style (i.e. reflection) 
is distinguished from a more maladaptive one (i.e. brooding). Internal consistency varied 
from .72 to .77 and test-retest reliability varied from .60 to .62 for the brooding and 
reflection subscales. The concept of  rumination seems to be sensitive to change through 
mindfulness-based interventions and has been shown to mediate the effect of  MBSR on 
depressive symptoms in oncology patients (Labelle, Campbell & Carlson 2010).
The psychological stress reaction is measured with the 15-item Impact of  Event Scale (IES) 
(Horowitz, Wilner & Alvarez 1979; Brom & Kleber 1985), which assesses two categories 
of  responses: intrusive experiences and avoidance of  thoughts and images associated 
with the event. Internal consistency varied from .65 to .92 (Sundin & Horowitz 2002) 
and test-retest reliability varied from .79 to .87 among the subscales (Horowitz, Wilner 
& Alvarez 1979). IES correlated with anxiety and depression subscales of  the General 
Health Questionnaire.
Adherence to MBSR is assessed during the entire study period with a calendar on which 
participants in the MBSR condition fill out on a daily basis whether they adhere to the 
mindfulness exercises: either formal practice (e.g. meditation exercise like the bodyscan), 
informal practice (e.g. activity with awareness) or no exercise. Adherence to MBSR has 
been shown to mediate the effects of  MBCT on depressive symptoms (Van Aalderen et 
al. 2012). 
Statistical analysis plan
Sample Size 
To determine the required sample size, first the sample size was calculated that would 
be needed for a simple t-test and subsequently it was corrected for clustering, repeated 
measurements and baseline. A two-sided t-test on the total HADS score (Zigmond & Snaith 
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1983; Spinhoven et al. 1997) (i.e. our primary outcome measure, examining psychological 
distress (HADS-total), anxiety symptoms (HADS-A) and depressive symptoms (HADS-D)) 
would require 64 participants in each group to have 80% power to detect a medium-sized 
difference (effect size = 0.5) with alpha = 0.05. To correct for clustering, we multiplied this 
sample size of  64 with the design factor (1+(n-1)*ICC), where n denotes the cluster size 
and where ICC denotes the intra-cluster correlation. In our study, the treatment groups 
will consist of  14 people, of  whom about 7 will be patients. With n = 7 and an estimated 
ICC = 0.01 (Van Aalderen et al. 2012), the correction factor equals 1.06. To correct for 
repeated measurements and the use of  the baseline measurement as a covariate, we multiplied 
the required sample size by the design factor ((1+ρ)/2-ρ0
2), where ρ denotes the correlation 
between the post-treatment HADS measurements, and ρ0 denotes the correlation between 
the baseline HADS with the post-treatment HADS measurements. With ρ = 0.8 and 
ρ0 = 0.5 as conservative estimates, the second design factor equals 0.65. Consequently, 
after correction for clustering and covariates, we arrived at a required sample size of  
0.65*1.06*64=44 patients per arm. So, 88 patients with lung cancer would be required 
for the study. Based on our pilot study (Van den Hurk et al. 2015), we expect a 20% 
dropout rate. Therefore, we intend to include 110 patients and 110 partners. 
Primary analysis
The samples of  lung cancer patients and partners will be analyzed separately. Baseline 
characteristics of  the population will be compared between MBSR and control group to 
ensure that key variables were evenly distributed by randomization. First, analyses will 
be based on the intention-to-treat approach. Next, we will perform per-protocol analyses 
with the treatment-adherent sample (i.e. in the MBSR condition participants have to 
attend at least four of  the eight MBSR sessions (Teasdale et al. 2000) and in the TAU 
condition participants do not attend a mindfulness-based programme). 
We will use linear mixed models to analyze all outcome variables (i.e. anxiety and 
depressive symptoms, quality of  life (only for patient), caregiver appraisal (only for partner), 
relationship quality and spirituality), with treatment as fixed factor, baseline measurement 
as covariate and a random intercept based on MBSR group. This procedure will use all 
observed data in our analyses. In addition, Cohen’s d effect size (Cohen 1988) will be 
reported based on the difference between the group means on baseline and follow-up 
scores, divided by the pooled standard deviation at baseline and follow-up. 
Secondary analyses
Cost Effectiveness. The quality of  life measures (i.e. QLQ-C30; QLQ-LC13) will be 
used to calculate Quality of  Adjusted Life Years (QALYs) for each individual. Costs 
and effects (in terms of  QALYs) will be combined in the incremental cost-effectiveness 
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ratio (ICER). The ICER expresses cost-effectiveness in terms of  incremental costs 
per QALY gained. To estimate confidence intervals for the mean of  the ICER a 
non-parametric bootstrapping method will be used, performing 1000 replications of  
the original data. In order to express the implications of  the cost-effectiveness results 
more clearly, a cost-acceptability curve will be constructed. In case of  dominance, a 
full cost analysis will be conducted to estimate the mean savings per patient per year. 
Mediation Analysis. To examine the possible underlying mechanisms of  change 
in MBSR, mediation analyses will be conducted. Only the data of  the treatment-
adherent sample will be included in these analyses. By means of  a multiple mediation 
model suggested by Preacher and Hayes (Preacher & Hayes 2008), we will test the 
mediating effect of  mindfulness skills, self-compassion, rumination and adherence to 
MBSR on anxiety and depressive symptoms, quality of  life (only in patients), caregiver 
appraisal (only in partners), relationship quality and spirituality.
DISCUSSION
In the last ten years MBSR has not only proven to be a feasible and acceptable 
intervention in cancer patients (Würtzen et al. 2012), but it also seems to be effective 
in reducing psychological distress (Piet, Würtzen & Zachariae 2012). However, the 
generalization of  these results is limited because most participants were female patients 
with breast cancer. A large part of  lung cancer patients already have advanced cancer 
at time of  diagnosis and are confronted with a poor prognosis and low health status. 
Consequently, they more often report psychological distress than patients with other 
diagnoses of  cancer (Zabora et al. 2001; Carlson et al. 2004). Hence, it is not yet clear 
whether MBSR is a feasible, acceptable and effective intervention in patients with 
lung cancer. Moreover, little is known about the effectiveness of  MBSR in partners 
of  cancer patients (Piet, Würtzen & Zachariae 2012), though they also often report 
psychological distress. 
Our pilot study of  19 lung cancer patients and 16 partners participating in an MBSR 
course provides preliminary evidence that MBSR is feasible and acceptable in this 
population (Van den Hurk et al. 2015). The current trial will answer the question 
whether MBSR is effective in patients with lung cancer and their partners. 
We started enrolment of  participants in February 2012. At the moment, we think 
recruiting a sufficient number of  patients and partners will be a challenge due to 
rapidly fluctuating health status and sudden changes in cancer treatment (Schofield 
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et al. 2008). Currently, the main reasons for declining participation in patients is 
‘being too ill’ or that it is ‘too much of  a burden during chemo and/or radiotherapy’. 
Furthermore, no perceived need or motivation for the training is commonly mentioned. 
Among partners, participation is highly depending on whether the patient is willing to 
participate. Although partners can take part separately, partners who are interested 
do often not participate when the patients decline participation. 
Considering the difficulty of  studying lung cancer patients and their partners 
(Schofield et al. 2008), our trial will offer valuable information on whether MBSR, as 
one of  the few available psychosocial care programmes, contributes to the alleviation 
of  their psychological distress. 
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ABSTRACT
Background
Lung cancer patients report among the highest distress rates of  all cancer patients. 
Partners report similar distress rates. The present study examined the effectiveness 
of  additional Mindfulness-Based Stress Reduction (CAU+MBSR) versus solely care 
as usual (CAU) to reduce psychological distress in lung cancer patients and/or their 
partners. 
Methods
We performed a multicentre, parallel-group, randomized controlled trial. MBSR is 
an 8-week group-based intervention, including mindfulness practice and teachings 
on stress. CAU included anti-cancer treatment, medical consultations and supportive 
care. The primary outcome was psychological distress. Secondary outcomes included 
quality of  life, caregiver burden, relationship satisfaction, mindfulness skills, self-
compassion, rumination and post-traumatic stress symptoms. Outcomes were assessed 
at baseline, post-intervention and 3-month follow-up. Linear mixed modeling was 
conducted on an intention-to-treat sample. Moderation (gender, disease stage, baseline 
distress, participation with/without partner) and mediation analyses were performed. 
Results
31 patients and 21 partners were randomized to CAU+MBSR and 32 patients 
and 23 partners to CAU. After CAU+MBSR patients reported significantly less 
psychological distress (p = .008, d = .69) than after CAU. Baseline distress moderated 
outcome: those with more distress benefitted most from MBSR. Additionally, after 
CAU+MBSR patients showed more improvements in quality of  life, mindfulness 
skills, self-compassion and rumination than after CAU. In partners, no differences 
were found between groups.
Conclusion
Our findings suggest that psychological distress in lung cancer patients can be 
effectively treated with MBSR. No effect was found in partners, possibly because they 
were more focused on patients’ wellbeing rather than their own.
Trial Registration: ClinicalTrials.gov (NCT01494883).
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INTRODUCTION
Lung cancer is the leading cause of  death by cancer worldwide and ranks number 
5 of  most burdensome diseases in western countries (WHO 2012). Lung cancer 
patients report among the highest rates of  psychological distress (43-58%) of  all 
cancer patients (Carlson et al. 2004). Partners report similar rates of  distress (Mosher, 
Bakas & Champion 2013). In addition, patients and partners seem to mutually affect 
one another, such that distress or wellbeing in patients affects those in partners, and 
vice versa (Manne & Badr 2008). This suggests both patients and partners should be 
included when treating distress in (lung) cancer. Possibly because of  the poor prognosis 
and fast deterioration of  physical health, limited research has been conducted in lung 
cancer on how to reduce patients’ and partners’ distress (Walker et al. 2013). 
There are multiple treatments that have been found effective in reducing psychological 
distress in cancer patients. Cognitive Behavioural Therapy, for example, focuses on 
challenging dysfunctional thoughts in order to change them into more realistic/
helpful ones (Beck 2005). However, as one of  the major challenges of  lung cancer is to 
emotionally come to terms with the existence of  the cancer rather than challenging it, 
experiential approaches which emphasize acceptance, allowing emotions and letting 
them take their natural course, might be more helpful (Kabat-Zinn 1990). MBSR 
is a group-based training in which participants practice mindfulness and receive 
teaching on stress. Mindfulness is defined as paying attention to present moment 
experiences in a non-judgmental way (Kabat-Zinn 1990). Several meta-analyses in 
cancer patients showed that compared to care as usual (CAU), mindfulness-based 
interventions (MBIs) are effective in improving psychological distress with moderate 
effect sizes (Piet, Würtzen & Zachariae 2012). Randomized controlled trials (RCT) 
also demonstrated MBIs effectiveness on fatigue, pain and quality of  life (Carlson et 
al. 2013; Johannsen et al. 2016; Lengacher et al. 2016).
Although MBIs seem effective in cancer patients, the generalizability of  these findings 
is limited because the vast majority of  study participants so far were women, had 
breast cancer and were curatively treated (Piet, Würtzen & Zachariae 2012). Hardly 
any evidence is available on the effectiveness of  MBIs in lung cancer patients (Lehto 
et al. 2015; Van den Hurk et al. 2015). In addition, only three non-randomized studies 
on MBIs for cancer patients included partners (Birnie, Garland & Carlson 2010; 
Lengacher et al. 2012; Van den Hurk et al. 2015). 
The aim of  this study was to examine the effectiveness of  MBSR added to CAU 
compared to CAU alone to reduce psychological distress in patients with lung cancer 
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and/or their partners. Secondary outcomes included quality of  life, caregiver burden, 
relationship satisfaction, mindfulness skills, self-compassion, rumination and post-
traumatic stress symptoms. Additionally, we examined potential moderating effects of  
gender, disease stage, baseline distress levels and participation with/without partner. 
We also explored the potential mediating role of  mindfulness skills, self-compassion 
and rumination. 
METHODS
Study design 
Following CONSORT guidelines (Schulz, Altman & Moher 2010), we conducted 
a multicentre, parallel-group, RCT comparing CAU+MBSR with CAU. The trial 
protocol has been published previously (Schellekens et al. 2014) and received approval 
by the local medical ethics committee (CMO Arnhem-Nijmegen, 2011-519).
Participants
The study population consisted of  patients and/or partners of  patients presenting 
with cytologically or histologically proven non-small cell or small cell lung cancer. 
Patients in the curative and palliative stage were included, with stage being based on 
the intent of  the anti-cancer treatment. To facilitate patients and partners they could 
decide how they wanted to participate, such that patients and partners were invited 
to participate together but both were welcome to participate alone if  preferred. 
Depending on whether the patient had a life partner who was willing to participate, 
“partners” could be the life partner or another close relative/friend. Exclusion 
criteria for patients and partners were: <18 years of  age, insufficient understanding 
of  Dutch language, former MBI participation, current participation in other 
psychosocial programme, current weekly treatment by psychologist/psychiatrist, 
physical impairments (i.e. hospitalization, life expectancy shorter than study period) 
or cognitive impairments (i.e. Mini-Mental State Examination <26 (Folstein, Folstein 
& McHugh 1975)) hampering participation. 
Patients and/or partners were recruited at the Radboud university medical centre 
Nijmegen, Canisius-Wilhelmina Hospital Nijmegen, Rijnstate Hospital Arnhem, 
Jeroen Bosch Hospital ‘s-Hertogenbosch, Elkerliek Hospital Helmond, Pantein 
Hospital Boxmeer by the nurse practitioner via telephone, invitation letter or face-
to-face. Interested patients and/or partners were invited for a research interview, 
in which eligibility criteria were checked, further explanation about the study was 
provided and written informed consent was obtained. 
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Randomization
Participants were randomly allocated to CAU+MBSR or CAU (ratio 1:1) via a 
randomization website specifically designed for this study. When participating together 
partners received the same treatment allocation as patients. Randomization was 
stratified by hospital and minimized by disease stage (curative versus palliative), baseline 
distress level (anxiety or depression subscale of  Hospital Anxiety and Depression Scale 
(HADS) ≥8), current versus no anti-cancer treatment (chemotherapy/radiotherapy) 
and participation (together versus patient or partner alone). A nurse practitioner 
enrolled participants in the trial, the researcher performed randomisation, after which 
the nurse practitioner informed the participants.
MBSR
The intervention was based on the original 8-week MBSR programme, consisting 
of   2.5-hour weekly sessions and one 6-hour silent day, including daily 45-min home 
practice (Kabat-Zinn 1990). Mindfulness exercises, such as bodyscan, gentle yoga, 
sitting and walking meditation were practiced. Participants received teachings on 
stress and grief, and were invited to share their experiences. For more details, see study 
protocol (Schellekens et al. 2014). Three formally trained MBSR teachers fulfilling the 
advanced criteria of  the Center for Mindfulness of  the University of  Massachusetts 
Medical School ran 9 MBSR groups in total with on average 9 participants per group 
(consisting of  both study participants and patients with other cancer types). Teachers 
maintained daily meditation practice and received regular peer supervision. Two 
experienced MBSR teachers/assessors, of  which one was independent of  the trial, 
rated two videotaped sessions for each teacher with the MBI Teaching Assessment 
Criteria (MBI:TAC) (Crane et al. 2012). They discussed the ratings and made an 
overall judgment of  teacher competence and programme adherence. One teacher 
was rated at beginner level and left the trial after two courses. The other two teachers 
were rated as proficient. The different teachers did not affect outcomes in patients 
and partners. 
CAU
In both groups, CAU consisted of  anti-cancer treatment (i.e. surgery, chemotherapy, 
radiotherapy), medical consultations and supportive care, including psychosocial care 
(e.g. visits to psychiatrist/psychologist, participation in psychosocial programme). 
After participation CAU participants were invited to MSBR. 
Outcome
The primary outcome for patients and partners was the total HADS score, a 14-
item questionnaire developed to assess psychological distress in patients with somatic 
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conditions (Zigmond & Snaith 1983). It includes an anxiety and depression subscale 
and shows good psychometric properties in the general medical population, including 
oncology patients (Bjelland et al. 2002). In the present study internal consistency was 
.90 in patients and .89 in partners.
Secondary outcomes for patients included quality of  life (European Organisation for 
Research and Treatment of  Cancer (EORTC) Quality of  Life Questionnaire-Global 
Health Status subscale (QLQ-C30-GHS) (Bjordal et al. 2000)), for partners caregiver 
burden (Self-Perceived Pressure from Informal Care (SPPIC) (Pot, Van Dyck & Deeg 
1995)), for patients and partners relationship satisfaction (Investment Model Scale-
Satisfaction subscale (IMS-S) (Rusbult, Martz & Agnew 1998)), mindfulness skills 
(Five Facet Mindfulness Questionnaire (FFMQ) (Baer et al. 2008)), self-compassion 
(Self-Compassion Scale (SCS) (Neff  2003)), rumination (Ruminative Response Scale-
Brooding subscale (RRS-BR) (Treynor, Gonzalez & Nolen-Hoeksema 2003)), and 
post-traumatic stress symptoms (Impact of  Event Scale (IES) (Horowitz, Wilner & 
Alvarez 1979)). All questionnaires showed acceptable to excellent internal consistency 
(.70-.93) in patients and partners. Assessments took place at baseline (T0), post 
intervention (T1) and three months post T1 (T2). See study protocol for further details 
(Schellekens et al. 2014). Information about patients’ frequency and nature of  health 
care use during the intervention period was collected via monthly self-reported health 
care diaries. Questions included visits to health care professionals and participation 
in psychosocial programmes.
Statistical analyses
We used G*Power to first calculate the sample size needed for an independent samples 
t-test. The power analysis was corrected for clustering using the factor (1+(n-1)*ICC) 
(Campbell et al. 2004) and corrected for repeated measurements and baseline distress 
using the factor ((1+ρ)/2-ρ0
2) (Borm, Fransen & Lemmens 2007). We also took account of  
a 20% dropout rate, resulting in a required number of  110 patients and 110 partners to 
detect a medium-sized difference (0.5) with 80% power and alpha ≤.05. As the recruitment 
rate was slower than anticipated, we extended the recruitment period from 2 to 3.5 years 
resulting in a sample of  63 patients and 44 partners.
Data of  patients and partners were analyzed separately. All analyses were conducted 
using (1) intention-to-treat (ITT) (i.e. all cases with T0 and either T1 and/or T2 scores) 
and (2) per-protocol (PP) samples (i.e. cases with ≥4 MBSR sessions in CAU+MBSR and 
no MBSR participation in CAU). Using linear mixed models, the T1 and T2 scores that 
were nested within individuals were compared between groups. We controlled for the 
T0 score and a priori specified variables, i.e. stratification and minimization variables 
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(Kraemer 2015). When no group × time interaction was found, the interaction term was 
dropped from the analysis for the respecting outcome variable. As the random effects for 
MBSR groups were negligible, analyses were conducted without group as random effect. 
Cohen’s d effect size was based on the difference between pooled group means (T1 and 
T2), divided by the pooled baseline standard deviation. Sensitivity analyses based on last 
observation carried forward (LOCF) and complete cases (CC; i.e. completed T0, T1, T2) 
were performed. Moderation was examined by adding the potential predictor and its 
interaction with group to the model. The following predictors were used: gender, disease 
stage (curative/palliative), baseline psychological distress and participation with/without 
partner. Mediation analyses were performed on PP sample, using the multiple mediation 
model by Preacher & Hayes (Preacher & Hayes 2008). We examined whether T0 to T1 
change in potential mediators (mindfulness skills, self-compassion, rumination, post-
traumatic stress symptoms) mediated T0 to T2 change in psychological distress.
I. RESULTS IN LUNG CANCER PATIENTS
Study sample
Between February 2012 and April 2015, 410 patients were assessed for eligibility. 
Of  the 359 eligible patients, 63 patients (18%) participated (Figure 1). Participating 
patients were younger (M = 58.7; SD = 7.9) than those refusing (M = 63.6; SD = 12.9, 
p = .030), but they did not differ in gender. Forty-one patients (65%) participated 
with a partner. There were no baseline differences between CAU+MBSR and CAU 
patients (Table 1), with the exception that CAU+MBSR patients reported a shorter 
time since diagnosis (p = .036) and more often received anti-cancer treatment during 
the intervention period (p = .039; Table 1) than CAU patients. Based on the cut-off  
level of  our screening study (HADS ≥15) (Schellekens, Van den Hurk et al. 2016), 
22 patients (35%) reported clinically heightened distress at baseline. Health care 
diaries, which were completed by 46 (75%) patients, indicated that visits to health care 
professionals and participation in psychosocial programmes did not differ between 
CAU+MBSR and CAU (Table S1).
There were no baseline characteristic differences between patients who were completers 
(n = 20; 65%) and non-completers of  MBSR (n = 11; 35%). The average time between 
filling out T0 and T1 was 3.5 months (SD = 1.1) and T1 and T2 was 3.1 months (SD = 0.8). 
Missing data at T1 and T2 assessment were equally distributed between CAU+MBSR 
and CAU. Patients not completing T1 and/or T2 assessment were more often in the 
palliative disease stage (71%) than patients completing both assessments (36%, p = .007). 
Six patients (10%) died during the study period. 
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Figure 1. CONSORT flow diagram.
Note. Completed MBSR = participated ≥ 4 sessions; Qs = questionnaires; FU = Follow-up; ITT = 
Intention-to-treat; PP = per protocol.
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Table 1. Baseline characteristics of  patients and partners.
Patients Partners
MBSR
(n = 31)
CAU
(n = 32) p
MBSR 
(n = 21)
CAU
(n = 23) p
Demographic characteristics, n (%) A
Age, M (SD) B 60.6 (6.8) 57.0 (8.5) .072 60.8 (8.2) 56.6 (10.4) .152
Gender .374 .967
     Females 18 (58) 15 (47) 12 (57) 13 (47) 
     Males 13 (42) 17 (53) 9 (43) 10 (53)
Marital status .758 .387
     Married / living together 27 (87) 27 (84) 20 (95) 21 (91)
     Alone / divorced / widowed 4 (13) 5 (16) 1 (5) 2 (9)
Education level C .906 .319
     Low 11 (36) 13 (41) 3 (14) 5 (22)
     Intermediate 11 (36) 10 (31) 9 (43) 13 (57)
     High 9 (29) 9 (28) 9 (43) 5 (22)
Currently employed 12 (38) 12 (39) .921 12 (57) 9 (39) .232
Clinical Characteristics, n (%) A
Tumour Type D .511
     Non-small cell 28 (90) 26 (81)
     Small cell 2 (7) 5 (16)
     Mesothelioma 1 (3) 1 (3)
Disease stage .379
     Curative 14 (45) 18 (56)
     Palliative 17 (55) 14 (44)
TNM Stage .981
     I 5 (16) 5 (16)
     II 3 (10) 3 (9)
     III 13 (42) 15 (19)
     IV 10 (32) 9 (28)
Months since diagnosis, M (SD) B 4.8 (4.5) 9.3 (10.8) .036
Current treatment .039
     Chemotherapy 15 (48) 6 (19)
     Radiotherapy 1 (3) 0 (0)
     Chemo- and Radiotherapy  0 (0)   1 (3) 
Note. A χ2test. B Independent Samples t-test. C Low = primary/lower secondary education; 
intermediate = upper secondary education; high = higher vocational training/university. D Despite 
inclusion criterion of  non-small and small cell lung cancer, two mesothelioma patients participated. 
Given these patients met the other eligibility criteria, we chose to retain them in the analyses.
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Table S1. The care as usual patients received in CAU+MBCT and CAU during intervention 
period. 
Care MBSR (n = 23)
n (%)
CAU (n = 23)
n (%)
p A
Medical consultant 22 (96) 19 (83) .155
Psychologist /psychiatrist 2 (8) 4 (17) .333
General practitioner 15 (65) 14 (61) .760
Physiotherapist 7 (30) 11 (48) .227
Nurse practitioner 17 (74) 16 (70) .743
Psychosocial intervention 2 (8) 1 (4) .500
Note. A Based on Chi-square test.
Effectiveness
ITT analyses revealed that patients in CAU+MBSR showed significantly less 
psychological distress at post-intervention and follow-up than those in CAU (p = .008, 
d = .69; Table 2). Examining the HADS subscales, CAU+MBSR patients reported 
less anxiety (Mean difference of  2.78, p = .007, d = .62) and less depressive symptoms 
(Mean difference of  -2.55, p = .027, d = .69) than CAU patients. Additionally, we found 
significant improvement in four of  six secondary outcomes: quality of  life (p = .047, 
d = .60), mindfulness skills (p = .001, d = .84), self-compassion (p = .009, d = .80) and 
rumination (p = .018, d = .67; Table 2). We also found a trend showing improvement in 
post-traumatic stress symptoms (p = .051, d = .37). PP analyses (n = 39) and sensitivity 
analysis based on LOCF (n = 63) and CC (n = 38) did not reveal any differences in 
direction or significance for the outcomes. Only PP and CC analysis on quality of  life 
were exceptions, showing no significant difference between groups. 
Moderation 
Baseline distress predicted the difference in psychological distress between 
CAU+MBSR and CAU (p = .023). With each additional unit of  baseline distress, 
the difference between CAU+MBSR and CAU increased with 0.52 (95% CI = 0.08; 
0.96). Gender, disease stage and participation with/without partner did not moderate 
the intervention effect. 
Mediation
The process measures that significantly improved after MBSR (mindfulness skills, 
self-compassion, rumination) were selected for mediation analysis. Bootstrapping the 
indirect effect of  intervention on psychological distress via the potential mediators 
showed no significant effects (as the confidence intervals contained zero), indicating 
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that baseline to post-intervention changes in mindfulness skills (95% CI = -.15; .09), 
self-compassion (95% CI = -.23; .04) and rumination (95% CI = -.19; .08) did not 
mediate the follow-up effect on psychological distress.
II. RESULTS IN PARTNERS
Study sample
Of  the 410 patients assessed for eligibility, 79 did not have a partner, of  37 it was 
unknown and of  22 patients the partner had not been assessed, leaving 272 partners 
to be assessed for eligibility (Figure 1). Of  the 249 eligible partners, 44 (18%) 
participated. Three partners (7%) participated without a patient. Partners were either 
the life partner (n = 38), ex-partner (n = 1), relative (n = 3) or friend (n = 2). There 
were no baseline differences between partners in CAU+MBSR and CAU (Table 1). 
Based on the cut-off  level of  our screening study (HADS ≥15) (Schellekens, Van den 
Hurk et al. 2016), 19 partners (43%) reported clinically heightened distress at baseline.
There were no baseline characteristic differences between completers (n = 13; 62%) 
and non-completers of  MBSR (n = 8; 38%). The average time between filling out T0 
and T1 was 3.2 months (SD = 0.7) and T1 and T2 was 3.3 months (SD = 0.9). Missing 
data at T1 and T2 assessment were equally distributed between CAU+MBSR and 
CAU. Partners who completed both assessments were more often life partners (93%) 
than those not completing T1 and/or T2 (69%, p = .032). 
Effectiveness
ITT analyses did not show any differences at post-intervention and follow-up 
between CAU+MBSR and CAU partners in psychological distress or any secondary 
outcome (Table 3). We did find a trend that relationship satisfaction decreased after 
CAU+MBSR compared to CAU (p = .055, d = .63). PP analyses (n = 32) and sensitivity 
analysis based on CC (n = 31) and LOCF (n = 44) resulted in similar findings. 
Moderation
Neither gender, nor distress levels or participation with/without patient moderated 
intervention outcome. 
Mediation
No mediation analyses were conducted as no significant effects on either outcome or 
potential mediator variables were found.
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DISCUSSION
This is the first identified RCT examining MBSR in addition to CAU in lung cancer 
patients and/or their partners. In patients, CAU+MBSR resulted in significant 
improvements in psychological distress, quality of  life, mindfulness skills, self-
compassion and rumination up until 3-month follow-up. They also tended to improve 
on psychological stress symptoms. Our findings correspond with former RCTs 
demonstrating the beneficial impact of  MBIs in patients with other cancer types, mainly 
breast cancer (Piet, Würtzen & Zachariae 2012). In line with previous research, baseline 
distress levels moderated outcome (Schneider et al. 2010). More distressed patients 
benefitted more than those less distressed. Change in mindfulness skills, self-compassion 
and rumination did not appear to mediate the effect of  MBSR on psychological distress 
at follow-up. However, statistical power was limited and future studies should explore 
this further. In contrast with our pilot study (Van den Hurk et al. 2015), in partners 
MBSR did not affect psychological distress or any other outcome measure. Other pilot 
studies showed mixed findings, with partners reporting no improvement (Lengacher et 
al. 2012) or less mood disturbance and stress after MBI participations (Birnie, Garland 
& Carlson 2010).  
An important limitation of  the current trial is the small sample size as a result of  difficulties 
with enrolment. Merely 18% of  all eligible patients and partners participated. The main 
reason for refusing participation was that patients and partners thought they did not 
need psychosocial support. Other patients felt too burdened by their physical symptoms 
or anti-cancer treatment to participate. Some, however, refused participation because 
they found talking about the cancer too distressing. These people might actually benefit 
most from MBSR, as becoming aware of  fears and worries might help participants 
to acknowledge rather than avoid thoughts and feelings, which can facilitate coping 
(Kabat-Zinn 1990). In addition to low enrolment, about a third of  patients and partners 
dropped out the intervention. Moreover, in both conditions patients and partners 
dropped out the study resulting in missing data (25-29%). Previous psychosocial studies 
in lung cancer reported similar dropout rates (Schofield et al. 2013), mostly due to 
physical impairments caused by either illness progression or anti-cancer treatment. 
The fact that patients who did participate benefitted from the intervention, stresses the 
importance of  reaching those for whom MBSR might be beneficial. It might be helpful 
if  psychosocial interventions such as MBSR would be better integrated in regular cancer 
care. Screening for psychological distress might be a first step to make both professionals 
and patients aware of  patients’ psychosocial needs. Given the cancer and mental health 
stigma, it might be important to support physicians to discuss MBSR with their patients, 
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particularly with those who may not be ready for therapy. Offering mindfulness training 
to physicians themselves, enabling them to offer short-term techniques to patients, or 
offering open introductory workshops to all who might be interested might be interesting 
options for this. In addition to the classical face-to-face format, individual, online or 
blended care versions of  MBSR could be developed to facilitate patients with poor 
functioning to participate.
MBSR participation did not affect patients’ relationship satisfaction. Patients scored 
high on relationship satisfaction at baseline, leaving little room for improvement. As 
patients are very sick and depend on the care of  their partner, patients might be reluctant 
to report dissatisfaction about their relationship. Partners did not seem to benefit from 
MBSR and in contrast with previous studies (Regan et al. 2012), their relationship 
satisfaction even tended to increase more after CAU than after CAU+MBSR, possibly 
because partners assume the role of  caregiver. Caregivers are often more concerned 
about the patients’ well-being than about their own issues (Wood, Gonzalez & Barden 
2015). During MBSR partners may feel conflicted when they are invited to pay 
attention to themselves and focus on their own needs (Wood, Gonzalez & Barden 2015), 
preventing them from fully benefitting (Van den Hurk et al. 2015) and leaving less space 
for their relationship satisfaction to develop. Moreover, partners might be reluctant to 
discuss their fears in order to protect the patient. The MBSR programme is not tailored 
to the specific problems that caregivers experience, such as balancing self-care with care 
for the patient or preparing for a future without their partner (O’Toole et al. 2016). In 
terms of  possible solutions one might consider addressing these specific problems of  
caregivers during MBSR and offer separate courses to partners, or use a format with 
partly combined and partly separate sessions. 
Our cross-sectional dyadic study in couples facing lung cancer suggested that mindfulness 
skills and self-compassion go beyond the individual and may impact couple functioning 
(Schellekens, Karremans et al. 2017). Without dyadic analyses potential associations 
between patients and partners remain obscured. Unfortunately, the current sample size 
of  couples was too small to conduct dyadic analyses. Future research should apply 
dyadic analyses on couples participating in MBSR to examine how change in one’s own 
and one’s partner processes affect one’s outcome (Karremans, Schellekens & Kappen 
2017).
In conclusion, this RCT confirmed the effectiveness of  MBSR in lung cancer patients on 
a range of  psychological outcomes, especially in distressed patients. Partners, however, 
did not seem to benefit from MBSR. More research is needed on what lung cancer 
patients and partners experience as facilitators and barriers of  participation in order to 
help researchers/clinicians to make effective psycho-social intervention more accessible.
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ABSTRACT
Objectives
Although lung cancer patients and partners report high rates of  psychological 
distress, several studies have reported difficulties recruiting patients and partners for 
psychosocial interventions. The aim of  this study was to examine how lung cancer 
patients and partners who refuse participation in a randomised controlled trial (RCT) 
on Mindfulness-Based Stress Reduction differ from those who participated and to 
qualitatively explore the underlying reasons.
Methods
Lung cancer patients and partners were recruited for the RCT after having been 
assessed for psychological distress. Using multivariate logistic regression, RCT 
refusers were compared with participants in terms of  demographic characteristics, 
clinical characteristics, and psychological distress. Additionally, via semi-structured 
interviews, reasons for refusing or participating were explored.
Results
Patients who were retired, who received no current anti-cancer treatment and who 
reported higher self-compassion levels were more likely to refuse (n = 116) than to 
participate (n = 21). Partners who reported lower distress levels were more likely to 
refuse (n = 83) than to participate (n = 13). Qualitative analysis showed that participants 
wanted to participate because they (or their partner) were distressed and in need of  
help. Some refusers did not want help because they were already coping successfully. 
Others, however, reported distress but refused participation because they did not want 
to acknowledge the fact they (or their partner) had lung cancer. 
Significance of  results
Although refusers reported less distress than participants, some patients and partners 
refused MBSR despite being highly distressed. By normalizing and integrating 
psychosocial interventions such as MBSR into regular cancer care, we might be able 
to reach those patients and partners in need of  psychosocial care. 
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INTRODUCTION
Lung cancer is the leading cause of  death by cancer worldwide (Ferlay et al. 2014). 
Besides facing a poor prognosis, patients suffer from severe physical symptoms and 
undergo intensive treatment (Van der Drift et al. 2012). Not surprisingly, lung cancer 
patients report among the highest rates of  psychological distress (43-58%) of  all cancer 
patients (Carlson et al. 2004). Patients’ partners are also emotionally affected by the 
lung cancer. They often take on the role as informal caregiver and live with the fear of  
potentially losing their life partner (Mosher et al. 2013). Partners report similar distress 
rates as patients (Mosher, Bakas & Champion 2013). 
Despite these high distress rates lung cancer patients are less likely to receive psychosocial 
care than patients with other types of  cancer (Walker, Hansen, Martin, Symeonides, 
Ramessur et al. 2014). Moreover, a limited number of  trials examined the effectiveness 
of  psychosocial interventions in lung cancer patients and their partners (Walker et al. 
2013), especially in comparison to the number of  psychosocial intervention trials in 
breast cancer (e.g. meta-analysis by Matthews, Grunfeld & Turner 2016). The few trials 
that did examine a psychosocial intervention in lung cancer reported difficulties with 
enrolling patients, which resulted in low uptake rates (e.g. Krebber et al. 2016; Schofield 
et al. 2013). Previously, researchers argued that patients’ poor performance status, their 
rapidly fluctuating health status and professionals who do not want to discuss a research 
project with the patient pose challenging conditions for intervention research in lung 
cancer (Schofield et al. 2008). So far, however, no identified study investigated patients’ 
reasons for refusing participation in psychosocial interventions. 
We aim to further explore the characteristics of  lung cancer patients and partners who 
participate and refuse participation in psychosocial care and their underlying reasons 
in more depth within the setting of  an RCT on the effectiveness of  Mindfulness-Based 
Stress Reduction (MBSR) (for study protocol, see Schellekens et al. 2014). MBSR is an 
8-week, group-based intervention, in which participants practice mindfulness skills and 
receive psycho-education about stress. Mindfulness is defined as paying attention to 
present moment experiences in a non-judgmental way (Kabat-Zinn 1990). Like previous 
RCTs in patients with other cancer types (for meta-analysis, see Piet et al. 2012) our 
RCT demonstrated that MBSR decreased psychological distress and improved quality 
of  life in lung cancer patients, but not among their partners (Schellekens, Van den Hurk 
et al. 2017). In comparison with other recent RCTs on mindfulness-based interventions 
in breast cancer (Johannsen et al. 2016; Lengacher et al. 2016) and advanced prostate 
cancer (Chambers et al. 2016) (20-50%), the uptake rate in our RCT in lung cancer was 
relatively low (18%).
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The aim of  the present study was to (1) examine possible differences in terms of  
demographic characteristics, clinical characteristics and psychological distress 
between lung cancer patients and partners who decided to refuse participation in 
the RCT on MBSR (i.e. the refusers) or to participate (i.e. the participants); and (2) 
qualitatively explore their reasons for refusing or participating.
METHODS
Study design
We conducted a mixed methods study according to the guidelines of  Good Reporting 
of  A Mixed Method Study (GRAMMS) (O’Cathain, Murphy & Nicholl 2008). It was 
conducted in a tertiary care academic medical centre from March 2013 to December 
2014 and was approved by the local ethics committee (CMO Arnhem-Nijmegen, 
2011–519).
Participants and procedure
The study population consisted of  lung cancer patients and partners who were screened 
for psychiatric disorders two months after diagnosis (for more details, see Schellekens, 
Van den Hurk et al. 2016) and  invited to participate in an RCT examining the 
effectiveness of  MBSR versus care as usual (CAU) in reducing psychological distress 
(Schellekens et al. 2014). Inclusion criteria for patients were: (a) cytologically or 
histologically proven non-small cell lung cancer or small cell lung cancer. Exclusion 
criteria for patients and partners were: (a) <18 years old; (b) insufficient understanding 
of  Dutch language; (c) former MBI participation; (d) current participation in other 
psychosocial program; (e) current regular treatment by psychologist/psychiatrist; and 
(f) physical or cognitive impairments hampering participation.
A nurse practitioner recruited patients and partners. After providing written consent, 
participants completed screening questionnaires and were interviewed to examine 
whether they fulfilled the criteria of  a psychiatric disorder. After participation in the 
screening study, patients and partners received information on the RCT and were 
invited to participate. In a subsample of  patients and partners, semi-structured 
face-to-face interviews were conducted to explore the reasons for either refusing or 
participating. 
Assessment
Demographic and clinical characteristics. Patients’ and partners’ demographic 
characteristics (i.e. sex, age, marital status, education level, work status) and patients’ 
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clinical characteristics (i.e. stage of  cancer, current anti-cancer treatment) were 
obtained from patients’ charts and interviews.
Psychological distress. The 14-item Hospital Anxiety and Depression Scale (HADS) 
was used to measure psychological distress and includes two subscales: anxiety and 
depression (Zigmond & Snaith 1983; Spinhoven et al. 1997).  It has been validated in 
somatic patient populations, including cancer patients (Bjelland et al. 2002) and their 
caregivers (Lambert, Pallant & Girgis 2011). Internal consistency of  the total scale in 
the present sample was .93 in patients and .92 in partners.
Mindfulness skills. The 24-item short form of  the Five Facet Mindfulness 
Questionnaire (FFMQ-SF) was used to assess mindfulness skills (Bohlmeijer et al. 
2011). It comprises five subscales: observing, describing, acting with awareness, 
non-judging of  inner experience and non-reactivity to inner experience. Internal 
consistency of  the total scale was .77 in patients and .75 in partners in the present 
study. 
Self-compassion. The 12-item short form of  the Self-Compassion Scale (SCS-
SF) (Raes et al. 2011) was used to assess self-compassion. It contains six subscales: 
self-kindness, self-judgment, common humanity, isolation, mindfulness and over-
identification. In the present study internal consistency of  the total scale was .76 in 
patients and .75 in partners. 
Qualitative assessment
Semi-structured interviews were conducted by a psychology intern to explore the 
reasons for refusing or participating (see interview guide in box 1). The interviewer 
was experienced in interviewing lung cancer patients and partners. Patients and 
partners were interviewed separately for 5 to 15 minutes. 
Box 1. Interview guide
• What is the reason that you wanted to participate? 
What is the reason that you refused participation?
• How are you doing at the moment?
• What kind of  expectations do you have of  the mindfulness training?
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Statistical analysis
Univariate logistic regression was used to examine differences between refusers and 
participants in the RCT on MBSR. Contributing factors with p-values <.10 were 
carried forward to a multivariate model. 
Qualitative analysis
Interviews were audio taped, transcribed verbatim and analysed with the thematic 
analysis approach (Braun & Clarke 2006). Data analysis started after the first interview 
had been transcribed and continued with each additional interview. Two researchers 
(a psychology intern; MS, a behavioural scientist) coded the transcripts independently 
to minimize subjectivity. After 15 interviews, codes were compared and discussed by 
three researchers (the psychology intern; MS; AS, a psychiatrist) until they reached 
consensus. This led to a new coding scheme for further use, to which new codes 
could be added. After the last interview, the three researchers grouped the codes 
into subthemes, and the subthemes into themes. Each subtheme is presented with a 
relevant quote. To connect quantitative with qualitative data we added whether the 
person behind each quote was highly distressed or less distressed (based on cut-off  
level of  our screening study (HADS ≥15) (Schellekens, Van den Hurk et al. 2016).
RESULTS
Study sample
Of  the 137 patients who were invited to participate in the RCT, 116 (85%) refused 
participation. Of  the 99 partners that were invited for the RCT, 86 (87%) refused 
(Table 1). As patients and partners were also recruited for the RCT via other channels, 
the present sample of  participants is a subsample of  the RCT participants (i.e. 63 
patients and 44 partners). 
Differences between refusers and participants
Patients. Table 2 shows that patients who were male (OR = 2.26, p = .089) and who 
were older (OR = 1.05, p = .072) tended to refuse more than to participate. Patients 
who were retired rather than had a job (OR = 0.14, p = .004) and who currently 
received no anti-cancer treatment such as chemo- and/or radiotherapy (OR = 0.29, 
p = .024) were more likely to refuse than to participate. Patients who reported lower 
psychological distress levels (OR = 0.95, p = .086) and higher self-compassion levels 
(OR = 1.05, p = .087) tended to refuse more than to participate. Controlling for 
all contributing univariate factors in the multivariate logistic regression model, 
being retired (OR = 16.85, p = .007), not currently receiving anti-cancer treatment 
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(OR = 0.05, p = .017) and having higher levels of  self-compassion (OR = 1.10, 
p = .021) remained independently associated with refusing participation in the RCT 
on MBSR.
Table 1. Demographic, clinical and psychological characteristics of  eligible patients and partners 
who were invited to participate in an RCT on MBSR.
Patients (n = 137) Partners (n = 99)
Demographic characteristics, n (%)
Sex
     Male 82 (60) 37 (37)
     Female 55 (40) 62 (63)
Age, M (SD) 63.2 (8.6) 62.3 (68.2)
Marital status
     Single 23 (17)
     Married/partnered 114 (83) 99 (100)
Education level A
     Low 46 (34) 26 (26)
     Middle 57 (42) 50 (51)
     High 33 (24) 22 (22)
Work status
     Having a job B 44 (32) 32 (32)
     Job without pay 11 (8) 24 (24)
     Disabled 21 (15) 2 (2)
     Retired 61 (45) 41 (41)
Clinical characteristics, n (%)
Stage of  cancer
     Curative 87 (64)
     Palliative 50 (36)
Current treatment
     No treatment 67 (49)
     Chemo- and/or radiotherapy 69 (50)
Psychological characteristics, M (SD)
Psychological distress (HADS) 10.5 (7.9) 12.2 (8.2)
Mindfulness (FFMQ-SF) 82.6 (10.6) 80.9 (10.2)
Self-compassion (SCS-SF) 56.9 (9.6) 57.0 (9.2)
Note. A Low educational level = primary and lower secondary education; intermediate = upper 
secondary education; high = higher vocational training and university. B Only 5 patients of  those 
who have a job were also currently working.
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Table 2. Demographic and clinical characteristics of  137 eligible patients related to refusing 
participation in an RCT of  MBSR.
Refusers Participants Univariate
Analysis 
Multivariate
Analysis
(n = 116) (n = 21) OR (95% CI) p OR (95% CI) p
Demographic characteristics n (%)
Sex
     Female (ref) 44 (37) 12 (57) 1 1
     Male 73 (63) 9 (43) 2.26 (0.88 to 5.81) .089 1.93 (0.58 to 6.41) .282
Age, M (SD) 63.8 (8.9) 60.1 (6.0) 1.05 (0.99 to 1.11) .072 0.97 (0.88 to 1.06) .498
Marital status
     Single (ref) 20 (17) 3 (14) 1
     Married/partnered 96 (83) 18 (86) 0.80 (0.22 to 2.98) .739
Education levelA
     Low (ref) 42 (36) 4 (19) 1
     Middle 47 (41) 10 (48) 0.49 (0.13 to 1.53) .201
     High 26 (22) 7 (33) 0.35 (0.09 to 1.33) .123
Work status
     Having a job (ref) 32 (28) 12 (57) 1 1
     Job without pay 7 (6) 4 (19) 0.66 (0.16 to 2.65) .554 0.91 (0.13 to 6.35) .927
     Disabled 19 (16) 2 (10) 3.56 (0.72 to 17.66) .120 7.88 (0.97 to 64.09) .054
     Retired 58 (50) 3 (14) 7.25 (1.91 to 27.60) .004 16.85 (2.17 to 130.79) .007
Clinical characteristics, n (%)
Stage of  cancer
     Curative 76 (65) 11 (52) 1
     Palliative 40 (35) 10 (48) 0.58 (0.23 to 1.48) .253
Current treatment
     No treatment (ref) 62 (53) 5 (24) 1 1
     Chemo- / radiotherapy 54 (47) 15 (71) 0.29 (0.10 to 0.85) .024 0.18 (0.05 to 0.74) .017
Psychological characteristics, M (SD)
Psychological distress (HADS) 10.0 (7.7) 13.3 (8.7) 0.95 (0.90 to 1.00) .086 1.10 (0.96 to 1.12) .387
Mindfulness (FFMQ-SF) 82.2 (10.5) 84.6 (11.52) 0.98 (0.93 to 1.03) .354
Self-compassion (SCS-SF) 57.6 (9.1) 53.5 (11.2) 1.05 (0.99 to 1.11) .087 1.10 (1.02 to 1.12) .021
Note. A Low educational level = primary and lower secondary education; intermediate = upper secondary 
education; high = higher vocational training and university.
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Partners. Table 3 shows that partners who were retired rather than had a job 
(OR = 6.50, p = .024), who reported lower psychological distress levels (OR = 0.91, 
p = .019) and higher self-compassion levels (OR = 1.10, p = .034) were more likely to 
refuse than to participate. Controlling for the contributing univariate factors in the 
multivariate logistic regression model, the only factor that remained a contributor was 
psychological distress (OR = 0.87, p = .040).
Table 3. Demographic and clinical characteristics of  99 eligible partners related to refusing 
participation in an RCT of  MBSR.
Refusers Participants Univariate 
Analysis
Multivariate 
Analysis
(n = 86) (n = 13) OR (95% CI) p OR (95% CI) p
Demographic characteristics n (%)
Sex
     Female (ref) 55 (64) 7 (54) 1
     Male 31 (36) 6 (46) 0.658 (0.203, 2.131) .485
Age, M (SD) 62.8 (8.2) 59.3 (7.7) 0.95 (0.89 to 1.02) .162
Education levelA .596
     Low 24 (28) 2 (15) 1
     Middle 42 (49) 8 (62) 0.45 (0.09 to 2.23) .320
     High 19 (22) 3 (23) 0.53 (0.08 to 3.49) .507
Work status
     Having a job 24 (28) 8 (62) 1 1
     Job without pay 21 (25) 3 (23) 2.33 (0.55 to 9.95) .252 4.65 (.62 to 34.82) .135
     Disabled 2 (2) 0 (0) -- >.99 -- >.99
     Retired 39 (45) 2 (15) 6.50 (1.27 to 33.20) .024 2.80 (0.44 to 17.64) .273
Psychological characteristics, M (SD)
Psychological distress (HADS) 11.4 (7.5) 17.1 (7.5) 0.91 (0.84 to 0.98) .019 0.87 (0.76 to 0.99) 040
Mindfulness (FFMQ-SF) 81.5 (10.4) 77.2 (8.8) 1.04 (0.98 to 1.11) .218
Self-compassion (SCS-SF) 57.8 (9.3) 51.1 (5.9) 1.10 (1.00 to 1.19) .034 1.05 (0.95 to 1.16) .336
Note. A Low educational level = primary and lower secondary education; intermediate = upper 
secondary education; high = higher vocational training and university.
Qualitative exploration of  reasons for refusing and 
participating
Thirteen patients and nine partners were interviewed about their reasons for refusing 
participation. Saturation was reached as after the last few interviews no new codes 
emerged. Three patients and three partners were interviewed about their reasons for 
participating. We gained a general idea of  reasons for participation, although saturation 
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was not reached. Since the answers of  patients and partners were rather similar, their 
answers were grouped together.
Reasons for refusing
Patients and partners refusing participation were not interested in MBSR either because 
they judged they did not need any psychosocial help in general or because they did not 
want to participate in MBSR in particular. From these two broad categories, four themes 
emerged, which could be subdivided into 12 subthemes (see Table 4). 
Category 1. No need for psychosocial interventions in general
An often-reported reason for refusing was that patients and partners preferred to cope 
with lung cancer by themselves. While psychosocial help might be helpful to others, they 
did not need it. The examples reported could be divided into adaptive and possibly non-
adaptive coping. 
Theme 1.1 Adaptive coping
Some refusers appeared to be able to cope with the lung cancer adequately and were 
therefore not in need of  any additional psychosocial support. 
Table 4. Categories, themes and subthemes why patients and partners either refuse or participate 
in an RCT on MBSR.
Categories Themes Subthemes
Refusers 1.  No need for 
psychosocial inter-
ventions in general
1.1 Adequate coping Acceptance
Seeking social support
Prioritizing 
1.2 Inadequate coping Passive avoidance
Active avoidance
Feeling helpless
Being strict for oneself
2.   Not interested in 
MBSR
2.1  Reluctance to take part 
in group interventions
Fear for negative group influence
Unwilling to share with group
2.2  Preconceptions about  
mindfulness
No preconception
Vague/woolly
Already familiar with mindfulness
Participants Open mind
Need for help
Support their partner
Interested in mindfulness
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Acceptance. They indicated to acknowledge the disease and were realistic about their 
future. One patient described how he had already decided on his will and organized 
his funeral. He attempted to be realistic about his situation, while at the same time 
not have too negative views on it.   
“Well, if  it is like it is now, like I just told you, you just accept it. It 
is like it is and what can we do about it. So, just exploring what the 
next steps could be to improve the situation.” Male patient (70), 
non-distressed.  
Seeking social support. Others rather received social support from their partner, 
family and friends than participating in a psychosocial intervention.
“I believe that the way we are in it now, with the two of  us and our 
family, friends and acquaintances, that is enough for us to accept 
what happened.” Female partner (65), non-distressed. 
Prioritizing. A few refusers mentioned to rather spend their time doing other things 
that were more important to them. Some patients wanted to focus on their anti-cancer 
treatment and physical recovery while others wanted to enjoy the good things in life, 
like spending time with their grandchildren.
“No time. I have 5 grandchildren which we babysit and all my other 
stuff. So there is nothing left, every day we’re busy. We have visited 
the hospital 31 times by now, every day after the other, chemo and 
radiotherapy together. No we don’t have the time.” Female partner 
(69), non-distressed.
Theme 1.2 Possibly non-adaptive coping
Although some patients and partners also mentioned they could cope with the illness 
themselves, they were distressed (HADS ≥15) and had difficulty with managing the 
lung cancer. For this reason we classified their reaction as possibly non-adaptive 
coping. 
Passive avoidance. Some refusers did not want to think about the illness and hoped 
for a better future, whether this was realistic or not. Both patients and partners did 
not want to talk about it, neither with each other nor with their family and friends.
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“We don’t talk about the disease, no that won’t be discussed here. 
Yes, we talk about the general things but we won’t sit together and 
think let’s talk 15 minutes about lung cancer. That doesn’t happen 
(…) No actually, I really wouldn’t know what to say about it. What 
can I say about lung cancer?” Female partner (63), distressed.
Active avoidance. Others actively sought distractions to not think about it. They 
attempted different strategies to push thoughts about the future away, such as doing 
household tasks. Some patients, however, did not feel distressed and active avoidance 
seemed a helpful way of  coping.
“Well, it’s not that I will sit and suffer the pain or something. That 
I won’t do. We will solve that, I will solve that (…) I’ll go to the 
garden or work around the house. Or I’ll do something else that 
isn’t necessary or anything but otherwise…” Male patient (63), non-
distressed.
Feeling helpless. A few patients and partners felt helpless and did not believe anything 
could change their situation. A partner described how she had difficulty taking care 
of  her husband and that talking about it would not fix anything. 
“Going along with this won’t change my situation. It really won’t. 
Even if  I could talk with someone for a whole day (…) It is a horrible 
situation. You have to push yourself  to the limit. I want to take care 
of  him but it can be a very ungrateful job. So you really can’t help 
anyone (…) They cannot help me. No one will be helped when I talk 
about it.” Female partner (76), distressed. 
Being strict for oneself. Other refusers mentioned they should be able to cope with 
it all by themselves. They should not ask for help. They just had to accept it without 
complaining about it. It would be more suitable for those who were more distressed 
and experienced more problems. 
“Yes, I see it as a positive thing if  it helps. If  it helps to feel better, 
you know. But initially, you think you have to do it yourself.” Female 
patient (66), distressed.
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Category 2. Not interested in MBSR
Besides not being interested in psychosocial interventions in general, patients and 
partners also mentioned more specific reasons for not being interested in MBSR. 
These could be divided into aversion towards a group intervention and preconceptions 
about mindfulness. 
Theme 2.1 Reluctant to take part in group interventions 
Some refusers did not want to participate in MBSR because it was offered as a group 
intervention and they did not want to be confronted with other patients and partners. 
Fear for negative influence of  group. They did not want to listen to other cancer 
stories and were afraid that it would have a negative influence on how they dealt with 
the illness. Some refusers also mentioned they did not want to hear others complaining 
about the cancer.
“I’m so afraid that there always will be a few who will be complaining 
about the disease, which really isn’t necessary. Okay, you got the 
disease but that doesn’t mean you have to complain about it, like I 
have this or I have that.” Female partner (81), non-distressed.
Not willing to share with group. A few patients and partners did not want to share 
their thoughts and emotions about the cancer, especially not with strangers. They felt 
that it was too private to share. 
“We have a rather large group of  acquaintances like I said who show 
their interest and with whom we can talk about it very well. So that’s 
how we feel supported. So I don’t feel the need to talk about it with 
others I don’t know.”  Male partner (67), non-distressed.
Theme 2.2 Preconceptions about mindfulness
For some refusers their views or lack of  knowledge about mindfulness was one of  the 
reasons they did not want to participate. 
No preconception. Despite the provision of  information leaflets and an explanation 
by the interviewer, some patients and partners had no idea of  what the mindfulness 
training entailed. They were not willing to learn more about it. 
“I wouldn’t know what to think of  it, what it exactly entails.” Female 
partner (81), non-distressed.
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Vague/woolly. Some refusers believed the training would be much too vague or 
woolly for them. They mentioned they were rational human beings and did not need 
to meditate.
“No I don’t feel anything for it. I’m completely averse to that woolly 
stuff  (...) I’m too rational for that. It absolutely does not appeal to 
me (...) This is the situation, this is where I stand and that’s how 
you should approach it. And you can’t go around like whoo this and 
whoo that. I don’t do that.”  Female patient (74), distressed. 
Already familiar with mindfulness. A few patients and partners were familiar with 
mindfulness. They had read about it or followed a workshop and felt already able to 
live in the moment. Therefore they did not feel the need to participate in an MBSR 
training. 
“I’m already working with it. And it works quite well. But also 
acquaintances, I have friends who work with it, so we often talk 
about it during our conversations on the phone.” Female patient 
(58), non-distressed.
Reasons for participating
With regard to possible reasons for participation four subthemes emerged from the 
qualitative data. Patients and partners participated because they were open minded 
about participation, were in need for help, wanted to support their partner or were 
specifically interested in mindfulness (Table 4).
Open mind. Most participants had an open mind about the intervention. They did not 
have any specific expectations beforehand but were curious about what the training 
would entail and how it would be to participate with fellow patients. They thought it 
would not hurt to try and it might even benefit them. 
With regards to that mindfulness I think very simple, it won’t hurt to 
try (…) For me it’s just a matter of  taking it on.” Male patient (61), 
non-distressed.
Need for help. Some participants felt burdened by their (partner’s) disease. They 
worried a lot and felt insecure about themselves due to the lung cancer. They wanted 
help to cope with the disease and were willing to try different options. 
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“How bad is it? Will she live? Will she die? How will I go on alone? So 
much questions that rattle you to the bone (…) I was just stuck. And 
then you’ll be looking around for something that might improve the 
situation or might solve the problem.” Male partner (69), distressed.
Support their partner. Both patients and partners participated because they wanted to 
support their spouse who was distressed and in need of  help. 
“We received the invite for the training when my wife felt down the 
first time. And then I got invited as well. I said ok I’ll do it. I might 
learn from it and might support my wife with it.” Male partner (64), 
distressed.
Interested in mindfulness. Some patients were already familiar with mindfulness and 
were interested in participating in a mindfulness training before they were diagnosed 
with lung cancer. They expected the training would help them to worry less and to 
find peace.
“For years I’m trying to participate in a workshop mindfulness. Just 
to know what kind of  options there are. And it never happened.” 
Female patient (63), distressed.
DISCUSSION
This is the first identified study examining refusal of  a psychosocial intervention for 
lung cancer. It combines quantitative data with more in-depth qualitative information, 
revealing answers to who refuses versus participates and why patients and partners 
refuse or participate. Our findings showed that lung cancer patients who were 
retired and who received no current anti-cancer treatment were more likely to refuse 
participation. Patients who are retired potentially experience less internal conflicts 
than those with a job (e.g. financial concerns, going back to work) and therefore 
feel less need to participate. Moreover, without the burden of  receiving anti-cancer 
treatment, patients might also feel less need to seek psychosocial help. More research 
is needed to examine how job status and anti-cancer treatment relate to refusing 
psychosocial care.
Patients who reported higher levels of  self-compassion and partners who reported 
lower psychological distress levels were more likely to refuse than to participate. The 
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qualitative exploration among refusers confirmed these latter findings, indicating 
that several patients and partners were not interested in help because they were 
already coping successfully with the cancer themselves by accepting their situation 
and receiving support from friends and family. In line with these findings a large 
screening study reported that patients often refuse help because they prefer to 
manage themselves (Clover et al. 2015). Moreover, participating patients and partners 
indicated they wanted to participate because they or their partner were distressed and 
in need of  psychological help, which confirms previous research showing that more 
distressed patients are more likely to participate in MBSR (Würtzen et al. 2012). 
Taken together, these findings are reassuring as it suggests that the majority of  those 
who feel distressed are willing to receive help and others who are already coping 
successfully and do not require help refuse psychosocial care.
However, some patients and partners reported heightened distress and did not want 
help because they did not want to feel or think about the cancer and believed they had 
to cope with it by themselves. These people might actually benefit most from MBSR, 
as becoming aware of  fears and worries might help participants to acknowledge rather 
than avoid thoughts and feelings, which in turn can facilitate coping (Kabat-Zinn 
1990). Note that some patients who actively avoided emotions and thoughts about 
the lung cancer were not highly distressed. These findings are in line with studies 
showing that denial can be an adaptive coping mechanism in lung cancer and should 
be respected in clinical practice (Vos et al. 2010).  
Health care providers can play an important role in identifying distressed patients 
and partners, and engaging them in psychosocial interventions. As such, the multi-
disciplinary team attending to the patients should be knowledgeable about the 
nature, rationale and outcome of  psychosocial interventions, such as MBSR. Ideally, 
professionals should not only talk from knowledge but also from personal experience 
with mindfulness. Studies have shown that after MBSR health care professionals report 
decreases in burn-out and distress (Irving, Dobkin & Park 2009). Interestingly, MBSR 
participation also indirectly benefitted the patients of  these health care professionals. 
Patients reported improvements on psychological distress and patient-centred 
care (Grepmair et al. 2007; Dobkin, Bernardi & Bagnis 2016). When psychosocial 
interventions such as MBSR are better integrated in regular cancer care, MBSR 
might become more accessible and acceptable for lung cancer patients and partners. 
Some patients and partners declined participation because they were reluctant to 
participate in a training with fellow patients and partners, as they wanted to avoid 
contact with other cancer patients. Several patients and partners remained having 
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misconceptions of  MBSR despite offering them an elaborate explanation of  the 
training. When inviting potential participants, it might be helpful to acknowledge 
patients and partners’ reluctance of  participating with fellow patients/partners. 
Qualitative studies have shown that not wanting to be confronted with fellow patients 
often diminishes throughout the MBSR training while the sense of  peer support 
increases (Van den Hurk et al. 2015; Schellekens, Jansen et al. 2016). More generally, 
psycho-education about distress, its negative effects and a clear description of  the 
available psychosocial interventions might help patients/partners with deciding 
whether they want psychosocial help.
A few limitations of  the current study should be noted. Since the majority of  patients 
in the current sample were in the curative stage of  cancer, the study sample might 
be less representative of  the lung cancer population as reported by the global cancer 
statistics (Jemal et al. 2011). This might be the result of  the large number of  patients 
who are referred to the Radboudumc in the early stage of  the disease to undergo 
surgery. Another limitation is that as in contrast with the refusers, data saturation was 
not reached among participants, not all reasons for participation might have been 
disclosed. 
Future research should examine how to better implement psychosocial interventions 
in cancer care. Extra attention should be paid to those patients and partners who are 
distressed but are not willing to receive help.  
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CHAPTER 7
Are mindfulness and self-compassion related to psychological 
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A dyadic approach
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ABSTRACT
Lung cancer patients and their spouses report high rates of  distress. Due to the 
increasing popularity of  and evidence for mindfulness-based interventions in cancer, 
mindfulness and self-compassion have been identified as potentially helpful skills 
when coping with cancer. This dyadic study examined how mindfulness and self-
compassion are related to psychological distress and communication about cancer 
in couples facing lung cancer. Using the actor-partner interdependence model, self-
reported mindfulness, self-compassion, psychological distress and communication 
about cancer were analyzed in a cross-sectional sample of  88 couples facing lung 
cancer. Regarding psychological distress, no difference was found between patients 
and spouses. In both partners, own levels of  mindfulness (B = -.19, p = .002) and 
self-compassion (B = -.45, p <.001) were negatively related to own distress levels. At 
a dyadic level, own self-compassion was less strongly associated with distress if  the 
partner reported high self-compassion (B = .03, p = .049). Regarding communication 
about cancer, patients reported to communicate more openly with their partner 
than spouses. However, after controlling for gender this difference was no longer 
significant. In both partners, own self-compassion (B = .03, p = .010) was significantly 
associated with own communication while mindfulness was not. A trend showed that 
mindfulness of  the partner was related to more open communication in the individual 
(B = .01, p = .080). These findings give a first indication that mindfulness and self-
compassion skills may go beyond the individual, and could impact couple functioning. 
Future research should examine whether couples facing (lung) cancer may benefit 
from programmes in which mindfulness and self-compassion are cultivated. 
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INTRODUCTION
Receiving a diagnosis of  lung cancer has a major impact. Patients with lung cancer 
develop severe physical symptoms, undergo radical treatment, and face a poor 
prognosis. As lung cancer is strongly associated with smoking, patients often feel 
stigmatized and tend to blame themselves and are blamed by others for developing 
cancer (Chapple, Ziebland & McPherson 2004; Else-Quest et al. 2009; Milbury, Badr 
& Carmack 2012), which has a negative impact on their wellbeing. In fact, lung cancer 
patients are more likely to meet the threshold of  psychological distress (23-63%) than 
patients with other types of  cancer (Carlson et al. 2004; Gao et al. 2010; Linden et 
al. 2012). Not only patients, but also their spouses can be heavily affected by the lung 
cancer diagnosis. Factors contributing to heightened distress include dealing with 
practical tasks, such as coordinating the patient’s medical care, managing the patient’s 
emotional reactions to the illness, and coping with an uncertain future (Mosher, Bakas 
& Champion 2013). In fact, the rates of  distress among spouses tend to be similar to 
those of  lung cancer patients (Mosher, Bakas & Champion 2013; Ostlund et al. 2010), 
although in general, females report the highest rates of  distress irrespective of  being 
patient or spouse (Hagedoorn et al. 2008). 
Most studies have examined the factors associated with psychological and relational 
distress for patients and their spouses separately. Yet, partners in long-term 
relationships are interdependent, mutually affecting each other (Kelley & Thibaut 
1978). In couples facing lung cancer, the coping of  one partner presumably affects 
the extent to which the other partner is able to cope. A meta-analysis of  35 studies on 
couples coping with various types of  cancer (ncouples = 2468) revealed that psychological 
distress levels between cancer patients and spouses are moderately associated with one 
another (r = .29), supporting the notion that couples coping with cancer respond as an 
interdependent emotional system rather than as two separate individuals (Hagedoorn 
et al. 2008). Such results emphasize the importance of  taking a dyadic approach when 
studying the functioning of  couples facing lung cancer. In dyadic studies, individual 
as well as partner factors are examined simultaneously in both patients and spouses, 
while taking their interdependency into account (Kenny, Kashy & Cook 2006). In the 
current study we refer to a patient’s partner as the spouse and use the term partner to 
refer to members of  the couple in general.
There are some findings from previous dyadic studies with couples coping with lung 
cancer. For instance, a longitudinal study with 158 couples showed that behavioural 
disengagement (i.e. giving up the attempt to cope), blaming the patient for having 
cancer, caregiver-related health problems and relationship maintenance behaviour 
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(e.g. engaging in shared tasks) affected one’s own, and often also the other partner’s 
psychological distress and/or dyadic adjustment (Badr & Carmack Taylor 2008; 
Carmack Taylor et al. 2008; Milbury, Badr & Carmack 2012; Milbury et al. 2013). 
Thus, in line with the notion of  interdependence, such findings suggest that if  one 
partner has difficulty in coping with the cancer diagnosis, it can negatively affect the 
other partner’s coping ability as well. 
So far, the exploration of  what factors may possibly protect patients and spouses from 
developing distress remains limited. Two potentially protective factors that may help 
couples cope with a lung cancer diagnosis are mindfulness skills and self-compassion. 
Mindfulness is defined as intentionally paying attention in a non-judgmental way to 
present moment experiences (Kabat-Zinn 1990). In essence, mindfulness can best be 
considered a state of  awareness (Bishop et al. 2004), although there are individual 
differences in the extent to which one is generally mindful to present moment 
experiences (i.e. as a trait or skill). Self-compassion involves acknowledging one’s 
pain and recognizing this is part of  the human experience while meeting the pain 
with kindness and understanding (Neff  2003). It has been argued that mindfulness is 
strongly related to self-compassion as paying mindful attention to painful experiences 
promotes the ability to actively comfort oneself  and remember that painful experiences 
are part of  being human (Neff  & Dahm 2014).  However, mindfulness and self-
compassion do not always co-arise. One can non-judgmentally accept present moment 
thoughts, emotions and sensations, without actively soothing oneself  or having a 
sense of  common humanity. In other words, mindfulness is aimed at the experience 
itself, whereas self-compassion is aimed at the experiencer, and includes feelings of  
kindness and common humanity not entailed by mindfulness alone (Germer 2009; 
Neff  & Dahm 2014).  Both these factors are receiving increasing scientific attention, 
partly due to the popularity and effectiveness of  mindfulness-based interventions in 
both healthy as well as chronically ill populations, including cancer patients (Piet, 
Würtzen & Zachariae 2012). A rapidly increasing and large body of  research has 
now demonstrated that mindfulness and self-compassion can have powerful effects 
on individual functioning and well-being, particularly in stressful situations (for an 
overview, see Creswell & Lindsay 2014).  
Two important outcomes that might be affected by the protective ability of  
mindfulness skills and self-compassion are psychological distress and communication 
about cancer. When people experience psychological distress, they can respond quite 
automatically, by ruminating about the past and worrying about the future (Carlson 
& Speca 2010). Cultivating the ability to mindfully turn towards one’s (distressing) 
thoughts and emotions while having a non-judgemental and accepting attitude, 
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can help acknowledge and allow these thoughts and emotions for what they are 
without getting immersed in them. Not directly reacting to thoughts and emotions 
but attending to them with open and accepting awareness can facilitate coping 
with stress and promotes taking better care of  oneself  (Segal, Williams & Teasdale 
2002). Supporting this notion, there is good evidence that, in general, self-reported 
mindfulness skills are related to less psychological distress, e.g. Baer et al. (2008). 
Also, there is some initial evidence that, in cancer patients, increases in mindfulness 
skills are related to decreases in stress symptoms (Birnie, Speca & Carlson 2010). 
Relatedly, being compassionate towards the suffering a cancer diagnosis may cause 
can reduce the additional distress that often results from self-blame and self-judgment 
(Neff  2003). In general, self-reported self-compassion has been significantly related 
to psychological well-being outcomes, such as less depression and anxiety and greater 
life satisfaction (Neff  2003). Also among cancer patients self-compassion has been 
related to less psychological distress (Przezdziecki et al. 2013).
A recent review showed that in couples facing cancer the quality of  communication 
between partners has important implications for their psychological and relational 
wellbeing (Traa et al. 2015). While open communication helps buffering relationship 
distress, protecting the other partner by avoiding communication of  one’s own 
worries and fears about the cancer can increase both partners’ distress (Manne et al. 
2007). Studies on communication about cancer have also shown gender differences 
overruling role differences, with female patients and female partners perceiving poorer 
communication within the family than their male counterparts (Lim, Paek & Shon 
2014). A prerequisite for effective communication is that partners are able to recognize 
and identify their emotions and thoughts. Whereas denial and suppression of  emotions 
often is a natural response when facing difficulties, mindful awareness of  current 
experiences should allow an individual to be better ‘in touch’ with his or her internal 
psychological state. Similarly, approaching difficult feelings with self-compassion may 
facilitate to identify and face these emotions more easily. By becoming aware of  and 
acknowledging one’s own and one’s partner’s pain, without judging oneself  or the 
other for it, partners may be more likely to consciously choose to discuss one’s regrets, 
hopes, and fears (Segal, Williams & Teasdale 2002). In this manner, mindfulness and 
self-compassion may facilitate more effective communication with the partner. 
There are some initial findings supporting this reasoning. Wachs & Cordova (2007) 
showed that self-reported mindfulness was associated with increased ability to 
identify and communicate emotions to the partner, which in turn promoted marital 
satisfaction. Similarly, Barnes et al. (2007) found that self-reported mindfulness 
was positively correlated with more constructive communication patterns between 
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partners during a conflict discussion in the lab. Also, some studies suggest that self-
compassion promotes communication. Yarnell & Neff  (2013) found that self-reported 
self-compassion was positively associated with the tendency to communicate about 
(rather than to subordinate) one’s own needs during conflict with the partner. Finally, 
a dyadic study by Neff  & Beretvas (2013) demonstrated that partners with relatively 
high levels of  self-reported self-compassion were described by their spouses as being 
more caring, emotionally connected, accepting, autonomy-supporting while being 
less detached, controlling, and importantly, less verbally aggressive than those lacking 
self-compassion.
In sum, there is some initial evidence that mindfulness and self-compassion are 
associated with more effective coping with distress, and improved communication 
about distress. However, most studies that examined the role of  mindfulness and self-
compassion in partner relationships focused on the individual (e.g. Burpee & Langer 
2005; Wachs & Cordova 2007; Yarnell & Neff  2013; for an overview, see Kozlowski 
2013). Although informative, such studies have not addressed how mindfulness skills 
and self-compassion of  one partner may be related to the psychological and relational 
functioning of  the other partner. As noted, coping with distress, and coping with lung 
cancer in particular, is something that concerns not only the patient, but concerns 
both partners’ coping abilities, potentially affecting each other mutually. The few 
dyadic studies that have examined mindfulness and self-compassion between partners 
show mixed findings regarding whether mindfulness skills or self-compassion of  one 
partner affect the functioning of  the other partner (Barnes et al. 2007; Neff  & Beretvas 
2013; Pakenham & Samios 2013; Williams & Cano 2014). As recently proposed based 
on a review of  the literature (Karremans, Schellekens & Kappen 2017), dyadic studies 
are needed to understand whether and how mindfulness and self-compassion play a 
role in the functioning of  partner relationships. 
In addition, research on the role of  mindfulness skills and self-compassion within 
partner relationships mostly has focused on non-distressed couples (e.g. Burpee & 
Langer 2005; Carson et al. 2004; Neff  & Beretvas 2013; Wachs & Cordova 2007), with 
the exception of  a study on couples facing Multiple Sclerosis (Pakenham & Samios 
2013) and a study with chronic pain patients (Williams & Cano 2014). The latter study 
found that spousal mindfulness skills were associated with higher perceived partner 
support in the patient. However, whether mindfulness and self-compassion promote 
dyadic coping in cancer patients and their spouses has not been studied yet. It can be 
reasoned that being able to respond mindfully and compassionately to both one’s own 
and the partner’s distress may affect a couple particularly during highly distressing 
episodes in life, such as when one partner has been diagnosed with lung cancer.  
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The aim of  the present study was (1) to examine whether mindfulness skills and self-
compassion are associated with lower psychological distress and better communication 
about cancer in patients with lung cancer and their spouses, and (2) to explore 
whether mindfulness skills and self-compassion of  one partner might be associated 
with the psychological distress and communication about cancer of  the other partner. 
To address these research questions, we examined whether, in both patients and 
spouses, higher levels of  own mindfulness skills and own self-compassion would be 
associated with lower levels of  own psychological distress, and with higher levels of  
own communication about cancer. We then explored whether mindfulness skills and 
self-compassion of  one partner would be associated with lower psychological distress 
and better communication about cancer in the other partner. Finally, we explored 
whether each partner’s mindfulness skills and self-compassion would moderate those 
of  the other partner for each outcome variable. For example, one partner in a couple 
with high levels of  mindfulness and self-compassion may compensate for the other 
partner’s lack of  mindfulness and self-compassion, possibly buffering distress and 
promoting communication in both partners (cf. Vohs, Finkenauer & Baumeister 
2011). Given previously found gender differences in distress and communication 
(Hagedoorn et al. 2008; Lim, Paek & Shon 2014), we controlled for possible gender 
differences.
METHOD
Participants
The majority of  participants was selected from a consecutive sample of  lung cancer 
patients and partners that participated in a systematic screening study for psychiatric 
disorders (Schellekens, Van den Hurk et al. 2016) (between March 2013 and March 
2014). This sample was supplemented with the (pre-randomisation) baseline scores 
of  lung cancer patients and spouses that participated in a randomized controlled 
trial (RCT) on the effectiveness of  Mindfulness-Based Stress Reduction (MBSR) in 
patients with lung cancer and their partners (Schellekens et al. 2014) (between March 
2012 and March 2013). Both the screening study and RCT have been approved by 
our ethical review board CMO Arnhem-Nijmegen and are registered under number 
2011-519. 
Included were patients who (a) were diagnosed with cytologically or histologically 
proven non-small cell lung cancer or small cell lung cancer and (b) completed or were 
still receiving treatment. Excluded were patients who (a) were younger than 18 years 
of  age, or (b) were not able to understand or use the Dutch language. For the current 
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study, we selected only data of  patients and spouses when both patient and spouse 
filled in the questionnaires. 
With an expected population correlation of  around 0.3 for the outcome variable 
psychological distress between patients and spouses (based on our pilot study, Van 
den Hurk et al. 2015) data from 80 dyads were needed to have 80% power to detect a 
medium-sized difference with an alpha of  0.05 (Kenny, Kashy & Cook 2006).
Procedure
In both studies, a nurse practitioner called patients and partners at least one month 
after diagnosis to explain the study procedure. Patients and/or spouses who were 
willing to participate were contacted separately by a researcher, who sent them 
an information leaflet and a consent form. After informed consent was received, 
participants filled out the questionnaires.
Measures
Demographic, relationship and clinical characteristics. Demographic (gender, age, 
educational level) and relationship characteristics (marital status, sexual orientation, 
relationship length) were assessed. Relationship satisfaction was measured with 
the 10-item Satisfaction subscale of  the Investment Model Scale (IMS-S) (Rusbult, 
Martz & Agnew 1998) on which participants can score how satisfied they are with 
different aspects of  their relationship. Total scores can range between 1 (totally not 
satisfied) and 8 (totally satisfied). Chart reviews were conducted to determine disease 
characteristics (stage of  disease, date of  diagnosis at the time of  study enrolment and 
current anti-cancer treatment).
Mindfulness skills. The Dutch validated 24-item short form of  the Five Facet 
Mindfulness Questionnaire (FFMQ-SF; Bohlmeijer et al. 2011) is a reliable and valid 
alternative to the original FFMQ (Baer et al. 2008), which is based on an exploratory 
factor analysis of  five mindfulness measures to provide an empirical integration of  
these independent attempts to operationalize mindfulness. The FFMQ-SF can be 
divided into five subscales: observing, describing, acting with awareness, non-judging 
of  inner experience and non-reactivity to inner experience. As applied in other 
studies (e.g. Bowlin & Baer 2012; Josefsson et al. 2011), we used the total scale of  
the FFMQ-SF in the analyses. A sample item is “I perceive my feelings and emotions 
without having to react to them”. Internal consistency for the total scale was .74 in 
the present study. 
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Self-compassion. The Dutch validated 12-item short form of  the Self-Compassion 
Scale (SCS-SF; Raes et al. 2011) is a reliable and valid alternative to the original 
SCS (Neff  2003). Items include: “I try to be understanding and patient towards those 
aspects of  my personality I don’t like” and “I’m disapproving and judgmental about 
my own flaws and inadequacies”. In the present study, internal consistency of  the 
total scale was .74.
Psychological distress. The Hospital Anxiety and Depression Scale (HADS) (Spinhoven 
et al. 1997; Zigmond & Snaith 1983) was developed to measure psychological distress 
in somatic patient populations and consists of  an anxiety and depression subscale. 
A sample item is “I feel tense or wound up”. The HADS has been validated in 
several Dutch patient populations and oncology patients, and showed good internal 
consistency (Bjelland et al. 2002; Spinhoven et al. 1997). Internal consistency of  the 
total scale was .89 in the present study.
Communication about cancer. We (MS, AS) translated the 18-item Mutual 
Interpersonal Sensitivity scale (MIS) into Dutch with a forward backward translation 
(Lewis et al. 2008). It measures the extent to which one communicates about the 
cancer with the partner. It consists of  two 9-item subscales: open communication 
and avoiding negative thoughts about the cancer. Items include: “We are comfortable 
sharing feelings about the lung cancer with each other”. In the present study, internal 
consistency of  the total scale was .88. 
Statistical analysis
Patients included in the dyadic dataset were compared with those not included, using 
independent sample t tests and χ2 tests. Moreover, included patients and partners that 
were recruited via the screening study were compared with patients and partners 
recruited via the RCT. To characterize the final sample, means and standard 
deviations of  participants’ characteristics and major study variables were calculated 
for patients and partners separately. Dependent sample t tests were conducted to 
examine differences between patient and partner scores on the major study variables. 
Pearson correlation of  the major study variables within patients and partners were 
calculated. Partial correlations examined the interdependence between patients and 
partners. 
Multilevel modelling in SPSS version 20 on a pairwise dataset was performed to 
examine the role of  actor and partner effects of  mindfulness and self-compassion 
on psychological distress and communication about cancer in couples coping with 
lung cancer, by using the actor-partner interdependence model (APIM) (Kenny, 
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Kashy & Cook 2006). Although not all couples are married, we refer to the patient’s 
partner as the spouse and use the term partner to refer to members of  the couple in 
general. The APIM is designed to analyze dyadic processes (Kenny, Kashy & Cook 
2006) and has been used to examine illness adjustment in several dyads, including 
lung cancer patients and their spouses (e.g. Badr & Carmack Taylor 2008). As data 
from partners within a couple are related, analyses must model the interdependence 
between partners and adjust for this interdependence to prevent bias in statistical 
tests. By means of  a multilevel modeling approach, the APIM takes into account the 
interdependence by treating data of  the two partners as nested within the couple. In 
the APIM, each person’s outcome (irrespective of  whether the person is a patient or a 
spouse) is associated with (1) his or her own score on the predictor variable, referred 
to as actor effects (e.g. partner A’s level of  mindfulness associated with partner A’s level 
of  distress) and (2) his or her partner’s score on the predictor variable, referred to as 
partner effects (e.g. partner B’s level of  mindfulness associated with partner A’s level of  
distress). See Figure 1 for a depiction of  the APIM.
Figure 1. Actor-partner interdependence model of  actor and partner mindfulness and actor and 
partner self-compassion in psychological distress and communication about cancer. Note that actor 
and partner effects are independent of  whether the individual is a patient or a spouse.
The linear mixed model included the couple as unit of  analysis at the upper level 
and partners within the couple at the lower level to estimate each outcome variable 
separately (psychological distress, communication about cancer) as a function of  
whether the subject is a patient or a spouse (coded as 1 and -1 respectively; referred to 
as cancer role), the predictors of  interest of  the actor and partner (mindfulness, self-
compassion), and possible interactions. First, we ran a mindfulness model (including 
mindfulness but no self-compassion predictors) and a self-compassion model (including 
self-compassion but no mindfulness predictors) for each outcome. We re-ran the models 
after trimming non-significant interaction terms to provide more stable estimates for 
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the main effects, showing similar findings as the full model for each predictor regarding 
direction and significance. Next, the actor and partner effects of  mindfulness and self-
compassion, and contributing interactions with p-values <.10 were carried forward 
to a combined model. In addition, the models were controlled for covariates (gender, 
age, relationship length, relationship satisfaction, cancer stage, time since diagnosis), 
showing that only gender substantively changed the interpretation of  the model 
communication about cancer, which was therefore added to both models (males coded 
as 1 and females coded as -1). To indicate to what extent continuous predictors are 
correlated with outcome, effect sizes for each significant continuous predictor were 
calculated. In accord with the APIM model, these are partial correlations, using the 
formula r = √(t2⁄(t2+df)) (Kenny, Kashy & Cook 2006). 
Since the correlation between mindfulness and self-compassion within participants 
was large (r(169) = .59, p <.001) we performed ordinary least squares regression with 
actor mindfulness and actor self-compassion as predictors to obtain the indices of  the 
impact of  multicollinearity on the precision of  estimation. For each outcome variables 
we found a variance inflation factor below the cut-off  of  10 (i.e. 1.6) and a tolerance 
value higher than the cut-off  of  0.1 (i.e. 0.6) indicating that multicollinearity did not 
threaten the stability of  the estimates (Cohen et al. 2003). 
RESULTS
Of  the 165 lung cancer patients who were eligible for the present study, 88 patients 
and 88 partners were included. Patients were excluded because they did not have a 
spouse (n = 35) their spouse did not participate (n = 34), patients did not fill out the 
questionnaires (n = 6) or for an unknown reason (n = 2).  The 88 patients did not 
differ from the patients who were excluded from the present study on demographic, 
relationship and clinical characteristics, and study variables. Patients and partners 
participating in the screening study (ncouples = 67) did not differ from patients and 
partners participating in the RCT (ncouples = 21) on demographic characteristics and 
study variables. However, patients from the screening study did appear to be more 
often in the curative stage of  the disease (64% versus 38%) and participated sooner 
after diagnosis (M = 2.3 months, SD = 13.1 versus M = 11.6 months, SD = 1.6) than 
did patients from the RCT. Patient and spouse characteristics can be found in Table 
1. Patients and partners were together for 34.9 years (SD = 14.3) and were generally 
satisfied with their relationship (M = 6.4; SD = 1.5). Based on their treatment, the 
majority of  patients were in the curative stage of  the disease (58%) and the mean time 
since diagnosis was 4.5 months (SD = 7.6). Patients in the curative disease stage did 
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Table 1. Demographic, relationship and clinical characteristics of  patients (n = 88) and spouses 
(n = 88).
 Patients Spouses
n (%) n (%)
Demographic Characteristics
Gender
     Male 59 (67) 28 (32)
     Female 29 (33) 60 (68)
Age, M (SD) 62.8 (8.2) 61.6 (8.4)
Educational levelA
     Low 34 (39) 27 (31)
     Intermediate 30 (34) 33 (38)
     High 22 (25) 23 (26)
Marital status
     Married 82 (93) 82 (93)
     Living together 6 (7) 6 (7)
Sexual orientation
     Opposite-sex 87 (99) 87 (99)
     Same-sex 1 (1) 1 (1)
Relationship length, M (SD) 34.9 (14.3) 34.9 (14.3)
Relationship satisfaction (IMS-S), M (SD) 6.5 (1.5) 6.2 (1.5)
Clinical Characteristics
Stage of  disease (curative/palliative) 51/37 (58/42)
     I 25 (28)
     II 15 (17)
     IIIa 16 (18)
     IIIb 11 (13)
     IV 21 (24)
Months since diagnosis, M (SD) 4.5 (7.6)
Current treatment 34 (19)
     Chemotherapy 24 (14)
     Radiotherapy 6 (3)
     Chemo- and radiotherapy 4 (2)
Note. A Low educational level = primary and lower secondary education; intermediate = upper 
secondary education; high = higher vocational training and university. IMS-S = Satisfaction 
subscale of  Investment Model Scale.
7137
not differ from palliative patients on any of  the study variables. Descriptive statistics 
of  mindfulness, self-compassion, psychological distress and communication about 
cancer for patients and spouses can be found in Table 2. Except for communication 
about the cancer, patients and spouses did not differ from each other. Interestingly, 
patients reported a better communication about the cancer with their partner than 
spouses did (t(78) = 2.80, p = .006). Based on the cut-off  levels of  our screening study 
(HADS-T  ≥15; Schellekens, Van den Hurk et al. 2016), 26 patients (29.5%) and 31 
spouses (31.8%) reported clinically heightened levels of  psychological distress.
Table 2. Mean and standard deviation of  study variables in patients (n = 88) and spouses 
(n = 88).
Potential
range
Patients Spouses
Variables M (SD) M (SD) p A
Mindfulness Skills (FFMQ-SF) 24 - 120 81.3 (10.4) 81.4 (9.6) .839
Self-Compassion (SCS-SF) 6 - 42 28.1 (5.6) 27.9 (4.4) .854
Psychological Distress (HADS) 0 - 42 11.8 (7.4) 12.4 (6.8) .550
Communication about Cancer (MIS) 1 - 5 3.9 (0.7) 3.7 (0.7) .006
Note. A Dependent Sample t-test. FFMQ-SF = Short form of  Five Facet Mindfulness Questionnaire; 
SCS-SF = Short form of  Self-Compassion Scale; HADS = Hospital Anxiety and Depression Scale; 
MIS = Mutual Interpersonal Sensitivity Scale. 
Associations within and between patient and spouse scores 
In patients (Table 3a), both mindfulness and self-compassion are significantly related 
to a lower level of  psychological distress (r(83) = -.49, p <.001; r(82) = -.55, p <.001, 
respectively) and a better communication about the cancer (r(80) = .33, p = .003; 
r(80) = .34, p = .002, respectively). In spouses (Table 3b), both mindfulness and 
self-compassion were related to lower levels of  psychological distress (r(85) = -.43, 
p <.001; r(85) = -.42, p <.001, respectively), but not to communication about cancer 
(r’s <.18, ns). In sum, both higher mindfulness and self-compassion were related 
to lower distress in both patients and spouses, and related to better quality of  
communication about the cancer, but only in patients. 
 
Paired-samples correlations (see Table 3c) showed that the scores were significantly 
associated for mindfulness (r(82) = .26, p = .016), self-compassion (r(81) = .22, 
p = .041), psychological distress (r(86) = .25, p = .020) and communication about cancer 
(r(77) = .43, p <.001), implying their interdependence. Controlling for gender, partial 
Pearson correlations showed that patients and spouse scores remained significantly 
correlated for all variables.
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Table 3. Correlations of  the study variables within and between patients (n = 88) and spouses 
(n = 88).
A. Correlations of  the study variables within patients 
1 2 3 4
1 Mindfulness Skills (FFMQ-SF) --
2 Self-Compassion (SCS-SF) .62** --
3 Psychological Distress (HADS) -.49** -.55** --
4 Communication about Cancer (MIS) .33** .34** -.10 --
B. Correlations of  the study variables within spouses
1 2 3 4
1 Mindfulness Skills (FFMQ-SF) --
2 Self-Compassion (SCS-SF) .55** --
3 Psychological Distress (HADS) -.43** -.42** --
4 Communication about Cancer (MIS) .10 .18 -.29* --
C. Correlations of  the study variables between patients and spouses 
Patients
1 2 3 4
1 Mindfulness Skills (FFMQ-SF) .26* .06 -.09 .10**
Spouses
2 Self-Compassion (SCS-SF) .21† .22* -.21* .09
3 Psychological Distress (HADS) -.22* -.15 .25* -.12
4 Communication about Cancer (MIS) .23* .10 -.02 .43**
Note. * p <.05; ** p < .01; † p <.10. FFMQ-SF = Short form of  Five Facet Mindfulness Questionnaire; 
SCS-SF = Short form of  Self-Compassion Scale; HADS = Hospital Anxiety and Depression Scale; 
MIS = Mutual Interpersonal Sensitivity Scale.
Actor-Partner Interdependence Model: Psychological distress 
Table 4 shows the results of  the mindfulness and self-compassion models for 
psychological distress. No significant difference between patients’ and spouses’ 
psychological distress was found in none of  the three models. Post hoc controlling for 
gender did not change the interpretation of  the effects in any of  the models. Only in 
the self-compassion model, gender was a marginally significant predictor, indicating 
that males tended to report less psychological distress than females.
In the mindfulness model, as the previous correlational analyses already indicated, we 
did find a significant actor effect of  mindfulness (B = -0.32, t(156) = -6.29, p <.001), 
indicating that higher scores on own mindfulness were related to lower scores on 
own psychological distress. No partner effect of  mindfulness was found. In the self-
compassion model, we found a significant actor effect of  self-compassion (B = -0.68, 
t(158) = -7.01, p <.001), indicating that higher scores on own self-compassion were 
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related to lower scores on own psychological distress. However, no partner effect of  
self-compassion was found. Yet, a marginally significant interaction effect was found 
between actor and partner self-compassion scores (B = 0.03, t(80) = 1.94, p = .056). 
Specifically, when the self-compassion of  the partner is relatively high the association 
between own self-compassion and psychological distress tended to be weaker. 
In the combined model (Table 5), the actor effects of  mindfulness (B = -0.19, 
t(151) = -3.13, p = .002) and self-compassion (B = -0.45, t(155) = -3.86, p <.001) 
remained significant, demonstrating that higher own mindfulness and self-compassion 
scores were related to lower own psychological distress scores. In addition, the 
interaction between actor and partner self-compassion scores became significant (B 
= 0.03, t(78) = 2.00, p = .049). As displayed in Figure 2, the association between own 
self-compassion and psychological distress was weaker when the self-compassion of  
the partner was relatively high. 
Table 4. Multi-level models estimating actor and partner effects of  (1) mindfulness and (2) self-
compassion on psychological distress and communication about cancer, controlling for gender in 
couples coping with lung cancer (n = 88).
Psychological distress
ES: r
Communication about cancer
B SE 95% CI t B SE 95% CI t ES: r
Mindfulness model
Intercept 12.32 0.53 11.26 to 13.38 23.12 3.80 0.06  3.67 to 3.93 58.99
Gender -0.77 0.50 -1.75 to 0.22 -1.54 0.06 0.05 -0.03 to 0.16 1.34
Cancer Role -0.04 0.47 -0.99 to 0.90 -0.09 0.08 0.05 -0.02 to 0.17 1.66
Actor Mindfulness -0.32 0.05 -0.42 to -0.22 -6.29** .45 0.01 0.01  0.00 to 0.02 1.91† .15
Partner Mindfulness -0.04 0.05 -0.14 to 0.06 -0.74 0.01 0.01  0.00 to 0.02 1.75† .14
Self-compassion model
Intercept 12.05 0.51 11.03 to 13.07 23.48 3.80 0.06  3.67 to 3.92 59.66
Gender -0.91 0.48 -1.87 to 0.04 -1.91† 0.04 0.05 -0.05 to 0.14 0.93
Cancer Role  0.07 0.47 -0.86 to 1.00 0.15 0.08 0.05 -0.01 to 0.17 1.85†
Actor Self-compassion -0.68 0.10 -0.87 to -0.49 -7.01** .49 0.03 0.01  0.01 to 0.06 3.23** .25
Partner Self-compassion -0.14 0.10 -0.34 to 0.05 -1.49 0.01 0.01 -0.01 to 0.02 0.74
Actor Self-compassion × 
Partner Self-compassion
 0.03 0.01  0.00 to 0.06 1.94† .21
Note. * p <.05; ** p < .01; † p <.10. B = unstandardised coefficient; SE = Standard Error; 
CI = confidence interval; Effect size r =√(t2⁄(t2+df)). Gender is coded 1 (males) and -1 (females). 
Cancer role is coded 1 (patients) and -1 (spouses).
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Table 5. Multi-level model estimating actor and partner effects of  mindfulness and self-compassion 
on psychological distress and communication about cancer, controlling for gender in couples coping 
with lung cancer (n = 88).
Psychological distress Communication about cancer
B SE 95% CI t ES: r B SE 95% CI t ES: r
Combined model
Intercept 12.12 0.50 11.12 to 13.11 24.28  3.80 0.06  3.67 to 3.93  59.19
Gender -0.73 0.49 -1.69  to 0.24 -1.49  0.06 0.05 -0.04 to 0.15  1.17
Cancer Role -0.04 0.47 -0.96 to 0.89 -0.08  0.08 0.05 -0.01 to 0.17  1.78†
Actor Mindfulness -0.19 0.06 -0.31 to -0.07 -3.13** .25 <0.01 0.01 -0.01 to 0.01 <0.01
Partner Mindfulness -0.01 0.06 -0.13 to 0.11 -0.15  0.01 0.01  0.00 to 0.02  1.76† .14
Actor Self-compassion -0.45 0.12 -0.68 to -0.22 -3.86** .30  0.03 0.01  0.01 to 0.06  2.60* .21
Partner Self-compassion -0.11 0.12 -0.34 to 0.12 -0.96 -0.01 0.01 -0.03 to 0.02 -0.40
Actor Self-compassion × 
Partner Self-compassion
 0.03 0.02 <0.01 to 0.06  2.00* .22
Note. * p <.05; ** p <.01; † p < .10. B = unstandardised coefficient; SE = Standard Error; 
CI = confidence interval; Effect size r =√(t2⁄(t2+df)). Gender is coded 1 (males) and -1 (females). Cancer 
role is coded 1 (patients) and -1 (spouses).
Figure 2. The partner effect of  self-compassion moderated the relationship between actor self-
compassion and actor psychological distress. High actor and partner effects of  self-compassion 
correspond with 1 SD above the mean and low actor and partner effects of  self-compassion 
correspond with 1 SD below the mean.
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Actor-Partner Interdependence Model: Communication about 
cancer 
Table 4 shows the results of  the mindfulness and self-compassion models for 
communication about cancer. Cancer role was a significant predictor of  communication 
about cancer in all three models, such that patients reported to communicate significantly 
more with their partner than spouses did. However, after controlling for gender this 
effect was no longer significant in any of  the models, suggesting that the difference 
between patients and spouses might be explained by more spouses being females. 
In the mindfulness model, there were marginally significant actor (B = 0.01, t(152) = 
1.91, p = .058) and partner effects (B = 0.01, t(152) = 1.75, p = .082) of  mindfulness, 
suggesting that higher scores on mindfulness of  oneself  and of  the partner tended 
to be associated with higher scores of  own communication about cancer. In the self-
compassion model, actor self-compassion (B = 0.03, t(151) = 3.23, p = .002) is a 
significant predictor of  communication about cancer, demonstrating that higher 
scores on own self-compassion were related to higher scores on own communication 
about the cancer. We did not find a significant partner effect of  self-compassion on 
communication. In the combined model (Table 5), the actor effect of  mindfulness 
was no longer marginally significant. Yet, the partner effect of  mindfulness remained 
marginally significant (B = 0.01, t(150) = 1.76, p = .080), indicating that higher 
mindfulness scores of  the partner tended to be associated with higher scores of  own 
communication about the cancer. The actor effect of  self-compassion remained 
significant (B = 0.03, t(147) = 2.60, p = .010), suggesting that higher own self-
compassion scores were related to higher own communication about cancer scores. 
DISCUSSION
The goal of  the present research was to explore the roles of  mindfulness and self-
compassion in couples facing lung cancer. Several findings should be highlighted. 
First, a person’s levels of  mindfulness and self-compassion were negatively related 
to his or her psychological distress level. These findings are consistent with studies 
showing that self-reported mindfulness skills and self-compassion are related to less 
psychological distress in cancer populations (Garland et al. 2013; Przezdziecki et al. 
2013) as well as in other populations (Baer et al. 2008; Neff  2003; Pakenham & 
Samios 2013). 
Second, and extending these findings, we also found some indication of  partner effects: 
the association between self-compassion and psychological distress in each individual 
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in the couple depends on the partner’s level of  self-compassion. Specifically, the 
higher the partner’s level of  self-compassion the weaker the association between own 
level of  self-compassion and psychological distress. This may suggest that when one 
partner displays less self-compassion, the other partner may compensate by showing 
more compassion, which alleviates the distress in both partners. As self-compassion 
may not always come as naturally to people (Feldman & Kuyken 2011), taking turns 
in showing more and less self-compassion may be an efficient way for couples to cope 
with a severe illness. Or, put differently, having at least one partner with high levels 
of  self-compassion in the relationship may compensate for a lack of  self-compassion 
in the other partner. These results are in line with previous research findings, showing 
that complementarity of  coping styles (e.g. acceptance of  illness, protective buffering) 
facilitated couples’ adjustment (Badr 2004; Pakenham & Samios 2013).
Third, regarding communication about the cancer, a number of  effects were obtained. 
We found a difference between patients and partners regarding communication about 
cancer, but controlling for gender this effect became non-significant. This suggests 
that the difference between patients and spouses might be partially explained by 
more spouses being female, such that female spouse might perceive less quality and 
frequency of  communication than their male counterparts do. Previous studies have 
shown that gender differences can overrule role differences, with female patients and 
female spouses perceiving poorer communication within the family than males (Lim, 
Paek & Shon 2014). Future research could further explore this difference between 
males and females, and whether there is an interaction with cancer role (i.e. patients 
versus spouses). Additionally, a persons’ level of  self-compassion was related to better 
communication about the cancer. This finding is in line with previous literature 
showing that self-compassion is associated with more constructive communication and 
relationship satisfaction (Neff  & Beretvas 2013; Yarnell & Neff  2013). Interestingly, 
we found a trend that own levels of  mindfulness tended to be associated with a better 
communication about cancer but when actor and partners self-compassion were 
added to the model this trend disappeared. This might suggests that self-compassion 
is possibly more important for communicating about cancer than mindfulness skills. 
Moreover, and importantly, we found some evidence for a partner effect (albeit 
marginally), such that individuals tended to communicate more openly about the 
cancer when the partner was relatively high (versus low) in mindfulness. Possibly, when 
partners anticipate that the other is better able to “handle” communication about 
distressing thoughts or feelings, they communicate more openly about distress related 
to the cancer. This is in contrast with previous findings on healthy couples by Barnes 
et al. (2007), who found that mindfulness was related to better communication only 
within the individual, not between partners.
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As a recent meta-analysis concluded, to better understand how coping with cancer 
operates within couples, dyadic studies taking the interdependency between partners 
into account have the greatest validity and clinical utility in this field (Regan et al. 
2015). By using multilevel modelling on a pairwise dataset we could not only examine 
associations within individuals but also between partners. Both self-compassion 
and mindfulness of  the partners affected the individual in ways that would remain 
obscured when examining their respective roles in distress and communication only 
at the level of  the individual. The present findings underline the importance of  taking 
a dyadic approach when examining coping mechanisms in couples with cancer. Such 
findings were obtained with an adequate number of  couples based on a predefined 
power-analysis. As noted, dyadic studies on coping in couples facing cancer or other 
diseases are relatively scarce. 
Despite these strengths of  the study, a few limitations should be noted. The cross-
sectional design prevents us from drawing conclusion about the causal relationship 
between the predictors mindfulness and self-compassion and the outcome variables 
psychological distress and communication about cancer. Future studies should adopt 
a dyadic approach in longitudinal designs to enable researchers to draw conclusions 
about whether mindfulness and self-compassion actually benefit couples facing lung 
cancer in the long run. In addition, since the majority of  patients in the current sample 
were in the curative stage of  the disease, the study sample is less representative of  the 
global lung cancer population as reported by the global cancer statistics (Jemal et al. 
2011). This might be indicated by the large number of  patients who are referred to the 
Radboud university medical centre in the early stage of  the disease to undergo surgery. 
Moreover, several couples did not participate in the study because spouses declined 
participation, mainly because they were physically impaired or they felt participation 
would be too stressful. Due to the omission of  these possibly more distressed couples, 
the range of  variables might be truncated, implicating that true relationships might 
be even stronger than presently reported. Another limitation is that we solely relied 
on self-report questionnaires for assessing mindfulness skills and self-compassion. 
While the validity of  these measures is under debate (Grossman & Van Dam 2011; 
Muris & Petrocchi 2016), the scales have high internal consistency, and have been 
adopted successfully in studies on the effects of  mindfulness (Baer 2011). Although the 
FFMQ and SCS measure closely related concepts, which could threaten the stability 
of  the estimates, statistical test showed no sign of  multicollinearity. In addition, due to 
shared method variance (Orth 2013), the chances of  finding actor effects are higher 
than finding partner effects because the actor effect is based on data from a common 
source (e.g. mindfulness level from actor predicts distress level from actor) while the 
partner effect is based on data from different sources (e.g. mindfulness level from 
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partner predicts distress level from actor). Future research examining mindfulness 
skills and self-compassion in the APIM should therefore consider using both self- as 
well as partner-reported questionnaires.  
In sum, this is one of  the first dyadic studies on mindfulness and self-compassion 
in couples coping with cancer. We found some preliminary evidence that more self-
compassion in the partner was related to less distress in individuals with low levels of  
self-compassion, and results suggest that having a mindful partner tends to promote 
the other partner’s willingness to communicate about the cancer. These findings point 
to the possibility that mindfulness and self-compassion skills go beyond the individual, 
and may impact couple functioning. In addition, our findings suggest that couples 
facing (lung) cancer may benefit from programmes aimed at improving mindfulness 
skills and self-compassion. In fact, MBSR and Mindfulness-Based Cognitive Therapy 
(MBCT) (Segal, Williams & Teasdale 2002) have proven to be effective in reducing 
anxiety and depressive symptoms in cancer patients (Piet, Würtzen & Zachariae 2012). 
Although self-compassion also seems to increase after MBSR/MBCT (Birnie, Speca 
& Carlson 2010; Kuyken et al. 2010), its focus lies on the cultivation of  mindfulness 
rather than self-compassion (Kabat-Zinn 1990; Labelle et al. 2014). However, as the 
present findings suggest that self-compassion might play an at least as important role as 
mindfulness skills in the dyadic coping of  couples facing lung cancer, an intervention 
focused on the cultivation of  (self-)compassion might also be a worthwhile possibility, 
e.g. Compassion Focused Therapy (Gilbert 2009), Mindful Self-Compassion (Neff  & 
Germer 2013), Mindfulness-Based Compassionate Living (Van den Brink & Koster 
2015). Future trials could examine the effectiveness of  mindfulness-based and self-
compassion-based interventions for couples facing cancer.
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The present thesis focused on examining whether Mindfulness-Based Stress Reduction 
(MBSR) is effective in reducing psychological distress in lung cancer patients and 
their partners. In this chapter the results from the previous chapters are summarized 
and discussed in relation to the current literature. Methodological considerations 
are discussed as well as implication for future research and implications for clinical 
practice.
SUMMARY
Lung cancer is the leading cause of  death by cancer worldwide, accounting for 
approximately 20% of  cancer deaths. Besides a poor prognosis, lung cancer patients 
suffer from severe physical symptoms and undergo intensive treatment. Also partners 
are emotionally affected by lung cancer as they often take on the role of  caregiver and 
face the fear of  losing their partner. The burden lung cancer poses on patients and their 
partners makes them vulnerable to developing psychological distress and psychiatric 
disorders. Lung cancer patients report among the highest psychological distress rates 
of  all cancer patients. Despite these high distress rates, lung cancer patients are less 
likely to receive psychosocial care than patients with other cancer types. Moreover, 
limited research has been conducted on the effectiveness of  psychosocial interventions 
in lung cancer patients and their partners. Recently, mindfulness-based interventions 
(MBIs), such as MBSR, have proven to be effective in reducing psychological distress 
in cancer patients. However, hardly any evidence is available on the effectiveness of  
MBSR in lung cancer patients and their partners. 
1.  How suitable are commonly used self-report questionnaires to differentiate between lung cancer 
patients and partners with and without a psychiatric disorder?
In a systematic screening study (Chapter 2), we examined to what extent the Hospital 
Anxiety and Depression Scale (HADS), Distress Thermometer, Beck Depression 
Inventory and State subscale of  State Trait Anxiety Inventory were suitable to screen 
for psychiatric disorders in lung cancer patients and partners. A consecutive sample 
of  144 patients and 99 partners completed the screening instruments and were 
interviewed with the Structured Clinical Interview DSM-IV (SCID-I) to diagnose 
psychiatric axis I disorders. Overall, 18% of  patients and 20% of  partners were 
diagnosed with a psychiatric disorder (i.e. anxiety disorders, depressive disorders and 
adjustment disorder). In patients and partners, the HADS total score outperformed 
the other questionnaires in terms of  both ruling out those without a psychiatric 
disorder and identifying those with a psychiatric disorder, using a cut-off  level of  ≥15. 
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The findings of  this screening study implied that the HADS seems the most suitable 
screening measure to differentiate between those with and without a psychiatric 
disorder. Patients and partners scoring above the cut-off  should be referred to a 
psychologist or psychiatrist for further diagnostics and treatment.
2. What is the currently available evidence for the effectiveness of  MBIs in reducing psychological 
distress in cancer patients?  
 
A systematic review (Chapter 3) was conducted on randomized controlled trials 
(RCT) that examined the effectiveness of  MBIs in cancer patients and have been 
published since an earlier meta-analysis in 2012. We included 5 RCTs (n = 690), 
which confirmed the effectiveness of  MBIs in decreasing psychological distress and 
improving quality of  life. The methodological quality of  the studies was good. Three 
RCTs reported on a comparison with an active control group, demonstrating that the 
MBI was superior to Supportive Expressive Group Therapy (SET) and a nutrition 
education programme in reducing distress, but inferior to Cognitive Behavioural 
Therapy in reducing insomnia. The external validity of  the RCTs was low once again. 
The majority of  participants were women and diagnosed with curable breast cancer. 
Fortunately, ongoing trials are examining other cancer populations, such as lung and 
prostate cancer, in palliative stages as well. 
Interestingly, since the publication of  this systematic review in 2015, four new RCTs 
have been published, of  which three demonstrated the effectiveness of  MBIs on a 
range of  outcomes in breast cancer patients, such as pain, fatigue and post-traumatic 
growth (Johannsen et al. 2016; Lengacher et al. 2016; Zhang, Zhou et al. 2016). 
Importantly, the RCT in advanced prostate cancer patients has also been published 
(Chambers et al. 2016), revealing that the men did not benefit from the six 45-min 
MBCT sessions delivered by telephone in comparison to minimally enhanced usual 
care. 
3. What is the effectiveness of  MBSR added to CAU compared to solely CAU in reducing 
psychological distress in lung cancer patients and their partners? 
In the MILON study, a multicentre, parallel-group RCT (Chapter 4), patients with 
lung cancer and their partners were randomised to either MBSR in addition to care 
as usual (CAU+MBSR) or solely CAU. MBSR is an 8-week group-based intervention, 
including mindfulness practices and teachings on stress. CAU included anti-cancer 
treatment, medical consultations and supportive care. The primary outcome was 
psychological distress (HADS). Secondary outcomes included quality of  life, caregiver 
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burden, relationship satisfaction, mindfulness skills, self-compassion, rumination and 
post-traumatic stress symptoms. Outcomes were assessed at baseline, post-intervention 
and at 3-month follow-up. Linear mixed modeling was conducted on an intention-to-
treat and per-protocol sample. Results of  the MILON study (Chapter 5) demonstrated 
that 63 patients and 44 partners were included in the trial; 31 patients and 21 partners 
were randomized to MBSR and 32 patients and 23 partners to CAU. As hypothesized, 
patients in the CAU+MBSR group reported significantly less psychological distress 
than those in the CAU group. Additionally, patients showed more improvements in 
quality of  life, mindfulness skills, self-compassion and rumination after CAU+MBSR 
versus CAU. Baseline distress levels appeared to predict treatment outcome: those 
with more distress benefitted most from MBSR. In partners, no differences were 
found between the two groups. To conclude, this RCT suggested that MBSR can 
reduce psychological distress and improve quality of  life in patients, especially in 
distressed patients. However, partners did not seem to benefit from MBSR, possibly 
because they  were more focused on patients’ wellbeing rather than their own.
4. How do lung cancer patients and their partners who refuse participation in a trial on MBSR 
differ from those who do participate? And what are the reasons of  patients and partners to refuse 
or to participate?
In a mixed methods study (Chapter 6) we examined the characteristics of  lung cancer 
patients and partners who participated and refused participation in the RCT on 
MBSR, and their underlying reasons for refusing or participating. After participation 
in the screening study (Chapter 2), a subsample of  137 lung cancer patients and 99 
partners were invited for the RCT, of  which 21 patients and 13 partners eventually 
participated. Patients who were retired, who received no current anti-cancer treatment 
and who reported higher levels of  self-compassion were more likely to refuse than 
to participate. Partners who reported lower psychological distress levels were more 
likely to refuse participation. Qualitative analysis showed that participants wanted to 
participate because they or their partner were distressed and in need of  help. Some 
refusers, however, reported distress but did not want help because they did not want 
to face the fact they (or their partner) had lung cancer. By integrating psychosocial 
interventions into regular cancer care, we might be able to better reach those patients 
and partners in need of  psychosocial care.    
5. What kind of  role do mindfulness and self-compassion play in the relationship between patients and 
partners with respect to psychological distress and communication about cancer? More specifically, to 
what extent are mindfulness and self-compassion of  oneself  and mindfulness and self-compassion of  
one’s partner related to one’s psychological distress and communication about cancer?
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In a cross-sectional sample (Chapter 7) of  88 couples facing lung cancer, the actor-
partner interdependence model was used to examine how mindfulness and self-
compassion are related to psychological distress and communication about cancer 
within and between partners. Within partners, levels of  mindfulness and self-compassion 
were inversely related to levels of  psychological distress. At a dyadic level we found that 
the association between self-compassion and distress in one partner was less strong 
if  the other partner reported higher levels of  self-compassion. In addition, within 
partners levels of  self-compassion were positively associated with communication 
about cancer, while levels of  mindfulness were not. At a dyadic level, mindfulness of  
one partner tended to be related to more open communication in the other partner. 
These findings point to the possibility that mindfulness and self-compassion skills go 
beyond the individual, and may impact couple functioning.
CRITICAL REFLECTION
Lung cancer patients
The MILON study (Chapter 5) presented in this thesis is one of  the first trials 
examining the effectiveness of  a psychosocial intervention targetting psychological 
distress in lung cancer. Our findings suggested that MBSR seems effective in reducing 
psychological distress and improving the quality of  life in lung cancer patients. Like 
previous RCTs in lung cancer, we ran into several difficulties regarding recruiting and 
retaining participants in the trial (Schofield et al. 2008). Merely 18% of  all eligible 
patients and partners participated. In comparison, other recent RCTs on MBIs in 
breast cancer patients (Johannsen et al. 2016; Lengacher et al. 2016) and advanced 
prostate cancer (Chambers et al. 2016) reported uptake rates between 20 to 50%. 
In our mixed methods study in which we explored the reasons for refusal of  participation 
(Chapter 6), we found that some patients and partners refused participation because 
they were already successfully coping with the cancer. Others, however, appeared 
distressed and did not want help because they did not want to think about the cancer 
or allow the difficult emotions associated with it. These people might actually benefit 
most from MBSR, as becoming aware of  fears and worries might help participants 
to acknowledge rather than avoid thoughts and feelings, which can facilitate coping 
(Kabat-Zinn 1990).
Besides low uptake, adherence to the MBSR programme was also rather low. The 
intervention dropout rate of  35% in patients and partners was higher than in other 
recent RCTs on MBIs in breast cancer  (Johannsen et al. 2016; Lengacher et al. 
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2016) and advanced prostate cancer (Chambers et al. 2016) (3-21%). Main reason 
for dropout in patients was physical impairments due to illness progression and/
or anti-cancer treatment. Former RCTs in lung cancer also reported that the poor 
performance and/or prognosis of  lung cancer patients hampered adherence and 
showed similar dropout rates (20-33%) (Porter et al. 2011; Schofield et al. 2013; 
Walker, Hansen, Martin, Symeonides, Gourley et al. 2014).
Partners of  lung cancer patients
In partners, the RCT (Chapter 5) demonstrated no effect of  MBSR on psychological 
distress or any other outcome measure. These findings are in contrast with our pilot 
study, which showed that MBSR resulted in a reduction of  caregiver burden (Van 
den Hurk et al. 2015). However, other pilot studies examining MBIs also found no 
significant improvements in partners when participating together with cancer patients 
(Lengacher et al. 2012). 
A possible explanation for these negative findings could be that during MBSR partners 
may assume the role of  caregiver rather than the role of  participant. They may attend 
more to the well-being of  the patients than their own issues (Wood, Gonzalez & Barden 
2015). Partners may experience inner conflicts when they are invited to focus on their 
own needs and communicate about this during MBSR (Wood, Gonzalez & Barden 
2015). Our qualitative pilot findings confirmed that when partners are focused on the 
patients’ wellbeing, it  may prevent them from fully participating in MBSR (van den 
Hurk et al. 2015). Moreover, studies have shown that partners are reluctant to share 
their own worries and fears because they do not want to pose an extra burden on the 
patient (Kuijer et al. 2000; Persson and Sundin 2008). 
Another explanation might be that the MBSR programme does not pay attention 
to the specific problems that caregivers experience, such as preparing for a future 
without their partner or balancing self-care with care for the patient (O’Toole et al. 
2016). For example, the partner might leave the house to spend time with a friend and 
at the same time experiences guilt and fear for leaving the patient alone. Especially 
when the patient is present, it might be difficult for partners to raise these issues 
during the training. 
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STRENGTHS AND LIMITATIONS
One of  the main strengths of  this thesis is the focus on lung cancer patients. With the 
exception of  a recent RCT in men with advanced prostate cancer, the effectiveness 
of  MBIs has mainly been studied in women with breast cancer. This is one of  the 
first identified RCTs (Chapter 5) that examined the effectiveness of  MBSR in patients 
with a notably worse prognosis. Likewise, this is the first identified RCT of  MBIs in 
cancer patients that also included partners. Although the current delivery of  MBSR 
did clearly not benefit partners, our findings provided helpful insights that can guide 
future research (see below for Implications for Future Research and Implications for 
Clinical Practice).
Moreover, several reserach designs and methodologies were used to examine the role 
of  mindfulness and MBSR in patients with lung cancer and their partners, varying 
from a literature studie (Chapter 3) to an intervention study (Chapter 4 and 5), and 
from a mixed methods study including qualitative data (Chapter 6) to a dyadic study 
(Chapter 7). Integrating these different sources of  information enabled us to answer 
some of  the questions that arose while conducting the RCT, such as “Why do patients 
and partners refuse participation?” and “How are mindfulness and self-compassion 
related between partners?” 
Besides these strengths, we also need to consider some limitations. As a result of  the 
low uptake, an obvious weakness of  the trial is the small sample size. The final sample 
size (63 patients, 44 partners) was considerably smaller than we had aimed for based 
on our power calculations (110 patients, 110 partners). Underpowered studies are less 
likely to discover effects that are genuinely true (type II error) (Button et al. 2013). 
In other words, it raises the concern as to whether the negative findings for certain 
outcomes are due to the study being underpowered rather than the effects  being 
absent. In our study, for example, it might raise the question whether the negative 
findings in partners mean that partners do not benefit from MBSR or might be due 
to the small sample size. 
When low-powered studies do discover a significant effect, the p-value is as reliable 
and valid as in a high-powered studies. However, it is likely that the estimate of  the 
magnitude of  that effect will be inflated (Button et al. 2013). In small studies, the 
estimates of  the true effects will be more variable around their true value, and only 
low-powered studies that, by chance, overestimate the magnitude of  the effect will pass 
the threshold for discovery. In our case, the effect size of  .69 in reducing psychological 
distress in patients might be inflated. Consequently, future studies should be careful 
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using this effect size for power calculations as this might lead to overly optimistic small 
sample sizes, hampering the replication process. 
In addition, as the majority of  participants in the trial and all participants in the 
systematic screening study (Chapter 2) were recruited in the Radboud university 
medical centre, the sample of  participants is less representative of  the population of  
lung cancer patients and partners as a whole. A large number of  patients with early 
stage lung cancer are referred to the Radboudumc to undergo surgery. Consequently, 
more than half  of  the patients in our study samples were curatively treated, while in 
the general population the vast majority of  lung cancer patients suffer from locally 
advanced or metastatic disease (Van der Drift et al. 2012; Jemal et al. 2011).  
The low uptake and adherence raise further concerns as to whether the final sample 
of  participants is representative of  the lung cancer patient population. For example, 
in our trial, particiants appeared to be younger than those who refused participation. 
In our mixed methods study (Chapter 6) we further examined the possible differences 
between participants and refusers and found that, while controlling for age, lung cancer 
patients who participated in the RCT reported higher rates of  current employment, 
current anti-cancer treatment and higher levels of  self-compassion than refusers. In 
partners, those with higher psychological distress were more likely to participate. 
With regard to retaining patients in the intervention, we did not find any difference 
between those who completed the intervention and those who dropped out. Although 
these findings indicate that there are differences between people willing to participate 
in MBSR and those who are not, it is important to realise that these characteristics 
are probably reflective of  those who will participate in this intervention in clinical 
practice. 
In addition, because of  patients’ poor prognosis we expected a large dropout rate over 
time, and therefore decided to limit the follow-up period to 3 months after treatment, 
which is relatively short. Research on psychological distress in cancer patients suggests 
distress can follow different trajectories and can be long-lasting in some individuals 
(e.g. Henselmans et al. 2010). If  we want to understand whether MBSR affects the 
course of  psychological distress in lung cancer, sufficient assessments over a longer 
period of  time are required. Future studies should consider longer follow-up periods. 
Another issue that concerns several studies presented in this thesis (Chapter 5 to 7) 
is that we solely relied upon the use of  self-report questionnaires. The validity of  
the measures assessing mindfulness and self-compassion are still under debate. The 
Five Facet Mindfulness Questionnaire (FFMQ) (Baer 2008) has been criticized for 
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oversimplifying mindfulness into a trait-like psychological construct that disregards 
its complex Buddhist origination (Grossman & Van Dam 2011). Another concern is 
that the items of  the FFMQ might only be adequatly understood after participation 
in MBSR, which negatively impacts the comparison with baseline assessment and 
control groups. Critics argue that the total score of  the Self-Compassion Scale (SCS) 
(Neff  2003) provides an overestimation of  self-compassion  because only the positive 
subscales (self-kindness, common humanity, mindfulness) and not their negative 
counterparts (self-judgment, isolation, over-identification) measure self-compassion 
(Muris & Petrocchi 2016). Despite these criticisms, there are few alternatives available 
so far. When we started conducting the studies presented in this thesis, the FFMQ and 
SCS were (and still are) the best available and most commonly used measures. They 
have been validated in several populations, have high internal consistency and have 
been adopted successfully in studies on the effects of  mindfulness and self-compassion, 
allowing comparisons with previous studies (Baer 2011; Neff  2016). Nevertheless, 
further refinement of  the construct of  mindfulness and (self-)compassion, and novel 
ways to measure it are necessary in order to take the field of  mindfulness research 
forward.
IMPLICATIONS FOR FUTURE RESEARCH
Replication through small trials
The low uptake and adherence and resulting small sample size limit the results of  our 
RCT (Chapter 5). More research is needed before we can make strong conclusions 
about the effectiveness of  MBSR in reducing psychological distress in lung cancer 
patients and their partners. A logical next step would be a larger, well-powered 
study.  Groups of  researchers from multiple centers can collaborate on performing 
replications of  these findings to increase the total sample size (and therefore the 
statistical power) while minimizing the labour and resource impact on any one 
contributor. For suggestions how such a future trial can overcome the obstacles of  low 
uptake and adherence, see Implications for Clinical Practice.
An alternative option to provide evidence for the effectiveness of  MBSR in lung 
cancer could be a series of  smaller trials. Recently, statisticians demonstrated that 
the evaluation of  a treatment should preferably be through a series of  smaller trials 
(with 30-50% power) (In ‘t Hout et al. 2016). The authors argued that it is less likely 
that multiple studies will suffer from the same type of  bias and that as a result their 
composite picture may be more informative than the result of  a single large trial. 
Through simulations they demonstrated that when evidence of  efficacy is based on 
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two or more smaller trials, the error rates are substantially lower than for evidence 
based on a single large trial (In ‘t Hout et al. 2016). In this way, our trial, even 
though it was underpowered, can serve as a first step towards collecting the necessary 
evidence for the effectiveness of  MBSR in reducing psychological distress in lung 
cancer patients and their partners. 
Advancing the field of  MBI research
The science of  MBIs has grown exponentially in the past 15 years. It has witnessed 
an everincreasing number of  studies and wide scope of  clinical applications. Recently, 
Dimidjian and Segal (Dimidjian & Segal 2015) situated the current knowledge base 
for MBIs in a broader framework of  clinical psychological science using the National 
Institutes of  Health (NIH) stage model (Onken et al. 2014). This model describes the 
complete journey of  intervention research, starting at stage 0 (basic, fundamental 
research) up till stage V (implementation and dissemination). By mapping the available 
studies across these stages, it became clear that stages I (intervention development/
refinement) and II (efficacy in research clinic) are highly overrepresented (Dimidjian 
& Segal 2015). In other words: many studies have investigated MBIs for an increasing 
variety of  symptoms and populations, but often with uncontrolled pilot studies and 
without proceeding to the later stages, including implementation. Dimidjian and 
Segal therefore provided a set of  recommendations to fill the gaps in this stage model, 
with the ultimate goal of  increasing the public health impact of  mindfulness research 
and practice. Two recommendations are of  particular relevance to advance the field 
of  MBI research in cancer. 
The comparison with other interventions
One of  the recommendations emphasizes the importance of  comparing MBIs with 
active control groups (Dimidjian & Segal 2015). Comparing MBIs with active controls 
that have been matched on several components (e.g. session frequency and duration) 
except for mindfulness meditation, will enable us to identify whether mindfulness 
meditation is the active ingredient of  MBIs. Thus, future research should further 
explore whether MBIs are more effective than matched active control groups. On the 
other hand, in a recent editorial Bower (2016) argued a more pragmatic viewpoint. 
Rather than designing a matched control group that is supposed to be  ineffective 
from a theoretical viewpoint and will never be used clinically, it may be more relevant 
to compare the MBI with a relevant psychosocial intervention or enhanced usual 
care and evaluate whether MBIs lead to additional benefits. Our systematic review 
(Chapter 3) demonstrated that thus far, two trials compared an MBI with another 
evidence-based psychosocial intervention showing that the MBI was superior to SET 
in reducting stress symptoms, while inferior to CBT in reducing insomnia. Future 
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studies should further examine how to identify patients who will more likely benefit 
from an MBI and those who will more likely benefit from other interventions.
Cost-effectiveness studies
Another recommendation of  Dimidjan and Segal (2015) concerns the cost-
effectiveness evaluation of  MBIs in the community setting. As psychological distress 
in cancer patients has been linked to longer hospital stays and higher medical costs 
(Egede 2007; Prieto et al. 2002), MBIs have the potential to reduce both medical and 
potentially also societals costs (Carlson & Bultz 2004). In the context of  health care 
budget constraints, an economic evaluation of  the effects of  MBIs in cancer can inform 
decisions which health care services are reimbursed for cancer patients. Although 
the need for cost-effectiveness evaluations of  psycho-oncological interventions has 
long been recognized (Carlson & Bultz 2004), information on the cost-effectiveness of  
MBIs is largely absent. Future trials should examine the cost-effectiveness of  MBIs in 
cancer patients on a larger scale (cf. Compen et al. 2015).
Promising methods
Actor-Partner Interdependence Model
The field of  MBI for cancer could also benefit from promising methods from behavioural 
science, such as the actor-partner interdependence model (APIM) (Kenny, Kashy & 
Cook 2006), which we used in our dyadic study (Chapter 7). By using the APIM, 
the interdependency between individuals is taken into account, enabling researchers 
to not only examine associations within individuals but also between individuals. As 
our dyadic study demonstrated, dyadic data analysis has the potential to reveal 
relationships between individuals, which might otherwise have remained obscured 
when examing phenomena at the level of  the individual. Future research should 
apply dyadic analyses on couples who participate together in MBSR to examine how 
change in one’s own and one’s partner processes affect one’s outcomes. Although 
we commonly think of  marital partners when considering dyadic relatinships, this 
method could also be easily applied to examine the processes between a doctor and a 
patient or between a mindfulness teacher and a participant. 
Experience Sampling Methodology
Another promising method from behavioural science is the experience sampling 
method (ESM). This is a method in which participants are asked to rate their 
situations, emotions and reactions at random moments during the day for multiple days 
(Csikszentmihalyi & Larson 1987, 2014). Compared to retrospective questionnaires 
which often assess constructs “over the past week”, ESM offers several advantages: 1) 
enhanced ecological validity because participants are assessed in their normal daily 
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environment, 2) minimized retrospective bias because participants’ experiences are 
assessed in the moment, and 3) enhanced reliability because participants’ are assessed 
repeatedly. ESM has the potential to overcome the limitations associated with small 
sample sizes. The multiple repeated measures that characterize ESM add statistical 
power which enhances the ability to detect patterns of  interest without having to 
include enormous sample sizes. 
ESM  is ideally suited to investigate the working mechanisms of  MBSR, as it measures 
changes in participants’ emotional reactions to their daily environment. For example, 
Geschwind et al. (2011) demonstrated that after MBCT depressed patients reported 
increased experience of  momentary positive emotions as well as greater appreciation 
of, and enhanced responsiveness to, pleasant daily-life activities. Moreover, ESM 
data can provide more detailed insight in how the moment-to-moment changes in 
working mechanisms (e.g. mindfulness, self-compassion) and outcomes (e.g. mood, 
cognition) affect each other. Garland and colleagues (2015) compared interactions 
between positive affect and cognitions before and after MBCT and found that MBCT 
appeared to enhance upward spirals between positive affect and positive cognition. 
Snippe and colleagues (2015) investigated daily affect changes during MBSR and 
found that changes in mindfulness preceded changes in affect. ESM could also be 
applied in patients with cancer. By using the ESM, one could measure the direct 
physical, emotional and cognitive reactions to anti-cancer treatment, to physical 
symptoms such as dyspnoea, but also to pleasant events, and importantly, examine 
whether MBSR will affect these reactions.
IMPLICATIONS FOR CLINICAL PRACTICE
Overcoming the obstacles of  uptake and adherence in lung 
cancer patients
Our trial demonstrated that it is rather difficult to include and retain lung cancer 
patients in MBSR, which resulted in a small sample size (Chapter 5). This is not only 
concerning from a statistical point of  view but also from a clinical perspective. In 
clinical practice MBSR will not be implemented if  lung cancer patients do not accept 
the offer of  MBSR or drop out of  the invention before a therapeutic dose is reached. 
This does not mean we should give up on studying psychosocial interventions in lung 
cancer, it means we should examine how we can overcome the obstacles in the uptake 
and adherence of  the intervention.
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Screening for high levels of  distress or psychiatric disorders.
In line with a meta-analysis on moderators of  psychosocial interventions in cancer 
(Schneider et al. 2010), our trial demonstrated that patients with higher levels of  
distress benefitted most from MBSR. This emphasizes the importance of  finding ways 
to increase the uptake of  MBSR among distressed lung cancer patients. Health care 
professionals may have an important role to play in this process. 
Systematically screening patients for high levels of  distress or even psychiatric 
disorders (Chapter 2) might be a first step to make both professionals and patients 
more aware of  patients’ psychosocial needs. In addition, it might make a difference 
to patients if  health care professionals have a thorough knowledge about the nature, 
rationale and outcome of  potential psychosocial intervention, such as MBSR. In this 
light, professionals could even consider participating in MBSR for their own benefit. 
Studies have shown MBSR can reduce the burnout symptoms and psychological 
distress of  health care professionals (Irving, Dobkin & Park 2009) and preliminary 
evidence suggests it might even indirectly benefit the patients’ wellbeing (Dobkin 2008; 
Grepmair et al. 2007). MBSR might contribute to a health care culture where both 
patients and doctors dare to be vulnerable and allow rather than suppress difficult 
thoughts and emotions (Irving, Dobkin & Park 2009; Verweij et al. 2016). 
Internet-delivered MBIs
Another way to increase both the uptake and adherence to MBSR in lung cancer 
patients is by adapting the programme in such a way that it becomes more feasible to 
participate for patients with poor physical functioning, such as an internet-delivered 
version of  the programme (Compen et al. 2015; Zernicke et al. 2014). Internet-
delivered interventions are easily accessible, available 24/7, save travelling time, allow 
patients to remain relatively anonymous and participate in their own environment 
(Spijkerman, Pots & Bohlmeijer 2016). So far, relatively few studies have been conducted 
on internet-delivered MBIs (eMBIs). Recently, Chambers et al. (2016) examined the 
effectiveness of  a shortened telephone-based MBCT in men with advanced prostate 
cancer in comparison to minimally enhanced usual care, finding that the men did not 
benefit of  the programme. By contrast, a recent review of  15 RCTs on eMBIs applied 
in several patient populations concluded that eMBIs showed significant improvements 
in psychological distress, wellbeing and mindfulness (Spijkerman, Pots & Bohlmeijer 
2016). Guided eMBIs resulted in larger effects than unguided eMBIs (Spijkerman, 
Pots & Bohlmeijer 2016). These guided eMBIs can be offered in groups (Zernicke et 
al. 2014) but are also often delivered individually (Compen et al. 2015; Wolvers et al. 
2015). Such an individual online programme can facilitate patients to participate at 
times of  their own choosing and is a good alternative for those who do not relish being 
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confronted with fellow patients. 
The disadvantage of  an individual eMBI is that patients miss out on peer support, 
which seems an important component of  MBIs. Previous qualitative research has shown 
that not wanting to be confronted with fellow patients often decreases throughout the 
training while feelings of  peer support increase (van den Hurk et al. 2015; Schellekens, 
Jansen et al. 2016). For instance, one man with lung cancer explained how after a few 
sessions he experienced a sense of  common humanity: “It gave me a liberating feeling to 
see that the others all had the same problem, you’re not alone, there are other people that have cancer.” 
MBIs seem to provide a safe environment, which enhances a sense of  community and 
facilitates patients to learn from one another (Schellekens, Jansen et al. 2016; van den 
Hurk et al. 2015; Chambers, Foley et al. 2012). In line with these qualitative findings, an 
RCT in breast cancer survivors demonstrated that social support increased more after 
the MBI than after the Supportive-Expressive group Therapy (SET), and this change in 
social support partially mediated the beneficial effects of  the MBI on mood and stress 
symptoms (Schellekens, Tamagawa et al. 2017). So, while fostering group support in 
the MBI is more an implicit part of  the programme than in SET, where it is a central 
objective, the MBI seemed to provide a supportive environment, which benefitted the 
wellbeing of  breast cancer survivors.  
Thus, while individual (e)MBIs might benefit cancer patients, these patients will miss out 
on the group support and observational learning that typically occurs in group-based 
settings. A blended care version of  the MBSR programme might be able to combine 
the benefits of  an individual eMBI and the original group-based face-to-face version. 
For instance, the blended format could have a face-to-face baseline assessment, and 
face-to-face meetings at the start, halfway through and at the end of  the programme, 
while the sessions in between are online. A face-to-face baseline assessment can address 
practical matters, such as the need for a quiet space at home and the importance of  self-
discipline in the eMBI. During the first group meeting, patients can share their reasons 
for participating and strengthen their commitment together. It is also a good chance 
to provide patients with technical support. During the meeting half  way through the 
programme participants can discuss home practice and share their experiences so far. 
A face-to-face session at the end provides the opportunity to share ideas on continuing 
the mindfulness practice and say goodbye to one another. Alternatively, participants 
could also be offered a fully individual online programme. In this way, we can tailor the 
programme to individual preferences and needs. 
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How partners may benefit from MBSR
Our trial suggests that partners do not benefit from MBSR (Chapter 5), possibly 
because partners take on the role of  caregiver and focus more on the patient’s 
wellbeing than their own. Moreover, it might be difficult for partners to share their 
experiences in the group, especially in presence of  the patient, which might prevent 
them from fully benefitting from the program. 
Adapting the programme
It might be more helpful to offer partners a (partly) separate training programme 
from the patients. A systematic literature review demonstrated that MBIs offered to 
caregivers of  dementia patients separately was effective in improving their quality of  
life (Jaffray et al. 2016). However, in our study several partners refused participation in 
the MILON study when the patient was not able or willing to participate. Moreover, 
qualitative findings of  our mixed methods study (Chapter 6) showed that one of  the 
reasons for partners to participate is to support the patient. In addition, our dyadic 
findings (Chapter 7) suggested that mindfulness skills and self-compassion go beyond 
the individual and may impact couple functioning, suggesting that partners might 
benefit of  developing these qualities together during the MBSR training. Taking this 
into account, one option could be to let partners participate in the blended care 
programme proposed above, with partly separate and partly shared sessions with the 
patients. This might provide space to both individual as well as mutual processes that 
patients and partners go through. Importantly, the blended programme should also 
address the caregiver-related stressors that partners face, such as balancing self  care 
with care for the patient. This can facilitate partners in sharing their experiences and 
help them to make more balanced choiches in their role as caregiver (Wood, Gonzalez 
& Barden 2015).
Mindfulness and grieving
The way partners experience the illness trajectory of  the patient can affect their 
grieving after the patient’s death. Thomas and colleagues (2014) demonstrated that 
distress experienced by close others during palliative care predicted symptoms of  
prolonged or complicated grief  13 months after the death of  the patient. Although 
there is consensus that grief  is a normal experience after major loss, in a minority of  
bereaved persons (10%–20%), debilitating grief  is experienced for an extended period 
of  time (Prigerson & Jacobs 2001). 
To examine whether mindfulness might help partners coping with their loss, we 
followed up partners by qualitatively exploring whether and how mindfulness played a 
role in grieving. To this end, we conducted in-depth interviews with partners after the 
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patient’s death, who formerly participated as a couple in the MBSR training. Partners 
participating in the RCT did not seem to benefit from the MBSR programme at the 
time. Interestingly, however, the first qualitative findings show that partners did seem 
to have made use of  what they had learnt during the MBSR course after the patient’s 
death. 
Partners mentioned the mindfulness practice brought them closer together in the 
last stage of  the patient’s life. They were able to support one another, communicate 
more openly with one another, and appreciate the precious moments they had left 
together. A female partner described how after MBSR she and her husband were able 
to enjoy the little things in life together: “We strenghtened one another during the process. 
I really felt that, we both felt that... For example, despite receiving bad news from the doctor we 
were able to enjoy a cup of  coffee in the patio. Sometimes, it is so close together, the unpleasant and 
the pleasant.” Partners also reported being better able to accept the patients’ death 
and to allow feelings of  sadness while being kind towards their own suffering. It also 
seemed important that partners had shared participating in MBSR with the patient. 
A female partner described how she  admired the way  her husband had coped with 
the situation, which helped her to remain calm and present: “He was very calm and that’s 
why I could let everything happen. Yes, he was calm to begin with but perhaps he also learned it in 
the training. And that’s why... I didn’t panic. Because he was calm, I was also able to be calm.”
These preliminary qualitative findings suggest that MBIs might also be of  benefit 
to bereaved partners. So far, only a few quantitative studies have examined the 
effectiveness of  MBIs on grieving. A controlled pilot study demonstrated that bereaved 
partners reported less depressive symptoms five monts after MBI participation 
compared to the control group (O’Connor, Piet & Hougaard 2014). Future studies 
should further examine the effectiveness of  MBIs on the wellbeing of  bereaved 
partners. Additionally, researchers could investigate the most optimal timing of  the 
intervention (e.g. together with the patient or after the patient’s death).
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CONCLUSION
The findings presented in this thesis suggest that MBSR can be a valuable treatment 
option to reduce psychological distress in lung cancer patients, especially for those 
who feel distressed. It proved to be difficult, however, to include and retain patients in 
the study resulting in a small sample size. Further evidence is needed to make strong 
conclusions about the effectiveness of  MBSR in reducing psychological distress in lung 
cancer. Furthermore, future research is necessary to improve the engagement of  those 
patients who are distressed but are not willing to receive help. Interestingly, MBSR 
did not seem to benefit partners. Future studies could examine how the programme 
can be better tailored to partners’ needs.  
Despite the difficulties associated with conducting intervention research in lung 
cancer patients and their partners, it is vital to conduct this work. It is the only way we 
can improve the knowledge about how to best support the patients and their partners 
who are confronted with this severe and often terminal disease.
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INLEIDING
Dit proefschrift is gebaseerd op een verzameling van artikelen die voortkomen uit het 
MILON (Mindfulness bij Longkanker Nijmegen) onderzoek dat in 2012 is gestart. 
Dit onderzoek was gericht op het verminderen van psychische klachten bij mensen 
met longkanker en hun partners door een mindfulness training te vergelijken met de 
gebruikelijke zorg. Hieronder volgt een Nederlandse samenvatting van de achtergrond 
van het onderzoek, de methode en resultaten van de verschillende studies en een 
discussie van de bevindingen vanuit een breder perspectief. 
Longkanker
Ieder jaar ontvangen wereldwijd 1.8 miljoen mensen de diagnose longkanker. In 
Nederland wordt jaarlijks bij circa 6900 mannen en 5300 vrouwen de diagnose 
longkanker gesteld (IKNL 2016). Aangezien de overgrote meerderheid van patiënten 
(ongeveer 75%) gevorderde ziekte of  metastase heeft op tijdstip van diagnose, overleeft 
slechts een klein percentage van de patiënten het eerste jaar. Met de best mogelijke 
behandelingen is de 5-jaars overlevingskans van longkanker 18% (Van der Drift et 
al. 2012). Door de hoge incidentie en slechte prognose is longkanker de nummer 
één doodsoorzaak door kanker wereldwijd. Ieder jaar sterven wereldwijd 1.6 miljoen 
mensen aan longkanker. Dit komt neer op circa 20% van alle sterfgevallen door 
kanker. In Nederland sterven jaarlijks ongeveer 6200 mannen en 4200 vrouwen aan 
longkanker (IKNL 2016). Naast een slechte prognose, lijden mensen met longkanker 
aan ernstige lichamelijke klachten en ondergaan ze intensieve behandelingen. In 
Nederland en andere Westerse landen is longkanker de nummer 5 ziekte met de 
meeste ziektelast.
Psychische klachten bij longkankerpatiënten en partners
Van alle kankerpatiënten rapporteren patiënten met longkanker het vaakst psychische 
klachten (43-62%) (Carlson et al. 2004). Bij circa 19% van de longkankerpatiënten zijn 
de psychische klachten zo ernstig dat ze voldoen aan de criteria van een psychiatrische 
stoornis. Voornamelijk depressie en aanpassingstoornissen komen veel voor. Psychische 
klachten bij kankerpatiënten hangen samen met allerlei beperkende factoren, zoals 
verminderde kwaliteit van leven, verminderd naleven van het behandelplan, langer 
verblijf  in het ziekenhuis, verhoogde ziektekosten en kortere levensduur. 
Naasten en in het bijzonder de levenspartner van patiënten worden ook geraakt 
door de longkanker. Partners worden vaak belast met de rol van mantelzorger en 
worden bovendien geconfronteerd met de angst om hun levenspartner te verliezen. 
Psychische klachten bij partners komt ongeveer even vaak voor als bij patiënten. 
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Van de partners heeft circa 13 tot 38% een psychiatrische stoornis. Voornamelijk 
angststoornissen komen veel voor bij partners. Psychische klachten bij partners zijn 
geassocieerd met verminderde kwaliteit van leven, verminderde immuun functie, 
relatie ontevredenheid, een langere periode van rouw na het overlijden van de patiënt 
en verhoogde mortaliteit. 
Tot dusver hebben de meeste studies die psychische klachten bij longkanker 
onderzochten dit apart gedaan voor patiënten en partners. De uitdagingen waar 
patiënten en partners mee worden geconfronteerd zijn echter onderdeel van een 
bredere relatie context. Kanker kan de bestaande rollen, verantwoordelijkheden 
en interactiepatronen tussen patiënt en partner beïnvloeden. Verschillende studies 
hebben laten zien dat de mate van psychische klachten van patiënten en partners 
verband houden met elkaar. Een longitudinaal dyadisch onderzoek bij longkanker 
heeft zelfs laten zien dat verschillende risicofactoren (e.g. patiënt schuld geven van 
het hebben van kanker of  mantelzorggerelateerde gezondheidsproblemen) niet 
alleen iemands eigen psychische klachten kan beïnvloeden maar ook de psychische 
klachten van de partner. Deze bevindingen suggereren dat stellen als één emotioneel 
systeem reageren in plaats van als twee aparte individuen (Hagedoorn et al. 2008). Dit 
benadrukt het belang om zowel de patiënt als de partner te betrekken bij onderzoek 
naar psychische klachten bij longkanker. 
Psychosociale interventies
Ondanks dat psychische klachten vaak voorkomen bij longkankerpatiënten ontvangen 
zij minder vaak psychosociale zorg dan patiënten met andere type kanker. Bovendien 
is er slechts een beperkt aantal studies die de effectiviteit van psychosociale interventies 
bij longkanker heeft onderzocht. Een van de redenen hiervoor kan de slechte prognose 
en snelle achteruitgang van de gezondheid zijn bij lonkanker. Dit kan het namelijk 
moeilijk maken om patiënten te werven en te behouden voor de studie. Een andere 
reden hiervoor zou kunnen zijn dat longkanker relatief  een stuk minder aandacht 
krijgt in de media dan andere vormen van kanker, zoals borstkanker. Dit heeft mogelijk 
een negatieve invloed op het verstrekken van subsidies voor longkankeronderzoek. 
Bovendien hebben anti roken campagnes niet alleen geleid tot de stigmatisering 
van roken maar mogelijk ook tot de stigmatisering van longkanker. Het beeld dat 
longkanker een ziekte is die de patiënt zelf  heeft veroorzaakt heeft mogelijk ook een 
negatieve impact op de verstrekking van onderzoeksubsidies. 
De paar studies die psychosociale interventies bij longkanker hebben onderzocht, 
tonen de effectiviteit aan van psychotherapie, een interventie voor ademnood 
en vroege palliatieve zorg (Walker et al. 2013). Deze resultaten laten zien dat 
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psychosociale interventies effectief  zijn en benadrukken het belang van onderzoek 
naar psychosociale zorg bij longkanker. Één van de meest onderzochte psychosociale 
interventies bij kanker is cognitieve gedragstherapie (CGT). Een meta-analyse heeft 
aangetoond dat CGT effectief  is in het verminderen van angst- en depressieklachten 
bij mensen met kanker, vooral bij patiënten met een psychiatrische stoornis. CGT 
focust zich op het identificeren en uitdagen van negatieve gedachten om ze te 
veranderen in meer realistische en behulpzame gedachten. Aangezien een van de 
grootste uitdagingen van patiënten en partners is om de situatie te erkennen, is een 
experientiële benadering zoals Mindfulness-Based Stress Reductie (MBSR) mogelijk 
meer geschikt. 
  
Mindfulness-Based Stress Reductie
MBSR is een geprotocoliseerde groepsinterventie die bestaat uit 8 wekelijkse sessies 
van 2,5 uur en een stiltedag tussen sessie zes en zeven (Kabat-Zinn 1990). Mindfulness 
wordt gedefinieerd als het aandacht besteden aan de ervaringen in het huidige 
moment met een accepterende, niet-oordelende houding. Tijdens de sessies beoefenen 
deelnemers mindfulness door middel van de lichaamsverkenning, zitmeditatie, rustige 
yoga en loopmeditatie. Daarnaast krijgen deelnemers educatie over het omgaan 
met stress en is er ruimte om ervaringen met elkaar te delen. Van de deelnemers 
wordt verwacht dat zij thuis dagelijks 45 minuten oefenen. Ter ondersteuning van 
de thuisbeoefening ontvangen deelnemers een informatiemap en CD met begeleide 
mindfulness oefeningen. Deelnemers worden ook aangemoedigd om mindfulness te 
integreren in hun dagelijkse leven door aandacht te besteden aan dagelijkse activiteiten 
zoals tanden poetsen en in communicatie met anderen. 
Door de mindfulness oefeningen leren deelnemers om herhaaldelijk hun aandacht 
terug te brengen naar ervaringen van het huidige moment. In plaats van te blijven 
hangen in het verleden of  te piekeren wat er allemaal mis kan gaan in de toekomst, 
leren deelnemers aanwezig te zijn bij ervaringen van dit moment. Deze experientiële 
benadering stelt deelnemers in staat zich meer bewust te worden van hun gedachten, 
gevoelens en lichamelijke sensaties en uiteindelijk meer inzicht te krijgen in hun 
automatische gedragspatronen. Door gedachten, gevoelens en lichamelijke sensatie te 
erkennen, kunnen deelnemers bewust kiezen hoe ze willen reageren op een stressvolle 
situatie in plaats van er automatisch op te reageren. MBSR helpt deelnemers effectief  
om te gaan met stress en meer compassievol te zijn voor zichzelf  en anderen (Kabat-
Zinn 1990). 
In de laatste jaren worden MBSR en andere vergelijkbare mindfulness interventies 
succesvol toegepast bij mensen met kanker. Steeds meer studies wijden zich aan het 
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onderzoeken van de effectiviteit van mindfulness interventies bij kanker. Sinds de 
eerste studie in 2000 positieve effecten liet zien op angst- en depressieklachten bij 
mensen met kanker (Speca et al. 2015), zijn er meer dan 15 zogenoemde “randomized 
controlled trials” (RCT) gepubliceerd. In dit soort studies wordt een mindfulness 
training vergeleken met gebruikelijke zorg of  een ander controlegroep om te zien 
waar patiënten beter op reageren. Verschillende meta-analyses (waarbij alle tot dan 
toe verschenen RCT’s samen worden geanalyseerd) tonen aan dat in vergelijking 
met gebruikelijke zorg of  een wachtlijstgroep, mindfulness interventies de psychische 
klachten van kankerpatiënten verminderen (e.g. Piet, Würtzen & Zachariae 2012). 
RCT’s lieten ook zien dat deelname aan een mindfulness training leidde tot een 
afname van angst voor terugkeer van kanker, pijn en vermoeidheid, en een toename 
van kwaliteit van leven en welzijn. 
Aanleiding voor het MILON onderzoek
Hoewel mensen met kanker baat lijken te hebben bij mindfulness interventies, is de 
generaliseerbaarheid van deze bevindingen beperkt omdat de overgrote meerderheid 
van de meer dan 2000 onderzoekdeelnemers tot dusver vrouw waren (circa 90%), 
gediagnosticeerd met borstkanker (circa 85%) en behandeld met curatieve intentie. 
Er is bijna geen bewijs beschikbaar voor de effectiviteit van MBSR bij mensen met 
longkanker. Een kleine RCT (n = 40) waarin een verkorte mindfulness training wordt 
vergeleken met een wachtlijst (Lehto et al. 2015) en onze niet-gecontroleerde pilot 
studie (n = 19) (Van den Hurk et al. 2015) suggereerden dat MBSR behulpzaam 
zou kunnen zijn voor mensen met longkanker. Met betrekking tot partners van 
kankerpatiënten zijn er slechts 3 niet-gecontroleerde studies, inclusief  onze pilot 
studie, naar de effecten van MBSR uitgevoerd. Deze resultaten geven voorlopig bewijs 
dat partners mogelijk ook baat kunnen hebben bij deelname aan een mindfulness 
training.
Het primaire doel van dit proefschrift was het onderzoeken van de effectiviteit van 
MBSR in het verminderen van psychische klachten bij longkankerpatiënten en hun 
partners. Hiervoor hebben we de volgende studies uitgevoerd:
•  Allereerst hebben we onderzocht in hoeverre zelfrapportage vragenlijsten geschikt 
zijn om psychiatrische stoornissen te identificeren bij mensen met lonkanker en hun 
partners (Hoofdstuk 2). 
•  Om de effectiviteit van mindfulness interventies op het verminderen van psychische 
klachten bij mensen met longkanker te onderzoeken, hebben we allereerst een 
literatuuroverzicht gemaakt van de effectiviteit van mindfulness interventies bij 
mensen met kanker (Hoofdstuk 3). 
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•  Vervolgens hebben we het MILON onderzoek opgezet. Dit betrof  een RCT waarin we 
onderzochten of  MBSR bovenop gebruikelijke zorg effectief  is in het verminderen van 
psychische klachten van longkankerpatiënten en hun partners (Hoofdstuk 4 en 5).
•  Omdat we moeilijkheden hebben ervaren tijdens het werven van patiënten en 
partners, hebben we ook de redenen geëxploreerd waarom men besloot wel of  niet 
deel te nemen aan de studie (Hoofdstuk 6).  
•  Bovendien waren we geïntrigeerd door de rol die mindfulness vaardigheden en 
zelfcompassie spelen in de relatie tussen patiënten en partners (Hoofdstuk 7). 
RESULTATEN
In een systematische screening studie (Hoofdstuk 2) hebben we onderzocht in 
hoeverre zelfrapportage vragenlijsten (Hospital Anxiety and Depression Scale 
(HADS), Distress Thermometer, Beck Depression Inventory en State subschaal van de 
State Trait Anxiety Inventory) geschikt waren om te screenen voor een psychiatrische 
stoornis bij mensen met longkanker en hun partners. Een consecutief  sample van 
144 patiënten en 99 partners vulden de vragenlijsten in en werden geïnterviewd met 
een diagnostisch interview (SCID-I) om een psychiatrische stoornis vast te stellen. In 
totaal werd 18% van de patiënten en 20% van de partners gediagnosticeerd met een 
psychiatrische stoornis, dat waren angststoornissen, depressie en aanpassingstoornis. 
In patiënten en partners was de totaalscore van de HADS, met een afkappunt van 
≥15, superieur ten opzichte van de andere vragenlijsten in zowel het uitsluiten van 
degenen zonder en het identificeren van degenen met een psychiatrische stoornis. Deze 
bevindingen impliceren dat de HADS het meest geschikte screening instrument is om 
te differentiëren tussen diegenen met en zonder een psychiatrische stoornis. Patiënten 
die boven het afkappunt scoren moeten worden verwezen naar een psycholoog of  
psychiater voor verdere diagnostiek en behandeling. 
In 2012 concludeerde een meta-analyse dat mindfulness interventies effectief  zijn 
in het verminderen van psychische klachten van kankerpatiënten (Piet, Würtzen 
& Zachariae 2012). De auteurs benadrukten dat de methodologische kwaliteit en 
generaliseerbaarheid van de verschillende studies beperkt is. In een literatuuroverzicht 
(Hoofdstuk 3) beschrijven we de RCT’s die de effectiviteit van mindfulness 
interventies bij kanker hebben onderzocht en na de meta-analyse van 2012 zijn 
gepubliceerd. We includeerden 5 RCT’s die de effecten van mindfulness interventies 
op het verminderen van psychische klachten en verbeteren van kwaliteit van leven 
bevestigden. De methodologische kwaliteit van de studies was goed. Drie RCT’s 
rapporteerden over de vergelijking met een actieve controle groep en demonstreerden 
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dat de mindfulness training effectiever was dan Supportive Expressive groep Therapie 
(SET) en een voedingseducatie programma in het verminderen van psychische 
klachten, maar minder effectief  was dan CGT in het verminderen van slapeloosheid. 
De generaliseerbaarheid van de studies was wederom laag. De meerderheid van 
de deelnemers was vrouw en gediagnosticeerd met borstkanker en werd curatief  
behandeld. In de lopende onderzoeken werden echter ook andere kankerpopulaties, 
zoals long- en prostaatkanker, in verschillende stadia van de ziekte onderzocht.
Sinds de publicatie van dit literatuuroverzicht in 2015 zijn er nog 4 RCT’s gepubliceerd. 
Drie van deze RCT’s demonstreerden de positieve effecten van mindfulness interventies 
op verschillende uitkomsten bij vrouwen met borstkanker, zoals een afname van pijn 
en vermoeidheid, en een toename van posttraumatische groei. Ook de RCT bij 
mannen met gevorderde prostaatkanker is ondertussen gepubliceerd (Chambers et al. 
2016). Deze studie liet zien dat mannen geen baat hadden bij de 6-weekse mindfulness 
training met sessies van 45 minuten die via de telefoon werden aangeboden. 
Hoofdstuk 4 beschrijft de opzet en het protocol van het MILON onderzoek. In deze 
RCT werden deelnemers geloot naar MBSR in aanvulling op de gebruikelijke zorg of  
alleen gebruikelijke zorg. MBSR is een 8-weekse groepsinterventie waar deelnemers 
mindfulness beoefenen en stresseducatie ontvangen. De gebruikelijke zorg bestond 
uit kankerbehandelingen, medisch consulten en aanvullende zorg. Deelnemers vulden 
vragenlijsten in bij de start van het onderzoek, direct na de interventieperiode en 
3 maanden na de interventieperiode. Onze primaire uitkomstmaat was psychische 
klachten (HADS). Secundaire uitkomstmaten bestonden uit kwaliteit van leven, 
mantelzorg belasting, relatietevredenheid, mindfulness vaardigheden, zelfcompassie, 
rumineren en posttraumatische stressklachten. 
In Hoofdstuk 5 worden de belangrijkste uitkomsten van de RCT gepresenteerd. 
In totaal namen 63 patiënten en 44 partners deel aan de trial; 31 patiënten en 21 
partners werden geloot naar MBSR en 32 patiënten en 23 partners naar gebruikelijke 
zorg. Zoals we vooraf  hadden verwacht, rapporteerden patiënten in de MBSR 
groep minder psychische klachten na deelname dan patiënten in de gebruikelijke 
zorg groep. Bovendien rapporteerden patiënten meer verbetering in kwaliteit van 
leven, mindfulness vaardigheden, zelfcompassie en rumineren na MBSR dan na 
gebruikelijke zorg. De psychische klachten die patiënten bij aanvang van het onderzoek 
rapporteerden bleek de uitkomsten van de interventie te voorspellen: degenen met 
meer psychische klachten hadden het meeste baat bij deelname aan MBSR. Bij 
partners vonden we geen verschillen tussen de MBSR en gebruikelijke zorg groep. De 
resultaten suggereren dat MBSR psychische klachten kan verminderen en de kwaliteit 
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van leven kan bevorderen van patiënten met longkanker, vooral van patiënten die al 
veel psychische klachten ervoeren. Partners lijken echter geen baat te hebben bij de 
training, mogelijk omdat partners meer bezig waren met het welzijn van de patiënt dan 
met hun eigen welzijn. 
Hoofdstuk 6 beschrijft de vergelijking tussen patiënten en partners die niet wilden 
deelnemen aan het MILON onderzoek met diegenen die wel wilden deelnemen. 
Ook werden door interviews de onderliggende redenen om wel of  niet deel te nemen 
geëxploreerd. Na deelname aan de screening studie (Hoofdstuk 2), werd een subsample 
van 137 patiënten en 99 partners uitgenodigd voor deelname aan het MILON onderzoek. 
Uiteindelijk besloten 21 patiënten en 13 partners hieraan deel te nemen. Patiënten 
die met pensioen waren, op dat moment geen kankerbehandeling ontvingen en een 
hogere mate van zelfcompassie rapporteerden waren meer geneigd om deelname te 
weigeren. Partners die minder psychische klachten rapporteerden waren meer geneigd 
om deelname te weigeren. De kwalitatieve analyse op basis van de interviews toonde 
aan dat patiënten en partners die besloten deel te nemen dit vaak deden omdat zijzelf  
of  hun partner psychische klachten ervoeren en behoefte aan hulp hadden. Degenen 
die weigerden, rapporteerden soms ook een hoge mate van psychische klachten maar 
wilden geen hulp omdat ze niet onder ogen wilden zien dat zij (of  hun partner) 
longkanker hadden. Wanneer psychosociale interventies beter worden geïntegreerd in 
de reguliere kankerzorg en het meer “normaal” is om hieraan deel te nemen, kunnen we 
de patiënten en partners die psychosociale zorg nodig hebben mogelijk beter bereiken. 
In een cross-sectionele dyadische studie (Hoofdstuk 7) met 88 stellen die geconfronteerd 
zijn met longkanker hebben we onderzocht hoe mindfulness vaardigheden en 
zelfcompassie gerelateerd zijn aan psychische klachten en communiceren over 
kanker. Door gebruik te maken van een dyadisch model waren we niet alleen in 
staat de associaties binnen een persoon maar ook de associaties tussen twee partners te 
onderzoeken. We vonden geen verschil tussen patiënten en partners met betrekking tot 
psychische klachten. De resultaten lieten wel zien dat binnen het individu een hogere 
mate van mindfulness en zelfcompassie geassocieerd is met minder psychische klachten. 
Op een dyadisch niveau vonden we dat de associatie tussen zelfcompassie en psychische 
klachten in de ene partner minder sterk is wanneer de zelfcompassie van de ander 
partner hoog is. Ook met betrekking tot communicatie over kanker vonden we geen 
verschil tussen patiënten en partners. Resultaten toonden aan dat binnen het individu 
zelfcompassie maar niet mindfulness samenhangt met een meer open communicatie 
over kanker. Op een dyadisch niveau zien we dat de mate van mindfulness van de ene 
partner gerelateerd lijkt te zijn aan een meer open communicatie van de andere partner. 
Deze bevindingen suggereren dat mindfulness en zelfcompassie niet alleen binnen maar 
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ook tussen individuen een rol spelen en een impact kunnen hebben op het functioneren 
van het stel. 
KRITISCHE REFLECTIE
MBSR voor mensen met longkanker
Het MILON onderzoek (Hoofdstuk 5) is één van de eerste RCT’s die de effectiviteit heeft 
onderzocht van een psychosociale interventie bij longkanker. We hebben aangetoond 
dat MBSR effectief  is in het verminderen van psychische klachten en verbeteren van 
kwaliteit van leven van longkankerpatiënten. Net als andere studies bij longkanker 
kwamen we verschillende moeilijkheden tegen tijdens het werven en behouden van 
deelnemers in de studie. Slechts 18% van de geschikte patiënten en partners namen 
deel. Ter vergelijking, andere recente RCT’s die de effectiviteit van mindfulness 
interventies bij borstkanker en gevorderde prostaatkanker onderzochten, rapporteerden 
inclusiecijfers van 20 tot 50%. 
De studie waarin we de redenen voor deelname onderzochten (Hoofdstuk 6), liet zien 
dat sommige patiënten en partners deelname weigerden omdat ze al succesvol konden 
omgaan met de kanker. Anderen leken echter psychische klachten te ervaren maar 
wilden toch geen hulp omdat ze niet over de kanker wilden nadenken of  de moeilijke 
emoties die daarbij horen niet wilden toelaten. Juist deze mensen hebben misschien wel 
het meeste baat bij MBSR. Bewust worden van angst en zorgen kan deelnemers helpen 
deze emoties te erkennen in plaats van ze te vermijden, wat behulpzaam kan zijn bij het 
omgaan met longkanker.
Naast geringe deelname was de therapietrouw ook laag. Het percentage 
longkankerpatiënten en partners die stopte met de interventie (35%) ligt hoger dan 
bij andere recente RCT’s die mindfulness interventies bij mensen met kanker hebben 
onderzocht (3-21%). De reden om te stoppen met de studie waren lichamelijke klachten 
door progressie van ziekte en/of  kankerbehandeling. Eerdere RCT’s bij longkanker 
rapporteerden ook dat het beperkte functioneren en de slechte prognose de therapietrouw 
hinderden en deze studies toonden vergelijkbare uitvalpercentages (20-33%)
MBSR voor partners van longkankerpatiënten
Bij partners van longkankerpatiënten vonden we geen afname van psychische 
klachten, noch verbetering in een van de andere uitkomstmaten na deelname aan 
MBSR (Hoofdstuk 5). Deze bevindingen zijn in strijd met onze pilot studie, die liet zien 
dat MBSR resulteerde in verminderde mantelzorgbelasting. 
Chapter 9. Nederlandse Samenvatting
182
Een mogelijke verklaring hiervoor zou kunnen zijn dat tijdens de training partners de 
rol van mantelzorger op zich nemen. Het zou kunnen zijn dat partners meer aandacht 
hebben voor het welzijn van de patiënt dan voor hun eigen problemen. Partners kunnen 
interne conflicten ervaren wanneer zij tijdens de training worden uitgenodigd om zich te 
concentreren op hun eigen behoeftes en hierover te communiceren. Onze kwalitatieve 
pilot bevinding lieten zien dat wanneer partners veel bezig zijn met het welzijn van de 
patiënt, het hen ervan weerhoudt om voluit deel te nemen aan de training. Bovendien 
zijn partners soms terughoudend om hun zorgen en angsten te delen omdat zij de 
patiënt niet willen belasten. 
Een andere verklaring voor het ontbrekende effect bij partners kan zijn dat het 
programma geen aandacht besteed aan de specifieke problemen die partners ervaren, 
zoals het voorbereiden op een toekomst zonder hun partner of  het balanceren van 
zelfzorg met de zorg voor de patiënt. Het kan moeilijk zijn voor partners om deze 
problemen te delen tijdens de training, zeker wanneer de patiënt aanwezig is. 
STERKE PUNTEN EN BEPERKINGEN
Een van de sterkste punten van dit proefschrift is de focus op patiënten met longkanker. 
Met uitzondering van een recente RCT bij mannen met gevorderde prostaatkanker 
(Chambers et al. 2016), is de effectiviteit van mindfulness interventies overwegend bij 
vrouwen met borstkanker onderzocht. Het MILON onderzoek is een van de eerste 
RCT’s die de effectiviteit van MBSR heeft onderzocht bij patiënten met een slechtere 
prognose (Hoofdstuk 5). Bovendien is dit de eerste RCT naar de effectiviteit van een 
mindfulness training bij kanker die ook partners erbij heeft betrokken. Hoewel partners 
duidelijk geen baat hadden bij de training, kunnen onze bevindingen van nut zijn voor 
toekomstig onderzoek. 
Bovendien zijn er verschillende onderzoeksopzetten en methodes gebruikt om de 
rol van mindfulness en MBSR bij longkanker te onderzoeken. Dit varieerde van een 
literatuurstudie (Hoofdstuk 3) tot een interventiestudie (Hoofdstuk 4 en 5), en van 
kwalitatief  onderzoek (Hoofdstuk 6) tot een dyadische studie (Hoofdstuk 7). Door 
deze verschillende informatiebronnen te integreren waren we in staat om antwoord te 
geven op vragen die omhoog kwamen tijdens de uitvoering van de RCT, zoals “waarom 
weigeren patiënten en partners deelname?” en “hoe zijn mindfulness en zelfcompassie 
gerelateerd tussen partners?”
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Naast deze sterke punten heeft het onderzoek ook een aantal beperkingen. Ten eerste 
is een duidelijke beperking het kleine aantal deelnemers in de studie. De uiteindelijke 
groepsgrootte (63 patiënten en 44 partners) was een stuk kleiner dan de benodigde 
groepsgrootte (110 patiënten en 110 partners). Met een zogenoemde “underpowered” 
studie is de kans groter op negatieve bevindingen en zijn de positieve bevindingen 
mogelijk geïnflateerd. Voor onze studie betekent dit dat we ons moeten afvragen of  de 
negatieve bevindingen bij partners aangeven dat partners echt geen voordeel hebben 
bij MBSR. En dat de effectgrootte met betrekking tot de reductie van psychische 
klachten bij patiënten mogelijk geïnflateerd is. 
Bovendien is de groep deelnemers minder representatief  voor de populatie van 
longkankerpatiënten omdat het merendeel van de deelnemers voor de RCT en 
alle deelnemers van de systematische screening studie in het Radboud Universitair 
Medisch Centrum zijn geworven. Een groot aantal patiënten met longkanker in een 
vroeg stadium worden doorverwezen naar het Radboudumc voor een operatie. Als 
gevolg is meer dan de helft van onze deelnemers curatief  behandeld, terwijl in de 
algemene populatie de grote meerderheid van patiënten longkanker heeft in een 
vergevorderd stadium.  
De geringe deelname en lage therapietrouw dragen ook bij aan de vraag of  de 
uiteindelijke groep van patiënten en partners die deelnamen representatief  is voor 
de gehele populatie van mensen met longkanker en hun partners. Hoofdstuk 5 en 
6 laten verschillen zien tussen deelnemers en weigeraars met betrekking tot leeftijd, 
arbeidstatus, kankerbehandeling en zelfcompassie bij patiënten en psychische klachten 
bij partners. Deze verschillen beperken de generaliseerbaarheid van onze bevindingen 
naar de populatie van longkankerpatiënten en partners. Hoewel deze bevindingen 
aangeven dat er verschillen zijn tussen die mensen die willen deelnemen aan MBSR 
en diegenen die deelname weigeren, is het belangrijk om te realiseren dat de mensen 
die deelnamen waarschijnlijk vergelijkbaar zijn met de groep die uiteindelijk in de 
klinische praktijk zal deelnemen. 
Daarnaast hebben we voor een relatieve korte vervolgperiode van 3 maanden gekozen 
omdat we vooraf  een groot uitvalpercentage verwachtten door de slechte prognose van 
mensen met longkanker. Als we beter willen begrijpen of  MBSR invloed heeft op het 
verloop van psychische klachten bij longkanker, moeten we meerdere meetmomenten 
over een langere tijdsperiode toevoegen. 
Een andere kwestie is dat we in verschillende studies (Hoofdstuk 5, 6 en 7) gebruik 
hebben gemaakt van zelfrapportage vragenlijsten om mindfulness en zelfcompassie 
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te meten, waarvan de validiteit nog wordt bediscussieerd. De Five Facet Mindfulness 
Questionnaire wordt bijvoorbeeld bekritiseerd omdat het een simplificatie van 
het construct mindfulness meet en het de complexe boeddhistische origine buiten 
beschouwing laat. Ook wordt gezegd dat de vragen anders geïnterpreteerd worden 
na het volgen van een mindfulness training dan bij aanvang wat de vergelijking met 
een controlegroep beperkt. Critici van de Self-Compassion Scale beargumenteren dat 
de totaalscore een overschat beeld geeft van zelfcompassie omdat alleen de positieve 
subschalen (zelfvriendelijkheid, gedeelde menselijkheid, mindfulness) en niet de 
negatieve subschalen (zelfveroordeling, isolatie, overidentificatie) zelfcompassie meten. 
Hoewel deze kritiek gegrond is, zijn er vooralsnog weinig alternatieven voorhanden, 
en dit was zeker het geval bij aanvang van dit onderzoek. Verdere ontwikkeling van 
de constructen mindfulness en (zelf)compassie en innovatie manieren om ze te meten 
zijn nodig om het veld weer een stap verder te brengen. 
IMPLICATIES VOOR VERVOLGONDERZOEK
Replicatie met kleinere studies
De geringe deelname en lage therapietrouw en resulterende kleine groepsgrootte 
beperken de resultaten van de RCT (Hoofdstuk 5). Meer onderzoek is nodig voordat we 
sterke conclusies kunnen trekken over de effectiviteit van MBSR op het verminderen 
van psychische klachten bij mensen met longkanker en hun partners. Een logische 
volgende stap zou  een grote goed gepowerede studie zijn. Onderzoeksgroepen van 
verschillende centra kunnen samenwerken om onze studie te repliceren zodat de 
groepsgrootte wordt verbeterd (en daarmee de statistische power) en het werk per 
onderzoeksgroep minder groot is. Voor suggesties over hoe zo’n toekomstige trial 
kan omgaan met geringe deelname en lage therapietrouw, zie Implicaties voor de 
Klinische Praktijk.
Een alternatieve optie om bewijs te leveren voor de effectiviteit van MBSR bij 
longkanker is het uitvoeren van een aantal kleinere RCT’s. Recentelijk hebben statistici 
laten zien de evaluatie van een interventie het best kan worden gedaan door een aantal 
kleine RCT’s (met 30% power) (In ‘t Hout et al. 2016). De auteurs beargumenteerden 
aan de hand van simulaties dat de kans minder groot is dat verschillende studies 
hetzelfde type bias hebben en dat het totaalplaatje meer informatief  is dan één grote 
trial. Op deze manier kan onze trial, ondanks dat deze underpowered is, fungeren als 
de eerste stap in de verzameling van het nodige bewijs voor de effectiviteit van MBSR 
bij longkanker. 
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Aanbevelingen voor onderzoek naar mindfulness interventies
Het onderzoek naar mindfulness interventies is exponentieel gegroeid in de afgelopen 
15 jaar. Een recent overzichtsartikel laat zien dat veel studies in toenemende mate 
mindfulness interventies toepassen bij een variëteit aan klachten en patiëntgroepen 
(Dimidjian & Segal 2015). Vaak zijn dit niet-gecontroleerde pilot studies en wordt er 
niet gekeken naar hoe deze bevindingen kunnen worden toegepast in de praktijk. De 
auteurs hebben een aantal aanbevelingen gedaan om het onderzoek naar mindfulness 
interventies te verbeteren en daarmee ook de impact te vergroten die mindfulness 
interventies kunnen hebben op de gezondheidszorg. Twee aanbevelingen waren 
specifiek relevant voor onderzoek bij mensen met kanker.
De vergelijking met andere interventies
Een van de aanbevelingen betreft het belang van het vergelijken van mindfulness 
interventies met actieve controlegroepen. Door mindfulness interventies met actieve 
controlegroepen te vergelijken die overeenkomen op verschillende componenten 
(bijvoorbeeld aantal en duur sessies) met uitzondering van mindfulness meditatie, 
kunnen we bekijken of  mindfulness meditatie het actieve ingrediënt is van een 
mindfulness training. Toekomstig onderzoek zou verder kunnen exploreren of  
mindfulness interventies effectiever zijn dan gematchte actieve controlegroepen. 
Vanuit een meer pragmatisch oogpunt wordt beargumenteerd dat het niet relevant is 
om een gematchte controlegroep te ontwikkelen die theoretisch gezien niet effectief  
is en niet gebruikt zal worden in de klinische praktijk. Het is nuttiger om mindfulness 
interventies te vergelijken met andere relevante psychosociale interventies en 
te evalueren of  MBSR effectiever is in het verminderen van psychische klachten. 
Ons literatuuroverzicht (Hoofdstuk 3) laat zien dat twee RCT’s een mindfulness 
training hebben vergeleken met andere veelgebruikte psychosociale interventies. Een 
mindfulness training bleek effectiever dan SET in het verminderen van psychische 
klachten maar minder effectief  dan CGT in het verminderen van slapeloosheid. 
Toekomstige studies moeten verder onderzoeken hoe we patiënten kunnen 
identificeren die meer baat hebben bij een mindfulness training of  meer baat bij een 
andere interventie. 
Kosteneffectiviteit studies
Een andere aanbeveling betrof  kosteneffectiviteit evaluaties. Aangezien psychische 
klachten van kankerpatiënten zijn gerelateerd aan langer verblijf  in het ziekenhuis en 
hogere medische kosten, hebben mindfulness interventies de potentie om medische 
kosten te verminderen. Een economische evaluatie van de effecten van een mindfulness 
training kan helpen bij de besluitvorming over welke psychosociale interventies 
vergoed worden voor mensen met kanker. Hoewel het belang van kosteneffectiviteit 
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evaluaties al lange tijd wordt erkend, wordt er maar weinig onderzoek naar gedaan. 
Toekomstig onderzoek zou de kosteneffectiviteit van een mindfulness training 
grootschalig moeten onderzoeken. 
Veelbelovende methodes
Dyadische modellen
Het onderzoeksveld zou ook kunnen profiteren van veelbelovende methodes uit de 
gedragswetenschappen, zoals het actor–partner interdependence model (APIM) die 
we hebben gebruikt in onze dyadische studie (Hoofdstuk 7). Met behulp van zulke 
dyadische modellen kunnen onderzoekers niet alleen associaties binnen het individu 
maar ook tussen individuen bestuderen. Dyadische studies hebben de potentie om 
relaties tussen individuen te ontdekken die mogelijk verborgen zouden zijn gebleven 
als het op een individueel niveau zou zijn onderzocht. Toekomstig onderzoek zou 
dyadische analyses moeten toepassen bij stellen die deelnemen aan MBSR om te 
onderzoeken of  processen van het individu en processen van de partner de uitkomsten 
van het individu beïnvloeden. Hoewel we vaak denken aan levenspartners wanneer we 
dyadische relaties bekijken, kan deze methode ook worden toegepast om de processen 
te onderzoeken tussen een dokter en een patiënt of  tussen een mindfulness trainer en 
een deelnemer. 
De Experience Sampling Methodologie 
Een andere veelbelovende methode uit de gedragswetenschappen is de “experience 
sampling methode” (ESM). Hiervoor worden deelnemers meerdere dagen op 
verschillende momenten gedurende de dag gevraagd naar hun situatie, emoties en 
reacties. Vergeleken met gebruikelijke vragenlijsten die vragen naar “de afgelopen 
week” heeft de ESM verschillende voordelen: 1) deelnemers worden in hun normale 
dagelijkse omgeving bevraagd, 2) deelnemers worden over dit moment bevraagd en 3) 
deelnemers worden herhaaldelijk bevraagd. Door de herhaalde metingen, voegt ESM 
statistische power toe zonder dat daar enorme groepsgroottes voor nodig zijn. 
ESM is zeer geschikt om de werkingsmechanismen van MBSR te onderzoeken, 
aangezien het veranderingen kan meten van emoties in reactie op het dagelijks leven. 
Daarbovenop biedt ESM data inzicht in hoe van-moment-tot-moment veranderingen 
van het werkingsmechanisme (bijvoorbeeld mindfulness of  zelfcompassie) 
samenhangen met van-moment-tot-moment veranderingen van de uitkomst 
(stemming, cognitie). ESM kan natuurlijk ook worden toegepast bij mensen met 
kanker. Men kan de directe lichamelijke, emotionele en cognitieve reacties meten op 
kankerbehandelingen en lichamelijke klachten zoals benauwdheid, maar ook reacties 
op prettige gebeurtenissen, en natuurlijk of  MBSR deze reacties beïnvloedt. 
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IMPLICATIES VOOR DE KLINISCHE PRAKTIJK
Het verbeteren van geringe deelname en lage therapietrouw
Onze trial liet zien dat het moeilijk is om longkankerpatiënten en hun partners te 
werven voor en te behouden in MBSR, wat tot een klein deelnemersaantal leidde 
(Hoofstuk 5). Dit is niet alleen een beperking vanuit een statistisch oogpunt maar 
ook vanuit een klinisch perspectief. In de klinische praktijk zal MBSR niet worden 
geïmplementeerd als de grote meerderheid van longkankerpatiënten niet ingaat op 
de uitnodiging voor MBSR of  uitvalt voordat een therapeutische doses is bereikt. 
Dit betekent niet dat we onderzoek naar MBSR bij longkanker moeten opgeven, het 
betekent dat we moeten onderzoeken hoe we geringe deelname en lage therapietrouw 
kunnen verbeteren. 
Screenen voor psychische klachten of  psychiatrische stoornissen
In lijn met eerder onderzoek, liet onze RCT zien dat patiënten met meer psychische 
klachten het meest profiteerden van MBSR. Dit benadrukt hoe belangrijk het is om 
ervoor te zorgen dat patiënten met psychische klachten willen deelnemen aan MBSR. 
Zorgprofessionals kunnen hier een belangrijke rol bij spelen. 
Het structureel screenen van patiënten voor een hoge mate van psychische klachten 
of  zelfs psychiatrische stoornissen (Hoofdstuk 2) is een eerste stap om zowel de 
professional als de patiënt meer bewust te maken van de psychosociale behoeften 
van patiënten. Voor patiënten kan het een belangrijk verschil maken als professionals 
kennis hebben van de inhoud, rationale en werkzaamheid van psychosociale 
interventies zoals MBSR. Professionals kunnen ook overwegen deel te nemen aan 
MBSR voor hun eigen welzijn. Studies laten zien dat MBSR burnout en psychische 
klachten kan verminderen bij zorgprofessionals. Er zijn eerste aanwijzingen die 
suggereren dat MBSR voor professionals indirect zelfs het welzijn van de patiënt ten 
goede kan komen. MBSR kan bijdragen aan een zorgcultuur waar de patiënt en de 
dokter zich kwetsbaar durven op te stellen en moeilijke emoties durven toe te laten in 
plaats van te vermijden. 
Online mindfulness training
Een andere manier om de geringe deelname en lage therapietrouw te vergroten is 
door het programma op een dergelijke manier aan te passen dat het meer haalbaar 
wordt voor longkankerpatiënten met lichamelijke klachten om deel te nemen, 
door bijvoorbeeld een online versie van het programma te ontwikkelen. Online 
interventies zijn gemakkelijk toegankelijk, 24/7 beschikbaar, besparen reistijd/
kosten, staan deelnemers toe redelijk anoniem te blijven en in hun eigen omgeving 
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deel te nemen. Een recent overzicht van 15 RCT’s naar online mindfulness 
interventies bij verschillende patiëntengroepen concludeert dat online mindfulness 
interventies resulteren in significante verbeteringen van psychische klachten, welzijn 
en mindfulness (Spijkerman, Pots & Bohlmeijer 2016). Begeleide online mindfulness 
interventies resulteren in grotere effecten dan onbegeleide online mindfulness 
interventies. De begeleide online mindfulness interventies kunnen in een groep of  
individueel worden aangeboden. Dergelijke individuele online interventies stellen de 
deelnemer in staat om op een tijdstip naar voorkeur deel te nemen en is een goed 
alternatief  voor degenen die liever niet geconfronteerd willen worden met lotgenoten. 
Het nadeel van een individuele online mindfulness training is dat de deelnemers 
geen lotgenotencontact hebben, wat een belangrijke component lijkt te zijn van 
mindfulness interventies. Kwalitatieve studies laten zien dat de angst om met 
lotgenoten geconfronteerd te worden vaak afneemt gedurende de training en dat de 
ervaren steun van lotgenoten toeneemt. Een man met longkanker beschreef  hoe hij 
na een aantal sessies een gevoel van saamhorigheid voelde: “Het gaf  me een bevrijdend 
gevoel om te zien dat anderen dezelfde problemen hadden. Je bent niet alleen. Er zijn andere mensen 
met kanker.” Mindfulness interventies lijken een veilige omgeving te bieden, wat het 
groepsgevoel en leren van elkaar stimuleert. In lijn met deze kwalitatieve bevindingen 
liet een studie zien dat vrouwen met borstkanker meer sociale steun ervoeren na 
deelname aan een mindfulness training en dat deze toename in sociale steun de 
vermindering van stemming- en stressklachten verklaarde. 
Kortom, terwijl patiënten met kanker baat kunnen hebben bij een individuele 
(online) MBI missen patiënten de ondersteuning van de groep en het leren van 
elkaar. Een “blended care”  versie van het MBSR programma kan de voordelen 
van een individuele online training combineren met de voordelen van een face-to-
face groepsinterventie.  Een blended versie kan bijvoorbeeld de eerste, middelste en 
laatste sessie van het programma face-to-face aanbieden terwijl de sessie daartussenin 
online zijn. Bij de eerste sessie kunnen patiënten hun reden voor deelname delen 
en hun commitment samen versterken. Het is ook een mooie kans om deelnemers 
technische ondersteuning te bieden. Tijdens de sessie halverwege de training kunnen 
deelnemers de thuisbeoefening bespreken en hun ervaringen tot dusver delen. Een 
groepsbijeenkomst aan het einde biedt deelnemers de gelegenheid met elkaar te delen 
hoe ze verder gaan na de training en afscheid te nemen van elkaar. Door deelnemers 
te interviewen over hun ervaring met een online programma, kunnen we onderzoeken 
wat de beste manier zou zijn om het programma aan te bieden. 
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Hoe partners baat kunnen hebben bij MBSR 
Onze trial suggereert dat partners geen baat hebben bij MBSR (Hoofdstuk 5). 
Waarschijnlijk omdat partners de rol van mantelzorger op zich nemen en zich meer 
focussen op het welzijn van de patiënt dan hun eigen welzijn. Bovendien kan het 
moeilijk zijn om hun ervaringen te delen in de groep, zeker in het bijzijn van de 
patiënt, waardoor ze niet voluit kunnen deelnemen aan het programma. 
Aanpassen van het programma
Het zou behulpzaam kunnen zijn om partners een training apart van de patiënt aan 
te bieden. Een literatuuroverzicht toonde aan dat wanneer mindfulness interventies 
apart worden aangeboden aan mantelzorgers (van dementiepatiënten), dit hun 
kwaliteit van leven ten goede komt. Aan het MILON onderzoek wilden verschillende 
partners echter niet deelnemen omdat de patiënt óf  niet wilde óf  niet kon deelnemen. 
Bovendien lieten onze kwalitatieve bevindingen (Hoofdstuk 6) zien dat een van de 
reden waarom partners deelnemen is om de patiënt te ondersteunen. Daarnaast 
suggereren onze dyadische bevindingen (Hoofdstuk 7) dat mindfulness vaardigheden 
en zelfcompassie niet alleen binnen een individu maar ook tussen partners een rol 
kan spelen, wat er op kan wijzen dat partners er mogelijk baat bij hebben om samen 
deze kwaliteiten te ontwikkelen in een MBSR training. Een tussenoplossing zou 
kunnen zijn om partners deel te laten nemen aan het hierboven besproken blended 
care programma met enkele sessies apart en enkele gedeeld met de patiënt. Dit kan 
ruimte bieden voor zowel de individuele als de gezamenlijke processen die patiënten 
en partners doormaken. Het is belangrijk dat het blended programma de specifieke 
mantelzorgproblemen adresseert waar partners mee geconfronteerd worden, zoals de 
balans tussen zelfzorg en zorg voor de patiënt. Aangezien het moeilijk kan zijn voor 
partners om deze ervaringen te delen is het van belang dat de mindfulness training 
deze specifieke problemen adresseert en partners helpt meer gebalanceerde keuzes te 
maken in hun rol als mantelzorger. 
Mindfulness en rouwverwerking
De manier waarop partners het ziekteproces van de patiënt ervaren kan effect hebben 
op hun rouwverwerking na het overlijden van de patiënt. De psychische klachten 
die naasten ervaren gedurende de palliatieve zorg voorspelden de symptomen van 
aanhoudende of  gecompliceerde rouw tot 13 maanden na het overlijden van de 
patiënt. Hoewel er consensus is dat rouwverwerking een normale ervaring is na 
een groot verlies, ontwikkelt een minderheid van de nabestaanden (10-20%) een 
gecompliceerde of  langdurige vorm van rouw. 
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Om te onderzoeken of  mindfulness partners kan helpen bij hun verlies, hebben 
we vervolgonderzoek gedaan bij partners en kwalitatief  geëxploreerd of  en hoe 
mindfulness een rol speelt bij rouwverwerking. Daarom hebben wij diepte interviews 
gehouden met partners na het overlijden van de patiënt die samen hebben deelgenomen 
aan de training. Partners die deelnamen aan het MILON onderzoek leken geen baat 
te hebben bij MBSR op dat moment. De eerste kwalitatieve bevindingen laten zien 
dat partners echter wel gebruik leken te hebben gemaakt van wat ze hadden geleerd 
tijdens de training na het overlijden van de patiënt.
Partners benoemden dat de mindfulness beoefening hen dichter bij elkaar had 
gebracht in de laatste fase van het leven van de patiënt. Ze waren in staat elkaar te 
ondersteunen, open met elkaar te communiceren en de bijzondere momenten die ze 
samen nog hadden te waarderen. Een vrouwelijke partner beschreef  hoe zij en haar 
man na MBSR in staat waren om de kleine dingen in het leven te waarderen: “We 
versterkten elkaar in het proces. Zo voelde ik dat, we voelden allebei dat… Bijvoorbeeld ondanks dat 
we slecht nieuws hadden gekregen van de dokter, konden we genieten van een kopje koffie in de patio. 
Soms ligt het zo dicht bij elkaar, het niet prettige en het prettige.” Partners rapporteerden ook 
dat ze beter in staat waren het overlijden van de patiënt te accepteren, hun verdriet 
toe te laten en hun lijden op een milde manier te bekijken. Ze benoemden ook dat het 
belangrijk was dat ze samen met de patiënt hadden deelgenomen aan de training. Een 
vrouwelijke partner beschreef  hoe ze haar man bewonderde voor de manier waarop 
hij omging met de situatie, wat haar hielp om kalm en aanwezig te blijven: “Hij was 
erg rustig en dat is waarom ik alles kon laten gebeuren, Ja, hij was daarvoor ook al rustig maar 
misschien heeft hij het ook bij de training geleerd. En dat is waarom… Ik raakte niet in paniek. 
Omdat hij rustig was, kon ik ook kalm blijven.” 
Deze eerste kwalitatieve bevindingen suggereren dat mindfulness interventies ook 
nuttig kunnen zijn voor nabestaanden. Tot dusver hebben slechts een paar studies 
gekeken naar de effectiviteit van mindfulness interventies bij rouwverwerking. Een 
gecontroleerde pilot studie demonstreerde dat nabestaanden minder depressieve 
klachten rapporteerden vijf  maanden na de mindfulness training in vergelijking met 
de controlegroep. Toekomstige studies kunnen verder onderzoeken of  mindfulness 
interventies het welzijn van nabestaanden ten goede komt. Bovendien kunnen 
onderzoekers kijken wat het beste moment is om de training aan te bieden (bijvoorbeeld 
samen met de patiënt of  na het overlijden van de patiënt). 
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CONCLUSIE
In dit proefschrift hebben we aangetoond dat MBSR een waardevolle behandeling 
kan zijn voor mensen met longkanker, vooral voor degenen die psychische klachten 
ervaren. Het bleek echter moeilijk om patiënten te werven en te behouden voor de 
studie. Meer bewijs is nodig om sterke conclusies te trekken over de effectiviteit van 
MBSR bij longkanker. Bovendien is meer onderzoek nodig dat zich richt op het 
verbeteren van de betrokkenheid van patiënten die psychische klachten ervaren maar 
geen hulp willen. MBSR leek niet behulpzaam bij partners. Toekomstige studies 
kunnen bekijken hoe het programma het beste kan worden aangepast aan de behoeftes 
van partners. 
Ondanks de moeilijkheden die gepaard gaan met het uitvoeren van interventieonderzoek 
bij mensen met longkanker en hun partners, is het essentieel om dit werk te verrichten. 
Het is de enige manier om meer te weten te komen over hoe we mensen die worden 
geconfronteerd met deze ernstige ziekte het beste kunnen ondersteunen. 
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